<html lang="en"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <link rel="shortcut icon" href="./favicon.png">
    <link rel="preload" href="./static/media/SourceSansPro-Regular.DZLUzqI4.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-SemiBold.sKQIyTMz.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-Bold.-6c9oR8J.woff2" as="font" type="font/woff2" crossorigin="">

    <title>app</title>

    <!-- initialize window.prerenderReady to false and then set to true in React app when app is ready for indexing -->
    <script>
      window.prerenderReady = false
    </script>
    <script type="module" crossorigin="" src="./static/js/index.BlylrL8P.js"></script>
    <link rel="stylesheet" crossorigin="" href="./static/css/index.DpJG_94W.css">
  <style media=""></style><style data-emotion="st-emotion-cache-global" data-s=""></style><style data-emotion="st-emotion-cache" data-s=""></style><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.BqlD3NTA.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.DW_MHI2K.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FormClearHelper.UtDFKbpT.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FileHelper.DV2KuUj6.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/ProgressBar.BtMHwdZZ.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/Hooks.YZgOFmbn.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/UploadFileInfo.C-jY39rj.js"></head>
  <body>
    <noscript>You need to enable JavaScript to run this app.</noscript>
    <div id="root"><div class=""><div class="withScreencast" data-testid="stScreencast"><div class="stApp stAppEmbeddingId-t7v4wopi4ufx st-emotion-cache-1r4qj8v ee4bbma0" data-testid="stApp" data-test-script-state="notRunning" data-test-connection-state="CONNECTED"><header tabindex="-1" class="stAppHeader st-emotion-cache-12fmjuu e4hpqof0" data-testid="stHeader"><div class="stDecoration st-emotion-cache-1dp5vir e4hpqof1" data-testid="stDecoration" id="stDecoration"></div><div class="stAppToolbar st-emotion-cache-15ecox0 e4hpqof2" data-testid="stToolbar"><div class="stToolbarActions st-emotion-cache-1p1m4ay e1i26tt72" data-testid="stToolbarActions"></div><span id="MainMenu" class="stMainMenu st-emotion-cache-czk5ss ev04twb8" data-testid="stMainMenu" aria-haspopup="true" aria-expanded="false"><button kind="headerNoPadding" data-testid="stBaseButton-headerNoPadding" aria-label="" class="st-emotion-cache-l1ktzw em9zgd018"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M12 8c1.1 0 2-.9 2-2s-.9-2-2-2-2 .9-2 2 .9 2 2 2zm0 2c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2zm0 6c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2z"></path></svg></button></span></div></header><div class="stAppViewContainer appview-container st-emotion-cache-1yiq2ps eht7o1d0" data-testid="stAppViewContainer" data-layout="narrow"><section tabindex="0" class="stMain st-emotion-cache-bm2z3a eht7o1d1" data-testid="stMain"><div class="stMainBlockContainer block-container st-emotion-cache-mtjnbi eht7o1d4" data-testid="stMainBlockContainer"><div data-testid="stVerticalBlockBorderWrapper" data-test-scroll-behavior="normal" class="st-emotion-cache-0 eu6p4el5"><div class="st-emotion-cache-b95f0i eu6p4el4"><div class="stVerticalBlock st-emotion-cache-1n76uvr eu6p4el3" data-testid="stVerticalBlock" width="704"><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stHeading" data-testid="stHeading"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 id="olmocr">OLMOCR<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#olmocr" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="st-emotion-cache-8atqhb e1mlolmg0"><div class="stFileUploader st-emotion-cache-0 e17y52ym15" data-testid="stFileUploader" width="704"><label data-testid="stWidgetLabel" aria-hidden="true" class="st-emotion-cache-1s2v671 e1dx5vew0"><div data-testid="stMarkdownContainer" class="st-emotion-cache-wq5ihp e1icttdg0"><p>Upload a PDF or Image</p></div></label><section role="presentation" tabindex="0" data-testid="stFileUploaderDropzone" aria-label="Upload a PDF or Image" class="st-emotion-cache-1gulkj5 e17y52ym0"><input data-testid="stFileUploaderDropzoneInput" accept="application/streamlit,.pdf,.png,.jpg,.jpeg" type="file" style="border: 0px; clip: rect(0px, 0px, 0px, 0px); clip-path: inset(50%); height: 1px; margin: 0px -1px -1px 0px; overflow: hidden; padding: 0px; position: absolute; width: 1px; white-space: nowrap;" tabindex="-1"><div data-testid="stFileUploaderDropzoneInstructions" class="st-emotion-cache-u8hs99 e17y52ym1"><span class="st-emotion-cache-nwtri e17y52ym2"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-6rlrad ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19.35 10.04A7.49 7.49 0 0012 4C9.11 4 6.6 5.64 5.35 8.04A5.994 5.994 0 000 14c0 3.31 2.69 6 6 6h13c2.76 0 5-2.24 5-5 0-2.64-2.05-4.78-4.65-4.96zM19 18H6c-2.21 0-4-1.79-4-4 0-2.05 1.53-3.76 3.56-3.97l1.07-.11.5-.95A5.469 5.469 0 0112 6c2.62 0 4.88 1.86 5.39 4.43l.3 1.5 1.53.11A2.98 2.98 0 0122 15c0 1.65-1.35 3-3 3zM8 13h2.55v3h2.9v-3H16l-4-4z"></path></svg></span><div class="st-emotion-cache-j7qwjs e17y52ym4"><span class="st-emotion-cache-9ycgxx e17y52ym3">Drag and drop file here</span><small class="st-emotion-cache-1rpn56r ejh2rmr0">Limit 200MB per file • PDF, PNG, JPG, JPEG</small></div></div><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02">Browse files</button></section><div class="st-emotion-cache-fis6aj e17y52ym5"><ul class="st-emotion-cache-14m29r0 e17y52ym6"><li class="st-emotion-cache-1l95nvm e17y52ym7"><div class="stFileUploaderFile st-emotion-cache-12xsiil e17y52ym10" data-testid="stFileUploaderFile"><div class="st-emotion-cache-10ix4kq e17y52ym12"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-4mjat2 ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zM6 20V4h7v5h5v11H6z"></path></svg></div><div class="stFileUploaderFileData st-emotion-cache-1l4firl e17y52ym8"><div class="stFileUploaderFileName st-emotion-cache-1uixxvy e17y52ym9" data-testid="stFileUploaderFileName" title="Epidemiology Module Competence_ Key Concepts and Applications.pdf">Epidemiology Module Competence_ Key Concepts and Applications.pdf</div><small class="st-emotion-cache-1rpn56r ejh2rmr0">0.8MB</small></div><div data-testid="stFileUploaderDeleteBtn"><button kind="minimal" data-testid="stBaseButton-minimal" aria-label="" class="st-emotion-cache-8ccstr em9zgd06"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41z"></path></svg></button></div></div></li></ul></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stButton st-emotion-cache-8atqhb e1mlolmg0" data-testid="stButton"><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1hyd1ho e1icttdg0"><p>Submit</p></div></button></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p><strong>Processing file:</strong> Epidemiology Module Competence_ Key Concepts and Applications.pdf</p></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p>5</p>
<p>studocu</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="epidemiology-none">Epidemiology - none<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#epidemiology-none" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Epidemiology II (Kenya Medical Training College)</p>
<p><img src="assets/images/image-20251226-00e5e115.jpeg" alt="img-0.jpeg"></p>
<p>Scan to open on Studocu</p>
<p>Studocu is not sponsored or endorsed by any college or university</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="epidemiology">EPIDEMIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#epidemiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="module-competence">MODULE COMPETENCE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#module-competence" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This module is designed to enable the learner apply epidemiological:</p>
<ol>
<li>Approaches</li>
<li>Prevention, and</li>
<li>Control of health problems in the community</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="module-units">MODULE UNITS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#module-units" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Concepts and historical evolution of epidemiology,</li>
<li>Disease prevention,</li>
<li>Epidemiological and demographic measures,</li>
<li>Public health surveillance,</li>
<li>Investigation of disease out-breaks.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="e9a2cff6">MODULE LEARNING OUT – COMES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#e9a2cff6" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>At the end of this module, the learner should be able to:</p>
<ol>
<li>Discuss concepts historical evolution of Epidemiology,</li>
<li>Understand the concept of disease prevention,</li>
<li>Apply Epidemiological and Demographic measures,</li>
<li>Carry out Public Health Surveillance, and</li>
<li>Conduct disease outbreak investigation.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="module-content-subject-out-line">MODULE CONTENT/SUBJECT OUT-LINE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#module-content-subject-out-line" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Concept and Historical Evolution of Epidemiology:
i. Definition of terms used in Epidemiology.
ii. Principles of Epidemiology.
iii. Uses of Epidemiology in Public Health.
iv. Disease determinants [A determining or causal element or factor].
v. History and uses of Epidemiology,
vi. Core Epidemiological functions,
vii. Epidemiological approaches,
viii. Descriptive Epidemiology</li>
</ol>
<p>Prepared by O.E. Akoth
This document is available on
5 studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>ix. Analytic Epidemiology,
x. Concepts of disease occurrence,
xi. Natural History and spectrum of disease,
xii. Chain of infection,
xiii. Epidemic disease occurrence.</p>
<ol start="2">
<li>
<p>Disease Prevention:
i. Levels of disease prevention:
a) Primordial (Having existed from the beginning; in an earliest or original stage or state)
b) Primary, Secondary and Tertiary levels.
ii. Disease prevention strategies:
a) Technological,
b) Educational,
c) Legal/policy related,
d) Cultural, and
e) Political.</p>
</li>
<li>
<p>Epidemiological and Demographic Measures:
i. Concept of demography,
ii. Frequency measures:
a) Morbidity and mortality frequency measures,
b) Natality (birth) measures,
c) Measures of association,
d) Measures of Public Health Impact.</p>
</li>
<li>
<p>Public Health Surveillance:
i. Purpose,
ii. Characteristics, and
iii. Types of public Health Surveillance,
iv. Identifying health problems for surveillance,
v. Data collection,
vi. Analysis,
vii. Interpretation, and
viii. Disseminating for surveillance,
ix. Evaluating and
x. Improving surveillance,
xi. Characteristics of a good surveillance system.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="5">
<li>Investigation of disease out-breaks:
i. Introduction to investigating an out-break,
ii. Steps of an out-break investigation.</li>
</ol>
<p>INTRODUCTION /PREAMBLE</p>
<p>Epidemiology, literally meaning "the study of what is upon the people", is derived from Greek epi, meaning "upon, among", demos, meaning "people, district", and logos, meaning "study, suggesting that it applies only to human populations. However, the term is widely used in studies of zoological populations (veterinary epidemiology), "epizoology" has also been applied to studies of plant populations (botanical or plant disease epidemiology).</p>
<p>The distinction between "epidemic" and "endemic" was first drawn to distinguish between diseases that are "visited upon" a population (epidemic) from those that "reside within" a population (endemic).</p>
<p>The term "epidemiology" appears to have first been used to describe the study of epidemics. Epidemiologists also study the interaction of diseases in a population, a condition known as a syndemic.</p>
<p>The term epidemiology is now widely applied to cover the description and causation of not only epidemic diseases, but of diseases in general, and even many non-disease health-related conditions, such as high blood pressure and obesity. Therefore, epidemiology is based upon how the pattern of the disease cause changes in the function of everyone.</p>
<p>Epidemiology is defined as the study of distribution and determinants of health related states in populations and use of this study to address health related problems.</p>
<p>The practice: Epidemiologists employ a range of study designs namely:</p>
<ol>
<li>Observational</li>
<li>Experimental and generally categorized as:
a) Descriptive,
b) Analytic (aiming to further examine known associations or hypothesized relationships), and
c) Experimental (a term often equated with clinical or community trials of treatments and other interventions).</li>
</ol>
<p>In observational studies, nature is allowed to "take its course", as epidemiologists observe from the sidelines with no control of the factors.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>3</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Conversely, in experimental studies, the epidemiologist is the one in control of all of the factors entering a certain case study.</p>
<p>Epidemiological studies are aimed, where possible, at revealing unbiased relationships between exposures such as alcohol or smoking, biological agents, stress, or chemicals to mortality or morbidity.</p>
<p>The identification of causal relationships between these exposures and outcomes is an important aspect of epidemiology.</p>
<p>Modern epidemiologists use informatics (The sciences of gathering, manipulating, storing, retrieving, and classifying recorded information) as a tool.</p>
<p>Observational studies have two components:</p>
<ol>
<li>Descriptive observational study, or</li>
<li>Analytical observational study.</li>
</ol>
<p>Descriptive observations pertain to the “who, what, where and when of health-related state occurrence”.</p>
<p>Analytical observations deal more with the ‘how’ of a health-related event.</p>
<p>Experimental epidemiology contains three case types:</p>
<ol>
<li>Randomized control trial (often used for new medicine or drug testing),</li>
<li>Field trial (conducted on those at a high risk of contracting a disease), and</li>
<li>Community trial (research on social originating diseases).</li>
</ol>
<p>The term 'epidemiologic triad'(A set of three similar things considered as a unit) is used to describe the intersection (common ground) of:</p>
<ol>
<li>Host,</li>
<li>Agent, and</li>
<li>Environment in analyzing an outbreak.</li>
</ol>
<p><img src="assets/images/image-20251226-d86f7932.jpeg" alt="img-1.jpeg"></p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="legal-interpretation">Legal interpretation:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#legal-interpretation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Epidemiological studies can only go to prove that an agent could have caused, but not that it did caused, an effect in any particular case.</li>
<li>Epidemiology is concerned with the incidence of disease in populations and does not address the question of the cause of an individual's disease.</li>
<li>Epidemiology addresses whether an agent can cause a disease, not whether an agent did cause a specific plaintiff's (complainant) disease."</li>
</ol>
<p>Population-based health management: Epidemiological practice and the results of epidemiological analysis make a significant contribution to emerging population-based health management frameworks.</p>
<p>Population-based health management encompasses the ability to:</p>
<ol>
<li>Assess the health states and health needs of a target population;</li>
<li>Implement and evaluate interventions that are designed to improve the health of that population; and</li>
<li>Efficiently and effectively provide care for members of that population in a way that is consistent with the community's:
i. Cultural,
ii. Policy and
iii. Health resource values.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="population-based-health-management-framework-called-life-at-risk-combines">Population-based health management framework called Life at Risk combines:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#population-based-health-management-framework-called-life-at-risk-combines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Epidemiological quantitative analysis with demographics,</li>
<li>Health agency operational research and</li>
<li>Economics to perform:</li>
</ol>
<p>a) Population Life Impacts Simulations: Measurement of the future potential impact of disease upon the population with respect to:
i. new disease cases (incidence),
ii. prevalence,
iii. premature death as well as
iv. potential years of life lost from disability and death;</p>
<p>b) Labor Force Life Impacts Simulations: Measurement of the future potential impact of disease upon the labor force with respect to:
i. new disease cases,
ii. prevalence,
iii. premature death and
iv. potential years of life lost from disability and death;</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>c) Economic Impacts of Disease Simulations: Measurement of the future potential impact of disease upon:</p>
<p>i. Private sector disposable income impacts (wages, corporate profits, private health care costs) and
ii. Public sector disposable income impacts (personal income tax, corporate income tax, consumption taxes, publicly funded health care.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="concept-and-historical-evolution-of-epidemiology">CONCEPT AND HISTORICAL EVOLUTION OF EPIDEMIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#concept-and-historical-evolution-of-epidemiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="terms-in-epidemiology">TERMS IN EPIDEMIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#terms-in-epidemiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Epidemiology is the study of:</li>
</ol>
<p>a) The distribution,
b) Frequency and
c) Determinants of:</p>
<ul>
<li>Health related states or</li>
<li>Events or</li>
<li>Diseases in specified populations against the background of its total environment.</li>
</ul>
<p>Epidemiology can also be defined as the study (or the science of the study) of:</p>
<ol>
<li>The patterns,</li>
<li>Causes, and</li>
<li>Effects of health and</li>
<li>Disease conditions in defined populations.</li>
</ol>
<p>It is the cornerstone of public health used in identifying:</p>
<ol>
<li>Risk factors for disease and</li>
<li>Targets for preventive medicine.</li>
</ol>
<p>Epidemiologists help with:</p>
<ol>
<li>Study design,</li>
<li>Collection and</li>
<li>Statistical analysis of data, and</li>
<li>Interpretation and</li>
<li>Dissemination of results (including peer review (Evaluate professionally a colleague's work) and occasional systematic review.</li>
</ol>
<p>Epidemiology has helped develop methodology used in:</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>Clinical research,</li>
<li>Public health studies and,</li>
<li>To a lesser extent, basic research in the biological sciences.</li>
</ol>
<p>Major areas of epidemiological study include disease:</p>
<ol>
<li>Etiology,</li>
<li>Outbreak investigation,</li>
<li>Surveillance and screening,</li>
<li>Bio-monitoring, and</li>
<li>Comparisons of treatment effects such as in clinical trials.</li>
</ol>
<p>Epidemiologists rely on other scientific disciplines like biology to better understand:</p>
<ol>
<li>Disease processes,</li>
<li>Statistics to make efficient use of the data and draw appropriate conclusions,</li>
<li>Social sciences to better understand, proximate and distal (Situated farthest from point of attachment or origin, as of a limb or bone) causes, and engineering for exposure assessment.</li>
</ol>
<p>Key terms in this definition reflect some of the important principles of epidemiology:</p>
<p>i. Study:</p>
<p>a) Epidemiology is a scientific discipline with sound methods of scientific inquiry at its foundation.
b) Epidemiology is data driven and relies on a systematic and unbiased approach to:
i. Collection,
ii. Analysis, and
iii. Interpretation
of data</p>
<p>Basic epidemiologic methods tend to rely on careful observation of valid comparison groups to assess whether what was observed, such as the number of cases of disease in a particular area during a particular time period or the frequency of an exposure among persons with disease, differs from what might be expected.</p>
<p>Epidemiology also draws on methods from other scientific fields, including:</p>
<ol>
<li>Biostatistics and</li>
<li>Informatics,</li>
<li>Biologic,</li>
<li>Economic, and</li>
<li>Social and</li>
<li>Behavioral sciences.</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>In fact, epidemiology is often described as the basic science of public health, and for good reason.</p>
<p>First, epidemiology is a quantitative discipline that relies on a working knowledge of:</p>
<ol>
<li>Probability,</li>
<li>statistics and</li>
<li>Sound research methods.</li>
</ol>
<p>Second, epidemiology is a method of causal reasoning based on developing and testing hypotheses grounded in such scientific fields such as:</p>
<ol>
<li>Biology,</li>
<li>Behavioral sciences,</li>
<li>Physics and</li>
<li>Ergonomics to explain health related:
i. Behaviors
ii. states, and
iii. Events.</li>
</ol>
<p>However, epidemiology is an integral component of public health, providing the foundation for directing practical appropriate publication based on science and causal reasoning.</p>
<p>ii. Distribution: Epidemiology is concerned with the frequency and pattern of health events in a population.</p>
<p>iii. Frequency: refers not only to the number of health events such as the number of cases of meningitis or diabetes in a population but also to the relationship of that number to the size of the population. The resulting rate allows epidemiologists to compare disease occurrence across different populations.</p>
<p>The occurrence of disease is examined in terms of relationship or pattern between man and his total environment. These include:</p>
<ol>
<li>Place,</li>
<li>Time and</li>
<li>Person.</li>
</ol>
<p>Place pattern: include:</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>a) Geographic variations
b) Climatic zone,
c) Country,
d) Region,
e) Province,
f) District,
g) Location,
h) City wards,
i) Urban and rural areas differences and
j) Institutions and locations of work sites.</p>
<p><strong>Time pattern:</strong> may be:
a) Annual,
b) Seasonal variations,
c) Weekly,
d) Daily,
e) Hourly,
f) Weekday versus weekends,
g) Secular trends,
h) Periodic changes,
i) Any other breakdown of time that may influence disease or injury occurrence.</p>
<p><strong>Personal pattern (person pattern):</strong> This includes:
a) Demographic factors which may be related to risk of:
i. illness,
ii. injury, or
iii. disability such as:</p>
<p>Prepared by O.E. Akoth
This document is available on
8
studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>a) age,
b) sex,
c) marital status, and</p>
<p>Socio-economic status, as well as behaviors and environmental exposures such as:</p>
<p>i. Education,
ii. Occupation,
iii. Social status,
iv. Nutrition,
v. Trauma, and
vi. Fatigue.</p>
<p>N/B Characterizing events by time, place, and person, are activities of descriptive epidemiology.</p>
<ol start="2">
<li>Determinant: This is any factor, whether</li>
</ol>
<p>i. Event,
ii. Characteristics or
iii. Other definable entity, that brings about a change in a health condition or other defined characteristic.</p>
<p>Epidemiology is also used to search for determinants which are the causes and other factors that influence the occurrence of disease and other health- events.</p>
<ol start="4">
<li>Population: The complete collection of individuals that have some particular characteristic(s) in common.</li>
<li>Population Risk: A defined population and comprises the number of individuals in that original population that is considered capable of acquiring the particular disease or disease characteristic.</li>
<li>Infection: The invasion of a living organism, the host, by another ling organism – the agent.</li>
<li>Infectivity: a measure of the ability of a disease agent to establish itself in the host. The term can be used qualitatively, when an agent is referred to as being low, medium or high infectivity or quantitatively. Attempts to quantify infectivity normally involve use of a statistic known as ID. This refers to the individual dose or numbers of the agent required to infect 50% of a specified population of susceptible s under controlled environmental</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>condition. Having become infected, the host may or may not become diseased, and this is again determined by a range of intrinsic determinants affecting the agent and the host. Two terms – virulence and pathogen city- are often used to describe the ability of the agent to cause disease.</p>
<ol start="8">
<li>
<p>Virulence: a measure of the severity of a disease caused by a specified agent. Virulence is a laboratory term and is used to measure the varying ability of disease agents to produce disease under controlled conditions. It is often quantified by a statistic known as <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mrow><mi mathvariant="normal">L</mi><mi mathvariant="normal">D</mi></mrow><mn>50</mn></msub></mrow><annotation encoding="application/x-tex">\mathrm{LD}_{50}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord"><span class="mord mathrm">LD</span></span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">50</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span> which refers to the individual dose or numbers of the agent which will kill <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>50</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">50\%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">50%</span></span></span></span></span> of specified population of susceptible under controlled environmental conditions.</p>
</li>
<li>
<p>Disease: a derangement (A state of mental disturbance and disorientation) in the function of the whole body of the host or any of its parts. It also can be defined as a derangement in the function of the whole body of the host or any of its parts, or it can be defined as abnormal medical condition of an organism that impairs bodily functions associated with specific symptoms and signs. It may be external factors such as infectious disease, or it may be caused by internal dysfunction such as auto-immune disease (Of or relating to the immune response of the body against substance normally present in the body.</p>
</li>
<li>
<p>Physiology: The branch of the biological sciences dealing with the functioning of organisms or Processes and functions of an organism.</p>
</li>
<li>
<p>Determinant: Any factor or variable that can affect the frequency with which a disease occurs in a population.</p>
</li>
</ol>
<p>Determinants can be broadly classified as being either intrinsic or extrinsic in nature.</p>
<p>a) Intrinsic Determinants of Disease: are physical or physiological characteristics of the host or disease agent [or intermediate host or vector, if present] which are generally determined genetically.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>11</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Disease agents as determinants of disease: Agents associated with disease can be categorized into two brad groups:</p>
<p>i. "Living" agents, such as:
a) Viruses,
b) Bacteria,
c) Rickettsia,
d) Protozoa,
e) Helminthes,
f) Protozoa etc.</p>
<p>ii. "Non-living" agents, such as:
a) Heat and
b) Cold,
c) Water,
d) Nutrients,
e) Toxic substances etc.</p>
<p>In instances of infectious diseases, the presence of the etiological agent is the main determining factor in the epidemiology of the disease. Obviously, disease cannot occur in the absence of the agent, but, conversely, disease need not always result from the presence of the agent. This leads to the important epidemiological distinction between infection and disease.</p>
<p>b) Extrinsic Determinants: are normally associated with some form of environmental influence on the host or disease agent [or intermediate host or vector, if present].</p>
<ol start="12">
<li>Health Related States or Events: is defined as states or events that affect the well-being of a population.</li>
</ol>
<p>Epidemiology was originally focused exclusively on epidemics of communicable diseases but was subsequently expanded to address endemic communicable diseases and non-communicable infectious diseases.</p>
<p>By the middle of 20th century, additional epidemiologic methods had been developed and applied in:</p>
<ol>
<li>Chronic diseases,</li>
<li>Injuries,</li>
<li>Birth defects,</li>
<li>Mental-child health,</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="5">
<li>Occupational health, and</li>
<li>Environmental health.</li>
</ol>
<p>Then epidemiologists began looking at behavior related to health and well-being such as:</p>
<ol>
<li>
<p>Amount of exercise, and</p>
</li>
<li>
<p>Use of seat-belt.</p>
</li>
<li>
<p>Specified Populations: Although epidemiologists and direct health-care providers are both concerned with occurrence and control of disease, they differ greatly in how they view patients. The clinician is concerned about the health of an individual; the epidemiologist is concerned about the collective health of the community or population. In other words, the clinician’s patient is an individual; the epidemiologist’s patient is the community. Therefore, the clinician and the epidemiologist have different responsibilities when faced with a person with illness. For example, when patients with diarrheal disease present, both are interested in establishing the correct diagnosis. However, while clinician usually focuses on treating and caring for the individual, the epidemiologist focuses on identifying the exposure or source that caused the illness; the number of persons who may have similarly exposed; the potential for further spread in community; and interventions to prevent additional cases or recurrences.</p>
</li>
</ol>
<p>Application: Epidemiology is not “just the study” of health in a population; it also involves applying the knowledge gained by the studies to community-based practice. Like the practice of medicine, the practice of epidemiology is both science and art. To make the proper diagnosis and prescribe appropriate treatment for a patient, the clinician combines medical (scientific) knowledge with experience, clinical judgment, and understanding of the patient. Similarly, the epidemiologist uses the scientific methods of descriptive and analytic epidemiology as well as experience, epidemiologic judgment, and understanding of local conditions in “diagnosing” the health of a community and proposing appropriate, practical, and acceptable public health interventions to control and prevent disease in the community.</p>
<ol start="14">
<li>Health: is the level of functional or metabolic efficiency of a living organism. In humans, it is the general condition of a person's mind and body, usually meaning to be free from illness, injury or pain (as in "good health" or "healthy").</li>
</ol>
<p>The World Health Organization (WHO) defined health in its broader sense in 1946 as "a state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity</p>
<p>In addition to health care interventions and a person's surroundings, a number of other factors are known to influence the health status of individuals, including their:</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>Background,</li>
<li>Lifestyle, and</li>
<li>Economic and</li>
<li>Social conditions.</li>
</ol>
<p>These are referred to as "determinants of health."</p>
<p>Studies have shown that high levels of stress can affect your health.</p>
<p><strong>Mental health</strong>: The World Health Organization describes mental health as "a state of well-being in which the individual realizes:</p>
<ol>
<li>His or her own abilities,</li>
<li>Can cope with the normal stresses of life,</li>
<li>Can work productively and fruitfully, and</li>
<li>Is able to make a contribution to his or her community.</li>
</ol>
<p>Mental Health is not just the absence of mental illness.</p>
<p><strong>Mental illness</strong> is described as the spectrum of:</p>
<ol>
<li>Cognitive,</li>
<li>emotional, and</li>
<li>Behavioral conditions that interfere with social and emotional wellbeing and the lives and productivity of people.</li>
</ol>
<p><strong>Public health</strong>: Public health has been described as "the science and art of:</p>
<ol>
<li>Preventing disease,</li>
<li>prolonging life and</li>
<li>Promoting health through the organized efforts and informed choices of:
i. Society,
ii. Organizations,
iii. Public and
iv. Private,
v. Communities and individuals."</li>
</ol>
<p>It is concerned with threats to the overall health of a community based on population health analysis. The population in question can be as small as a handful of people or as large as all the inhabitants of several continents (for instance, in the case of a pandemic).</p>
<p>Public health has many sub-fields, but typically includes the interdisciplinary categories of:</p>
<ol>
<li>Epidemiology,</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="2">
<li>Biostatistics and</li>
<li>Health services.</li>
<li>Environmental health,</li>
<li>community health,</li>
<li>behavioral health, and</li>
<li>Occupational health is also important areas of public health.</li>
</ol>
<p>The focus of public health interventions is to:</p>
<ol>
<li>Prevent and</li>
<li>Manage diseases,</li>
<li>Injuries and</li>
<li>Other health conditions through surveillance of cases and the promotion of healthy behavior,</li>
<li>Communities, and</li>
<li>(in aspects relevant to human health) environments.</li>
</ol>
<p>Its aim is to prevent health problems from happening or re-occurring by implementing:</p>
<ol>
<li>Educational programs,</li>
<li>Developing policies,</li>
<li>Administering services, and</li>
<li>Conducting research.</li>
</ol>
<p>In many cases, treating a disease or controlling a pathogen can be vital to preventing it in others, such as during an outbreak. Vaccination programs and distribution of condoms to prevent the spread of communicable diseases are examples of common preventive public health measures, as are educational campaigns to promote vaccination and the use of condoms (including overcoming resistance to such).</p>
<p>Public health also takes various actions to limit the health disparities between different areas of the country and, in some cases, the continent or world. One issue is the access of individuals and communities to:</p>
<ol>
<li>health care in terms of financial,</li>
<li>Geographical or socio-cultural constraints to accessing and using services. Applications of the public health system include the areas of:
i. Maternal and child health,
ii. Health services administration,
iii. Emergency response, and
iv. Prevention and control of infectious and chronic diseases.</li>
</ol>
<p>The great positive impact of public health programs is widely acknowledged. Due in part to the policies and actions developed through public health, the 20th century registered a decrease in</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>15</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>the mortality rates for infants and children and a continual increase in life expectancy in most parts of the world.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="self-care-strategies-personal-health-depends-partially-on-the">Self-care strategies: Personal health depends partially on the:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#self-care-strategies-personal-health-depends-partially-on-the" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Active,</li>
<li>Passive, and</li>
<li>Assisted cues people observe and adopt about their own health.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="these-include">These include:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#these-include" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Personal actions for preventing or minimizing the effects of a disease, usually a chronic condition, through integrative care.</li>
<li>They also include personal hygiene practices to prevent infection and illness, such as:</li>
</ol>
<ul>
<li>v. Bathing and washing hands with soap;</li>
<li>vi. Brushing and flossing teeth;</li>
<li>vii. Storing,</li>
<li>viii. Preparing and handling food safely; and many others.</li>
</ul>
<p>The information gleaned from personal observations of daily living – such as</p>
<ol>
<li>about sleep patterns,</li>
<li>exercise behavior,</li>
<li>nutritional intake, and</li>
<li>environmental features – may be used to inform personal decisions and actions (e.g., "I feel tired in the morning so I am going to try sleeping on a different pillow"), as well as clinical decisions and treatment plans (e.g., a patient who notices his or her shoes are tighter than usual may be having exacerbation of left-sided heart failure, and may require diuretic medication to reduce fluid overload).</li>
</ol>
<p>Personal health also depends partially on the social structure of a person's life.</p>
<p>The maintenance of strong social relationships, volunteering, and other social activities have been linked to positive mental health and even increased longevity.</p>
<p>One American study among seniors over age 70, found that frequent volunteering was associated with reduced risk of dying compared with older persons who did not volunteer, regardless of physical health status.</p>
<p>Another study from Singapore reported that volunteering retirees had significantly better cognitive performance scores, fewer depressive symptoms, and better mental well-being and life satisfaction than non-volunteering retirees.</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Prolonged psychological stress may negatively impact health, and has been cited as a factor in cognitive impairment with:</p>
<ol>
<li>Aging,</li>
<li>Depressive illness, and</li>
<li>Expression of disease.</li>
</ol>
<p>Stress management is the application of methods to either reduce stress or increase tolerance to stress.</p>
<p>Relaxation techniques are physical methods used to relieve stress.</p>
<p>Psychological methods include:</p>
<ol>
<li>Cognitive therapy,</li>
<li>Meditation, and</li>
<li>Positive thinking, which work by reducing response to stress.</li>
</ol>
<p>Improving relevant skills, such as problem solving and time management skills, reduces uncertainty and builds confidence, which also reduces the reaction to stress-causing situations where those skills are applicable.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="environment-may-refer-to">Environment may refer to:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#environment-may-refer-to" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Environment (biophysical), the physical and biological factors along with their chemical interactions that affect an organism</li>
<li>Environment (systems), the surroundings of a physical system that may interact with the system by exchanging mass, energy, or other properties</li>
<li>Environments (series), a series of LPs, cassettes and CDs depicting natural sounds</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="it-may-also-refer-to">It may also refer to:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#it-may-also-refer-to" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Built environment, constructed surroundings that provide the setting for human activity, ranging from the large-scale civic surroundings to the personal places</li>
<li>Knowledge environment, social practices, technological and physical arrangements intended to facilitate collaborative knowledge building, decision making, inference or discovery</li>
<li>Natural environment, all living and non-living things</li>
<li>Social environment, the culture that an individual lives in, and the people and institutions with whom they interact</li>
<li>Physical environment, in ecology</li>
</ol>
<p>Environmental health is that branch of public health that is concerned with all aspects of the natural and built environment that may affect human health. Other phrases that concern or refer to the discipline of environmental health include environmental public health, and</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>environmental protection. The field of environmental health is closely related to environmental science and public health as environmental health is concerned with environmental factors affecting human health.</p>
<p>"Environmental health addresses all the:</p>
<ol>
<li>physical,</li>
<li>chemical, and</li>
<li>Biological factors external to a person and all the related factors impacting behaviours.</li>
</ol>
<p>It encompasses the assessment and control of those environmental factors that can potentially affect health. It is targeted towards preventing disease and creating health-supportive environments.</p>
<p>This definition excludes behaviour not related to environment, as well as behaviour related to the social and cultural environment, as well as genetics."</p>
<p>Environmental health is defined by the World Health Organization as those aspects of the human health and disease that are determined by factors in the environment. It also refers to the theory and practice of assessing and controlling factors in the environment that can potentially affect health.</p>
<p>Environmental health services are defined by the World Health Organization as:</p>
<p>vi. Those services which implement environmental health policies through monitoring and control activities. They also carry out that role by promoting the improvement of environmental parameters and by encouraging the use of environmentally friendly and healthy technologies and behaviors. They also have a leading role in developing and suggesting new policy areas.</p>
<p>vii. Environmental medicine may be seen as the medical branch of the broader field of environmental health. Terminology is not fully established, and in many European countries they are used interchangeably.</p>
<p>Environmental health profession: Environmental health professionals may be known as</p>
<ol>
<li>Environmental health officers,</li>
<li>Environmental protection officers,</li>
<li>Public health inspectors,</li>
<li>Environmental health specialists,</li>
<li>Environmental health practitioners,</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="6">
<li>Sanitarians, environmental inspectors, or</li>
<li>Environmental specialists.</li>
</ol>
<p>"Scope of practice in environmental health" means the practice of environmental health by registered environmental health specialists in the public and private sector and includes, but is not limited to:</p>
<ol>
<li>organization,</li>
<li>management,</li>
<li>education,</li>
<li>enforcement,</li>
<li>consultation, and</li>
<li>emergency response for the purpose of prevention of environmental health hazards and the promotion and protection of the public health and the environment in the following areas:</li>
</ol>
<p>i. food protection;
ii. housing;
iii. institutional environmental health;
iv. land use;
v. community noise control;
vi. recreational swimming areas and waters;
vii. electromagnetic radiation control;
viii. solid,
ix. liquid, and
x. hazardous materials management;
xi. underground storage tank control; onsite septic systems; vector control;
xii. drinking water quality;
xiii. water sanitation;
xiv. emergency preparedness; and
xv. milk and dairy</p>
<p>The environmental health profession had its modern-day roots in the sanitary and public health movement of the United Kingdom. This was epitomized by Sir Edwin Chadwick, who was instrumental in the repeal of the poor laws and was the founding president of the Association of Public Sanitary Inspectors in 1884, which today is the Chartered Institute of Environmental Health.</p>
<p>Disciplines: Three basic disciplines generally contribute to the field of environmental health:</p>
<ol>
<li>Environmental epidemiology,</li>
<li>Toxicology, and</li>
<li>Exposure science.</li>
</ol>
<p>Each of these disciplines contributes different information to describe problems in environmental health, but there is some overlap among them.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>19</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Environmental epidemiology studies the relationship between environmental exposures (including exposure to chemicals, radiation, microbiological agents, etc.) and human health. Observational studies, which simply observe exposures that people have already experienced, are common in environmental epidemiology because humans cannot ethically be exposed to agents that are known or suspected to cause disease.</p>
<p>While the inability to use experimental study designs is a limitation of environmental epidemiology, this discipline directly observes effects on human health</p>
<p>Toxicology studies show how environmental exposures lead to specific health outcomes, generally in animals, as a means to understand possible health outcomes in humans.</p>
<p>Toxicology has the advantage of being able to conduct randomized controlled trials and other experimental studies because they can use animal subjects. However there are many differences in animal and human biology, and there can be a lot of uncertainty when interpreting the results of animal studies for their implications for human health.</p>
<p>Exposure science studies human exposure to environmental contaminants by both identifying and quantifying exposures.</p>
<p>Exposure science can be used to:</p>
<ol>
<li>Support environmental epidemiology by better describing environmental exposures that may lead to a particular health outcome,</li>
<li>Identify common exposures whose health outcomes may be better understood Through a toxicology study, or</li>
<li>Can be used in a risk assessment to determine whether current levels of exposure might exceed recommended levels.</li>
</ol>
<p>Exposure science has the advantage of being able to very accurately quantify exposures to specific chemicals, but it does not generate any information about health outcomes like environmental epidemiology or toxicology.</p>
<p>Information from these three disciplines can be combined to conduct a risk assessment for specific chemicals or mixtures of chemicals to determine whether an exposure poses significant risk to human health. This can in turn be used to develop and implement environmental health policy that, for example, regulates chemical emissions, or imposes standards for proper sanitation.</p>
<p>Concerns: Environmental health addresses all human-health-related aspects of both the natural environment and the built environment.</p>
<p>Environmental health concerns include:</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>Air quality, including both ambient outdoor air and indoor air quality, which also comprises concerns about environmental tobacco smoke.</li>
<li>Body art safety, including tattooing, body piercing and permanent cosmetics.</li>
<li>Climate change and its effects on health.</li>
<li>Disaster preparedness and response.</li>
<li>Food safety, including in agriculture, transportation, food processing, wholesale and retail distribution and sale.</li>
<li>Hazardous materials management, including hazardous waste management, contaminated site remediation, the prevention of leaks from underground storage tanks and the prevention of hazardous materials releases to the environment and responses to emergency situations resulting from such releases.</li>
<li>Housing, including substandard housing abatement and the inspection of jails and prisons.</li>
<li>Childhood lead poisoning prevention.</li>
<li>Land use planning, including smart growth.</li>
<li>Liquid waste disposal, including city waste water treatment plants and on-site waste water disposal systems, such as septic tank systems and chemical toilets.</li>
<li>Medical waste management and disposal.</li>
<li>Noise pollution control.</li>
<li>Occupational health and industrial hygiene.</li>
<li>Radiological health, including exposure to ionizing radiation from X-rays or radioactive isotopes.</li>
<li>Recreational water illness prevention, including from swimming pools, spas and ocean and freshwater bathing places.</li>
<li>Safe drinking water.</li>
<li>Solid waste management, including landfills, recycling facilities, composting and solid waste transfer stations.</li>
<li>Toxic chemical exposure whether in consumer products, housing, workplaces, air, water or soil.</li>
<li>Vector control, including the control of mosquitoes, rodents, flies, cockroaches and other animals that may transmit pathogens.</li>
</ol>
<p>Prevalence: In epidemiology, the prevalence or prevalence proportion is the proportion of a population found to have a condition (typically a disease or a risk factor such as smoking or seatbelt use).</p>
<p>It is arrived at by comparing the number of people found to have the condition with the total number of people studied, and is usually expressed as a fraction, as a percentage or as the number of cases per 10,000 or 100,000 people.</p>
<p>"Point prevalence" is the proportion of a population that has the condition at a specific point in time.</p>
<p>Prepared by O.E. Akoth
This document is available on
8
studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>"Period prevalence" is the proportion of a population that has the condition at some time during a given period ("12-month prevalence", etc.), and includes people who already have the condition at the start of the study period as well as those who acquire it during that period.</p>
<p>"Lifetime prevalence" (LTP) is the proportion of a population that at some point in their life (up to the time of assessment) have experienced the condition.</p>
<p>Prevalence estimates are used by epidemiologists, health care providers, government agencies, and insurers.</p>
<p>Prevalence is contrasted with incidence, which is a measure of new cases arising in a population over a given period (month, year, etc.). For memory purposes, the difference between prevalence and incidence can be summarized thus:</p>
<p>That prevalence answers "How many people have this disease right now?" and</p>
<p>That incidence answers "How many people per year newly acquire this disease?"</p>
<p>In science, prevalence describes a proportion (typically expressed as a percentage). For example, the prevalence of obesity among American adults in 2001 was estimated by the U. S. Centers for Disease Control (CDC) at approximately 20.9%.</p>
<p>Prevalence is a term which means being widespread and it is distinct from incidence. Prevalence is a measurement of all individuals affected by the disease at a particular time, whereas incidence is a measurement of the number of new individuals who contract a disease during a particular period of time.</p>
<p>To illustrate, a long term disease that was spread widely in a community in 2002 will have a high prevalence at a given point of 2003 (assuming it has a long duration) but it might have a low incidence rate during 2003 (i.e. lots of existing cases, but not many new ones in that year). Conversely, a disease that is easily transmitted but has a short duration might spread widely during 2002 but is likely to have a low prevalence at any given point in 2003 (due to its short duration) but a high incidence during 2002 (as many people develop the disease). As such, prevalence is a useful parameter when talking about long lasting diseases, such as HIV, but incidence is more useful when talking about diseases of short duration, such as chickenpox.</p>
<p>Uses: include the following:</p>
<ol>
<li>Lifetime prevalence: Lifetime prevalence (LTP) is the number of individuals in a statistical population that at some point in their life (up to the time of assessment) have experienced a "case" (e.g., a disorder), compared to the total number of individuals (i.e. it is expressed as a ratio or percentage). Often, 12-month prevalence (or some other type of "period prevalence") is used in conjunction with lifetime prevalence.</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="2">
<li>
<p>There is also point prevalence, the prevalence of disorder at a more specific (a month or less) point in time. There is also a related figure lifetime morbid risk - the theoretical prevalence at any point in life for anyone, regardless of time of assessment.</p>
</li>
<li>
<p>Period prevalence: In epidemiology, Period prevalence is the proportion of the population with a given disease or condition over a specific period of time. It could describe how many people in a population had a cold over the cold season in 2006, for example. It is expressed as a percentage of the population and can be described by the following formula:</p>
</li>
</ol>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mtext>Period&nbsp;prevalence&nbsp;(ratio)</mtext><mo>=</mo><mfrac><mrow><mtext>Number&nbsp;of&nbsp;cases&nbsp;that&nbsp;occurred&nbsp;in&nbsp;a&nbsp;given&nbsp;period</mtext><mo>×</mo><mn>10</mn><mo separator="true">,</mo><mn>000</mn></mrow><mtext>Number&nbsp;of&nbsp;people&nbsp;in&nbsp;the&nbsp;population&nbsp;during&nbsp;this&nbsp;Period</mtext></mfrac></mrow><annotation encoding="application/x-tex">\text{Period prevalence (ratio)} = \frac{\text{Number of cases that occurred in a given period} \times 10,000}{\text{Number of people in the population during this Period}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord text"><span class="mord">Period&nbsp;prevalence&nbsp;(ratio)</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 2.2519em; vertical-align: -0.8804em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.3714em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord text"><span class="mord">Number&nbsp;of&nbsp;people&nbsp;in&nbsp;the&nbsp;population&nbsp;during&nbsp;this&nbsp;Period</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord text"><span class="mord">Number&nbsp;of&nbsp;cases&nbsp;that&nbsp;occurred&nbsp;in&nbsp;a&nbsp;given&nbsp;period</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mord">10</span><span class="mpunct">,</span><span class="mspace" style="margin-right: 0.1667em;"></span><span class="mord">000</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.8804em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></div>
<p>The relationship between incidence (rate), point prevalence (ratio) and period prevalence (ratio) is easily explicated via an analogy with photography. Point prevalence is akin to a flash lit photograph: what is happening at this instant frozen in time. Period prevalence is analogous to a long exposure (seconds, rather than an instant) photograph: the number of events recorded in the photo whilst the camera shutter was open. In a movie each frame records an instant (point prevalence); by looking from frame to frame one notice new events (incident events) and can relate the number of such events to a period (number of frames).</p>
<ol start="4">
<li>
<p>Point prevalence: In epidemiology, point prevalence is a measure of the proportion of people in a population who have a disease or condition at a particular time, such as a particular date. It is like a snap shot of the disease in time. It can be used for statistics on the occurrence of chronic diseases. This is in contrast to period prevalence which is a measure of the proportion of people in a population who have a disease or condition over a specific period of time, say a season, or a year. Point prevalence can be described by the formula: Prevalence = Number of existing cases on a specific date ÷ Number of people in the population on this date</p>
</li>
<li>
<p>Limitations: It can be said that a very small error applied over a very large number of individuals (that is, those who are not affected by the condition in the general population during their lifetime; for example, over 95%) produces a relevant, non-negligible number of subjects who are incorrectly classified as having the condition or any other condition which is the object of a survey study: these subjects are the so-called false positives; such reasoning applies to the 'false positive' but not the 'false negative' problem where we have an error applied over a relatively very small number of individuals to begin with (that is, those who are</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>affected by the condition in the general population; for example, less than 5%). Hence, a very high percentage of subjects who seem to have a history of a disorder at interview are false positives for such a medical condition and apparently never suffered a fully clinical syndrome.</p>
<p><strong>Incidence</strong>: Incidence is the number of:</p>
<ol start="4">
<li>New cases or a condition,</li>
<li>Symptom,</li>
<li>Death, or</li>
<li>Injury that develop during a specific time period, such as a year.</li>
</ol>
<p>The number is often expressed as a percentage of a population. For example, 25% of Americans were diagnosed with the flu in 2002.</p>
<p>Incidence shows the likelihood that a person in that population will be affected by the condition.</p>
<ol start="8">
<li>
<p><strong>Incidence</strong> is a measure of the <strong>risk</strong> of developing some new condition within a specified period of time. Although sometimes loosely expressed simply as the number of new cases during some time period, it is better expressed as a proportion or a rate with a denominator.</p>
</li>
<li>
<p><strong>Incidence proportion</strong> (also known as cumulative incidence)</p>
</li>
</ol>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mfrac><mrow><mtext>The&nbsp;number&nbsp;of&nbsp;new&nbsp;cases&nbsp;within&nbsp;a&nbsp;specified&nbsp;time&nbsp;period</mtext><mo>×</mo><mn>1000</mn></mrow><mtext>The&nbsp;size&nbsp;of&nbsp;the&nbsp;population&nbsp;initially&nbsp;at&nbsp;risk.</mtext></mfrac></mrow><annotation encoding="application/x-tex">\frac{\text{The number of new cases within a specified time period} \times 1000}{\text{The size of the population initially at risk.}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 2.2519em; vertical-align: -0.8804em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.3714em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord text"><span class="mord">The&nbsp;size&nbsp;of&nbsp;the&nbsp;population&nbsp;initially&nbsp;at&nbsp;risk.</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord text"><span class="mord">The&nbsp;number&nbsp;of&nbsp;new&nbsp;cases&nbsp;within&nbsp;a&nbsp;specified&nbsp;time&nbsp;period</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mord">1000</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.8804em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></div>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mn>28</mn><mo>×</mo><mn>100</mn><mo>=</mo><mn>2.8</mn><mi mathvariant="normal">%</mi></mrow><annotation encoding="application/x-tex">28 \times 100 = 2.8\%</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7278em; vertical-align: -0.0833em;"></span><span class="mord">28</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">100</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.8056em; vertical-align: -0.0556em;"></span><span class="mord">2.8%</span></span></span></span></span></div>
<p>1000</p>
<p>For example, if a population initially contains 1,000 non-diseased persons and 28 develop a condition over two years of observation, the incidence proportion is 28 cases per 1,000 persons, i.e. 2.8%.</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="10">
<li>Incidence rate: The incidence rate is the number of new cases per population at risk in a given time period.</li>
</ol>
<p>When the denominator is the sum of the person-time of the at risk population, it is also known as the incidence density rate or person-time incidence rate.</p>
<p>In the same example as above, the incidence rate is 14 cases per 1000 person-years, because the incidence proportion (28 per 1,000) is divided by the number of years (two). Using person-time rather than just time handles situations where the amount of observation time differs between people, or when the population at risk varies with time. Use of this measure implicitly implies the assumption that the incidence rate is constant over different periods of time, such that for an incidence rate of 14 per 1000 persons-years, 14 cases would be expected for 1000 persons observed for 1 year or 50 persons observed for 20 years.</p>
<ol start="11">
<li>Incidence vs. prevalence: Incidence should not be confused with prevalence, which is the proportion of cases in the population at a given time rather than rate of occurrence of new cases. Thus, incidence conveys information about the risk of contracting the disease, whereas prevalence indicates how widespread the disease is. Prevalence is the proportion of the total number of cases to the total population and is more a measure of the burden of the disease on society with no regard to time at risk or when subjects may have been exposed to a possible risk factor. Prevalence can also be measured with respect to a specific subgroup of a population (see: denominator data). Incidence is usually more useful than prevalence in understanding the disease etiology: for example, if the incidence rate population of a disease increases, then there is a risk factor that promotes the incidence.</li>
</ol>
<p>For example, consider a disease that takes a long time to cure and was widespread in 2002 but dissipated in 2003. This disease will have both high incidence and high prevalence in 2002, but in 2003 it will have a low incidence yet will continue to have a high prevalence (because it takes a long time to cure, so the fraction of affected individuals remains high). In contrast, a disease that has a short duration may have a low prevalence and a high incidence. When the incidence is approximately constant for the duration of the disease, prevalence is approximately the product of disease incidence and average disease duration, so <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>p</mi><mi>r</mi><mi>e</mi><mi>v</mi><mi>a</mi><mi>l</mi><mi>e</mi><mi>n</mi><mi>c</mi><mi>e</mi><mo>=</mo><mi>i</mi><mi>n</mi><mi>c</mi><mi>i</mi><mi>d</mi><mi>e</mi><mi>n</mi><mi>c</mi><mi>e</mi><mo>×</mo><mi>d</mi><mi>u</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><mi>n</mi></mrow><annotation encoding="application/x-tex">prevalence = incidence \times duration</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mord mathnormal">p</span><span class="mord mathnormal">re</span><span class="mord mathnormal" style="margin-right: 0.03588em;">v</span><span class="mord mathnormal">a</span><span class="mord mathnormal" style="margin-right: 0.01968em;">l</span><span class="mord mathnormal">e</span><span class="mord mathnormal">n</span><span class="mord mathnormal">ce</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.7778em; vertical-align: -0.0833em;"></span><span class="mord mathnormal">in</span><span class="mord mathnormal">c</span><span class="mord mathnormal">i</span><span class="mord mathnormal">d</span><span class="mord mathnormal">e</span><span class="mord mathnormal">n</span><span class="mord mathnormal">ce</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord mathnormal">d</span><span class="mord mathnormal">u</span><span class="mord mathnormal" style="margin-right: 0.02778em;">r</span><span class="mord mathnormal">a</span><span class="mord mathnormal">t</span><span class="mord mathnormal">i</span><span class="mord mathnormal">o</span><span class="mord mathnormal">n</span></span></span></span></span>. The importance of this equation is in the relation between prevalence and incidence; for example, when the incidence increases, then the prevalence must also increase. Note that this relation does not hold for age-specific prevalence and incidence, where the relation becomes more complicated.</p>
<ol start="12">
<li>Epidemic: In epidemiology, an epidemic (from ὄπι (epi), meaning "upon or above" and δήμος (demos), meaning "people") occurs when new cases of a certain</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>0</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>disease, in a given human population, and during a given period, substantially exceed what is expected based on recent experience. Epidemiologists often consider the term outbreak to be synonymous to epidemic, but the general public typically perceives outbreaks to be more local and less serious than epidemics.</p>
<p>Epidemics of infectious disease are generally caused by a change in the ecology of the host population (e.g. increased stress or increase in the density of a vector species), a genetic change in the parasite population or the introduction of a new parasite to a host population (by movement of parasites or hosts). Generally, an epidemic occurs when host immunity to a parasite population is suddenly reduced below that found in the endemic equilibrium and the transmission threshold is exceeded.</p>
<p>An epidemic may be restricted to one location; however, if it spreads to other countries or continents and affects a substantial number of people, it may be termed a pandemic. The declaration of an epidemic usually requires a good understanding of a baseline rate of incidence; epidemics for certain diseases, such as influenza, are defined as reaching some defined increase in incidence above this baseline. A few cases of a very rare disease may be classified as an epidemic, while many cases of a common disease.</p>
<p><strong>Causes:</strong> There are several changes that may occur in an infectious agent that may trigger an epidemic these included.</p>
<ol>
<li>Increased virulence</li>
<li>Introduction into a novel setting</li>
<li>Changes in host susceptibility to the infectious agent</li>
</ol>
<p>An epidemic disease is not required to be contagious, and the term has been applied to West Nile fever and the obesity epidemic, among others.</p>
<p>The conditions which govern the outbreak of epidemics include infected food supplies such as contaminated drinking water and the migration of populations of certain animals, such as rats or mosquitoes, which can act as disease vectors. Certain epidemics occur at certain seasons: for example, whooping-cough occurs in spring, whereas measles produces two epidemics, one in winter and one in March. Influenza, the common cold, and other infections of the upper respiratory tract, such as sore throat, occur predominantly in the winter. There is another variation, both as regards the number of persons affected and the number who die in successive epidemics: the severity of successive epidemics rises and falls over periods of five or ten years.</p>
<p><strong>Types:</strong></p>
<ol>
<li><strong>Common source outbreak:</strong> In a common source outbreak, the affected individuals had an exposure to a common agent. If the exposure is singular and all of the affected individuals develop the disease over a single</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>exposure and incubation course, it can be termed a point source outbreak. If the exposure was continuous or variable, it can be termed a continuous outbreak or intermittent outbreak, respectively.</p>
<ol start="2">
<li>Propagated outbreak: In a propagated outbreak, the disease spreads person-to-person. Affected individuals may become independent reservoirs leading to further exposures.</li>
</ol>
<p>Many epidemics will have characteristics of both common source and propagated outbreaks. For example, secondary person-to-person spread may occur after a common source exposure or an environmental vector may spread a zoonotic diseases agent.</p>
<p><strong>Transmission:</strong></p>
<ol>
<li>Airborne transmission: Airborne transmission is the spread of infection by droplet nuclei or dust in the air. Without the intervention of winds or drafts the distance over which airborne infection takes place is short, say 10 to 20 feet.</li>
<li>Arthropod transmission: Arthropod transmission takes place by an insect, either mechanically through a contaminated proboscis or feet, or biologically when there is growth or replication of an organism in the arthropod.</li>
<li>Biological transmission: Involving a biological process, e.g. passing a stage of development of the infecting agent in an intermediate host. Opposite to mechanical transmission.</li>
<li>Colostral transmission: A form of vertical transmission via successive generations.</li>
<li>Contact transmission: The disease agent is transferred directly by biting, sucking, chewing or indirectly by inhalation of droplets, drinking of contaminated water, traveling in contaminated vehicles.</li>
<li>Cyclopropagative transmission: The agent undergoes both development and multiplication in the transmitting vehicle.</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>0</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="7">
<li>
<p>Developmental transmission: The agent undergoes some development in the transmission vehicle.</p>
</li>
<li>
<p>Fecal-oral transmission: The infectious agent is shed by the infected host in feces and acquired by the susceptible host through ingestion of contained material.</p>
</li>
<li>
<p>Horizontal transmission: Lateral spread to others in the same group and at the same time; spread to contemporaries.</p>
</li>
<li>
<p>Mechanical transmission: The transmitter is not infected in that tissues are not invaded and the agent does not multiply.</p>
</li>
<li>
<p>Propagative transmission: The agent multiplies in the transmission vehicle.</p>
</li>
<li>
<p>Vertical transmission: From one generation to the next, perhaps transovarially or by intrauterine infection of the fetus. Some retroviruses are transmitted in the germ line, i.e. their genetic material is integrated into the DNA of either the ovum or sperm.</p>
</li>
</ol>
<p>Pandemic: The word pandemic comes from the Greek pandemos meaning "pertaining to all people". The Greek word pan means "all" and the Greek word demos means "people". According to the Medilexicon's medical dictionary a pandemic is "Denoting a disease affecting or attacking the population of an extensive region, country, continent, global; extensively epidemic."</p>
<p>A pandemic is an outbreak of global proportions. It happens when a novel virus emerges among humans - it causes serious illness and is easily human transmissible (spreads easily from person-to-person).</p>
<p>A pandemic is an epidemic of infectious disease that has spread through human populations across a large region; for instance multiple continents, or even worldwide. A widespread endemic disease that is stable in terms of how many people are getting sick from it is not a pandemic. Further, flu pandemics generally exclude recurrences of seasonal flu. Throughout history there have been a number of pandemics, such as smallpox and tuberculosis. More recent pandemics include the HIV pandemic as well as the 1918 and 2009 H1N1 pandemics.</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Definition and stages: A pandemic is an epidemic occurring on a scale which crosses international boundaries, usually affecting a large number of people.</p>
<p>A disease or condition is not a pandemic merely because it is widespread or kills many people; it must also be infectious. For instance, cancer is responsible for many deaths but is not considered a pandemic because the disease is not infectious or contagious.</p>
<p>In a virtual press conference in May 2009 on the influenza pandemic, Dr Keiji Fukuda, Assistant Director-General ad Interim for Health Security and Environment, WHO said "An easy way to think about pandemic ... is to say: a pandemic is a global outbreak. Then you might ask yourself: "What is a global outbreak"? Global outbreak means that we see both spread of the agent ... and then we see disease activities in addition to the spread of the virus."</p>
<p>Current pandemics: HIV and AIDS: HIV spread to the United States and much of the rest of the world beginning around 1969. HIV, the virus that causes AIDS, is currently a pandemic, with infection rates as high as 25% in southern and eastern Africa. In 2006 the HIV prevalence rate among pregnant women in South Africa was 29.1%. Effective education about safer sexual practices and blood borne infection precautions training have helped to slow down infection rates in several African countries sponsoring national education programs. Infection rates are rising again in Asia and the Americas. AIDS could kill 31 million people in India and 18 million in China by 2025, according to projections by U.N. population researchers. AIDS death toll in Africa may reach 90–100 million by 2025.</p>
<p>Pandemics and notable epidemics through history: There have been a number of significant pandemics recorded in human history, generally zoonoses which came about with domestication of animals, such as influenza and tuberculosis. There have been a number of particularly significant epidemics that deserve mention above the "mere" destruction of cities:</p>
<p>What is the difference between a pandemic and an epidemic? : A pandemic is different from an epidemic or seasonal outbreak.</p>
<ol>
<li>Put simply, a pandemic covers a much wider geographical area, often worldwide. A pandemic also infects many more people than an epidemic. An epidemic is specific to one city, region or country, while a pandemic goes much further than national borders.</li>
<li>An epidemic is when the number of people who become infected rises well beyond what is expected within a country or a part of a country. When the infection takes place in several countries at the same time it then starts turning into a pandemic.</li>
<li>A pandemic is usually caused by a new virus strain or subtype - a virus human either have no immunity against, or very little immunity. If immunity is low or non-existent the</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>virus is much more likely to spread around the world if it becomes easily human transmissible.</p>
<ol start="4">
<li>
<p>In the case of influenza, seasonal outbreaks (epidemics) are generally caused by subtypes of a virus that is already circulating among people. Pandemics, on the other hand, are generally caused by novel subtypes - these subtypes have not circulated among people before. Pandemics can also be caused by viruses, in the case of influenza, that perhaps have not circulated among people for a very long time.</p>
</li>
<li>
<p>Pandemics generally cause much higher numbers of deaths than epidemics. The social disruption, economic loss, and general hardship caused by a pandemic are much higher than what an epidemic can cause.</p>
</li>
</ol>
<p><strong>What are the Six Stages of a pandemic?</strong> The World Health Organization has a Six Stage influenza program, plus two Periods:</p>
<ol>
<li>
<p><strong>Stage 1</strong>: No animal influenza virus circulating among animals have been reported to cause infection in humans.</p>
</li>
<li>
<p><strong>Stage 2</strong>: An animal influenza virus circulating in domesticated or wild animals is known to have caused infection in humans and is therefore considered a specific potential pandemic threat.</p>
</li>
<li>
<p><strong>Stage 3</strong>: An animal or human-animal influenza reassortant virus has caused sporadic cases or small clusters of disease in people, but has not resulted in human-to-human transmission sufficient to sustain community-level outbreaks.</p>
</li>
<li>
<p><strong>Stage 4</strong>: Human-to-human transmission of an animal or human-animal influenza reassortant virus able to sustain community-level outbreaks has been verified.</p>
</li>
<li>
<p><strong>Stage 5</strong>: The same identified virus has caused sustained community level outbreaks in two or more countries in one WHO region.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="6">
<li>
<p>Phase 6: In addition to the criteria defined in Phase 5, the same virus has caused sustained community level outbreaks in at least one other country in another WHO region.</p>
</li>
<li>
<p>Lost Peak Period: Levels of pandemic influenza in most countries with adequate surveillance have dropped below peak levels.</p>
</li>
<li>
<p>Post Pandemic Period: Levels of influenza activity have returned to the levels seen for seasonal influenza in most countries with adequate surveillance.</p>
</li>
</ol>
<p>According to the WHO, if an influenza pandemic were to emerge today, we could expect:</p>
<ol>
<li>
<p>As people today are highly internationally mobile, the pandemic virus would spread rapidly around the world.</p>
</li>
<li>
<p>Vaccines, antiviral agents, and antibiotics to treat secondary infections would rapidly be in short supply</p>
</li>
<li>
<p>Several months would be needed before any vaccine became available. This is because pandemic viruses are new ones.</p>
</li>
<li>
<p>Medical facilities would be overwhelmed</p>
</li>
<li>
<p>There would be sudden and potentially considerable shortages of personnel to provide vital community services as the illness became widespread.</p>
</li>
</ol>
<p>Holoendemic: A disease is holoendemic when essentially every individual in a population is infected. As the disease is ubiquitous, the young are more likely to express pathogenic responses,</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>31</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>whilst the older hosts will carry the disease asymptotically, or with reduced damage, due to adaptive immunity. Examples of this holoendemic pattern are seen with malaria in areas of sub-saharan Africa (where 75% of the deaths are in children under 5) and trachoma in areas of Saudi-Arabia.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="basic-principles-of-epidemiology">BASIC PRINCIPLES OF EPIDEMIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#basic-principles-of-epidemiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Epidemiology is the study of the distribution and determinants and frequency of health-related states or events in specified populations, and the application of this study to the control of health problems.</p>
<p>Every public health worker should be familiar with the basic principles in this definition and how they are useful.</p>
<ol>
<li>
<p>Distribution - Epidemiology is concerned with the frequency and pattern of health events in a population. Frequency includes not only the number of events in a population, but also the rate or risk of disease in the population. Determining the rate of disease occurrences (number of events divided by size of the population) is critical for making valid comparisons across different populations.</p>
</li>
<li>
<p>Determinants - Epidemiology is also used to search for causes and other factors that influence the occurrence of health-related events. The occurrence of a health-related event is usually related to multiple determinants that should be considered.</p>
</li>
</ol>
<p>Examples of determinants include:</p>
<p>i. Host susceptibility to a disease, and
ii. Opportunity for exposure to a microorganism,
iii. Environmental toxin,
iv. Insect vector or
v. Other infected individual that may pose a risk for acquiring disease.</p>
<ol start="3">
<li>
<p>Specified populations - Epidemiologists are concerned with the collective health of people in a community or other area and the impact of health events on that population.</p>
</li>
<li>
<p>Application - Epidemiology provides data for directing public health action.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>An epidemiologist uses the scientific methods of descriptive and analytic epidemiology in "diagnosing" the health of a community.</p>
<p>Disease surveillance usually begins with descriptive epidemiology — defining the:</p>
<p>i. What,
ii. Who,
iii. When and
iv. Where of health-related events.</p>
<ol>
<li>What - Define the disease events and/or its determinants</li>
<li>Who - Descriptions of demographic characteristics are helpful in determining which groups are at risk for some outcome?</li>
</ol>
<p>The demographic characteristics usually include:</p>
<p>i. Age,
ii. Sex and
iii. Race/ethnicity.</p>
<p>Other categories include:</p>
<p>a) Socioeconomic status,
b) History of occupation, or
c) Smoking habits, which provide useful information about exposures that, may present a risk.</p>
<p>A history of underlying diseases may be useful for determining susceptibility to certain conditions.</p>
<ol start="3">
<li>When - Knowledge of the seasonality of certain diseases helps identify unusual occurrences that may define epidemics.</li>
</ol>
<p>Temporal associations between particular exposures on illness give information about incubation periods and exposures posing a risk to others.</p>
<p>Prepared by O.E. Akoth
This document is available on
33
studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="4">
<li>Where - Insight into the geographical extent of health-related events gives an idea of where the agent that causes a disease normally lives and multiplies, what may carry or transmit it and how it spreads.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="uses-of-epidemiology-in-public-health">Uses of Epidemiology in Public Health<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#uses-of-epidemiology-in-public-health" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>It is used in the investigation of:
i. Diseases – communicable and non-communicable.
ii. Problems.
iii. Situations, and
iv. Events that have affected or are affecting or will be affecting the health of the organism in our environment.</p>
</li>
<li>
<p>It is a basic tool for looking for signs and symptoms in the health of a community.</p>
</li>
<li>
<p>It can be used to:
i. Elucidate [make clear and (more) comprehensible] causal mechanism,
ii. explain local health characteristics of disease occurrence, and
iii. For administrative guidance in the provision of health services.</p>
</li>
<li>
<p>It can be used on preventive interventions.</p>
</li>
<li>
<p>It can be used to determine the fertility of a population.</p>
</li>
<li>
<p>It can determine the number of accidents and their causes.</p>
</li>
<li>
<p>It can be used to study the health history of a population.</p>
</li>
<li>
<p>It can be used to diagnose the health of a community and measures of ill-health in terms of:
i. Incidence,
ii. Prevalence, and
iii. Mortality from a defined disease.</p>
</li>
<li>
<p>It can be used to study the working and utilization of health services.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="10">
<li>
<p>It can be used to estimate the group experience; what the individual’s risk on the average of disease incidence and defects.</p>
</li>
<li>
<p>It can be used to complete a clinical picture of a chronic disease and describe its natural history.</p>
</li>
<li>
<p>It can be used to identify syndromes [pattern of symptoms indicative of some disease] by describing:
i. The distribution,
ii. Association, and
iii. Disassociation of phenomena [any remarkable development] on the population.</p>
</li>
<li>
<p>It can be used to search for cases of health and disease by studying the incidence in different groups to estimate the relative importance of different causes in multiple etiologies.</p>
</li>
<li>
<p>It can be used as a strategy [an elaborate and systematic plan] of action for studying man and his total environment.</p>
</li>
<li>
<p>It can be used to develop knowledge about both the earliest and beginnings of dysfunction and characteristics of individuals within the groups that predispose them to futuristic problems.</p>
</li>
<li>
<p>It can be used to develop knowledge about both the earliest and beginnings of dysfunction and characteristics of individuals within the groups that predispose them to futuristic problems.</p>
</li>
<li>
<p>It is used to make a community diagnosis, so that you identify and describe health problems in a community. This will be a cross-sectional study since observations are made at a specific time e.g.
i. Prevalence anemia.
ii. Weight for height profile of children.</p>
</li>
<li>
<p>It is used to monitor continuously over a period of time the change of health in a community. This will be a longitudinal as it involves the collection of information over a period of time and will commonly be related to measures which have been taken e.g. effect of program of vaccination, health, education, nutritional supplementation, safe water supply and sanitation etc.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth
This document is available on
35
studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="19">
<li>
<p>It is used to practice surveillance for specific diseases e.g. cholera in order to act quickly and cut short any out-break.</p>
</li>
<li>
<p>It is used to investigate an out-break of communicable disease, analyze the reasons for it, plan a feasible remedy and carry out and monitor the effects of the remedy on the out-break.</p>
</li>
<li>
<p>It is used to plan effective health services.</p>
</li>
</ol>
<p>Note: Epidemiology is about information - the information needed for health planning and supervision and evaluation of health promotion and disease control activities.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="determinants-of-disease">DETERMINANTS OF DISEASE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#determinants-of-disease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The determinants explored below are organized into four categories, based upon a model developed by Murray &amp; Lopez (see figure below)</p>
<table><thead><tr><th>Social/Environmental/Political Determinants</th><th>Behavioral/Individual Determinants</th><th>Clinical/Physiological Determinants</th><th>Health Outcomes [</th></tr></thead><tbody><tr><td>physical environment (transport)</td><td>alcohol</td><td>heart disease</td><td>ischemic heart disease*</td></tr><tr><td>social inequality (low SES)</td><td>firearms/violence</td><td>high blood pressure</td><td>hiv/aids</td></tr><tr><td></td><td>illicit drugs</td><td>diabetes (type 2)</td><td>lung cancer stroke* depression*</td></tr><tr><td>social exclusion (institutional racism)</td><td>motor vehicle traffic</td><td>high cholesterol</td><td>suicide</td></tr><tr><td>social support (lack of social connectedness)</td><td>physical inactivity</td><td>overweight/obesity</td><td>breast cancer</td></tr><tr><td></td><td>poor diet</td><td>asthma</td><td>poisonings (overdose)</td></tr><tr><td></td><td>tobacco</td><td>hiv/aids</td><td>traffic accidents</td></tr><tr><td></td><td>unsafe sex</td><td>depression</td><td>drug overdose</td></tr><tr><td></td><td>stress</td><td>malnutrition</td><td>hypertensive heart disease</td></tr><tr><td></td><td></td><td>substance use problems</td><td>colorectal cancer</td></tr><tr><td></td><td></td><td></td><td>COPD</td></tr><tr><td></td><td></td><td></td><td>violence (homicide)</td></tr><tr><td></td><td></td><td></td><td>Alzheimers/dementia osteoarthritis</td></tr><tr><td></td><td></td><td></td><td>alcohol use disorder</td></tr><tr><td></td><td></td><td></td><td>colorectal cancer</td></tr><tr><td></td><td></td><td></td><td>diabetes</td></tr><tr><td></td><td></td><td></td><td>cirrhosis of liver</td></tr><tr><td></td><td></td><td></td><td>sexually transmitted disease</td></tr><tr><td></td><td></td><td></td><td>tuberculosis</td></tr></tbody></table>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Prepared by O.E. Akoth</p>
<p>|   |  |  | low birth weight
infant mortality
abscess  |
| --- | --- | --- | --- |
|   |  |  | * leading health
outcomes
(cardiovascular
disease is main cause
of premature
mortality; depression
is leading cause of
DALYs)  |</p>
<p>Determinants of health: Generally, the context in which an individual lives is of great importance for his health status and quality of life. It is increasingly recognized that health is maintained and improved not only through the advancement and application of health science, but also through the efforts and intelligent lifestyle choices of the individual and society. According to the World Health Organization, the main determinants of health include:</p>
<ol>
<li>The social and economic environment,</li>
<li>The physical environment, and</li>
<li>The person's individual characteristics and behaviors.</li>
</ol>
<p>More specifically, key factors that have been found to influence whether people are healthy or unhealthy include:</p>
<ol>
<li>Income and social status</li>
<li>Social support networks</li>
<li>Education and literacy</li>
<li>Employment/working conditions</li>
<li>Social environments</li>
<li>Physical environments</li>
<li>Personal health practices and coping skills</li>
<li>Healthy child development</li>
<li>Biology and genetics</li>
<li>Health care services</li>
<li>Gender</li>
<li>Culture</li>
</ol>
<p>An increasing number of studies and reports from different organizations and contexts examine the linkages between health and different factors, including:</p>
<ol>
<li>lifestyles,</li>
<li>environments,</li>
<li>health care organization, and</li>
</ol>
<p>37</p>
<ol start="4">
<li>health policy, and the series of World Health Reports of the World Health Organization, which focuses on global health issues including access to health care and improving public health outcomes, especially in developing countries.</li>
</ol>
<p>The concept of the "health field," as distinct from medical care, emerged from the Lalonde report from Canada. The report identified three interdependent fields as key determinants of an individual's health. These are:</p>
<ol>
<li>Lifestyle: The aggregation of personal decisions (i.e., over which the individual has control) that can be said to contribute to, or cause, illness or death;</li>
<li>Environmental: All matters related to health external to the human body and over which the individual has little or no control;</li>
<li>Biomedical: All aspects of health, physical and mental, developed within the human body as influenced by genetic make-up.</li>
</ol>
<p>The maintenance and promotion of health is achieved through different combination of:</p>
<ol>
<li>Physical,</li>
<li>Mental, and</li>
<li>Social well-being, together sometimes referred to as the "health triangle."</li>
</ol>
<p><img src="assets/images/image-20251226-6f3039a0.jpeg" alt="img-2.jpeg"></p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>The WHO's 1986 Ottawa Charter for Health Promotion further stated that health is not just a state, but also "a resource for everyday life, not the objective of living.</p>
<p>Health is a positive concept emphasizing social and personal resources, as well as physical capacities."</p>
<p>Focusing more on lifestyle issues and their relationships with functional health, data from the Alameda County Study suggested that people can improve their health via:</p>
<ol>
<li>Exercise,</li>
<li>Enough sleep,</li>
<li>Maintaining a healthy body weight,</li>
<li>Limiting alcohol use, and</li>
<li>Avoiding smoking.</li>
</ol>
<p>The ability to adapt and to self manage has been suggested as core components of human health.</p>
<p>The environment is often cited as an important factor influencing the health status of individuals. This includes characteristics of:</p>
<ol>
<li>The natural environment,</li>
<li>The built environment, and</li>
<li>The social environment.</li>
</ol>
<p>Factors such as:</p>
<ol>
<li>clean water and</li>
<li>air,</li>
<li>adequate housing, and</li>
<li>safe communities and</li>
<li>Roads all have been found to contribute to good health, especially to the health of infants and children.</li>
</ol>
<p>Some studies have shown that a lack of neighborhood recreational spaces including natural environment leads to lower levels of personal satisfaction and higher levels of obesity, linked to lower overall health and well being. This suggests that the positive health benefits of natural space in urban neighborhoods should be taken into account in public policy and land use.</p>
<p>Genetics, or inherited traits from parents, also play a role in determining the health status of individuals and populations. This can encompass both the predisposition to certain diseases and health conditions, as well as the habits and behaviors individuals develop through the lifestyle of their families.</p>
<p>For example, genetics may play a role in the manner in which people cope with:</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>Stress,</li>
<li>Mental,</li>
<li>Emotional or</li>
<li>Physical.</li>
</ol>
<p>Social determinants of health: are the economic and social conditions – and their distribution among the population – that influence individual and group differences in health status.</p>
<p>They are risk factors found in one's living and working conditions (such as the distribution of income, wealth, influence, and power), rather than individual factors (such as behavioural risk factors or genetics) that influence the risk for a disease, or vulnerability to disease or injury. According to some viewpoints, these distributions of social determinants are shaped by public policies that reflect the influence of prevailing political ideologies of those governing a jurisdiction. The World Health Organization says that “This unequal distribution of health-damaging experiences is not in any sense a ‘natural’ phenomenon but is the result of a toxic combination of poor social policies, unfair economic arrangements [where the already well-off and healthy become even richer and the poor who are already more likely to be ill become even poorer], and bad politics</p>
<p>Commonly accepted social determinants of health: There is no single definition of the social determinants of health, but there are commonalities, and many governmental and non-governmental organizations recognize that there are social factors which impact the health of individuals.</p>
<p>In 2003, the World Health Organization (WHO) Europe suggested that the social determinants of health included:</p>
<ol>
<li>Social gradients (life expectancy is shorter and disease is more common further down the social ladder)</li>
<li>Stress (including stress in the workplace)</li>
<li>Early childhood development</li>
<li>Social exclusion</li>
<li>Unemployment</li>
<li>Social support networks</li>
<li>Addiction</li>
<li>Availability of healthy food</li>
<li>Availability of healthy transportation</li>
</ol>
<p>The WHO later developed a Commission on Social Determinants of Health, which in 2008 published a report entitled "Closing the Gap in a Generation." This report identified two broad areas of social determinants of health that needed to be addressed.</p>
<ol>
<li>The first area was daily living conditions, which included:
a) Healthy physical environments,
b) Fair employment and decent work,</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>c) Social protection across the lifespan, and
d) Access to health care.</p>
<ol start="2">
<li>The second major area was distribution of:
b) power,
c) money, and
d) resources,
e) including equity in health programs,
f) public financing of action on the social determinants,
g) economic inequalities,
h) resource depletion,
i) healthy working conditions,
j) gender equity,
k) political empowerment, and
l) A balance of power and prosperity of nations.</li>
</ol>
<p>The 2011 World Conference on Social Determinants of Health brought together delegations from 125 member states and resulted in the Rio Political Declaration on Social Determinants of Health.</p>
<p>This declaration involved an affirmation that health inequities are unacceptable, and noted that these inequities arise from the societal conditions in which people are;</p>
<ol start="2">
<li>Born,</li>
<li>Grow, live,</li>
<li>Work, and</li>
<li>Age, including</li>
<li>Early childhood development,</li>
<li>Education,</li>
<li>Economic status,</li>
<li>Employment and decent work,</li>
<li>Housing environment, and</li>
<li>Effective prevention and treatment of health problems.</li>
</ol>
<p>The United States Centers for Disease Control defines social determinants of health as "life-enhancing resources:</p>
<ol start="2">
<li>Such as food supply,</li>
<li>Housing,</li>
<li>Economic and</li>
<li>Social relationships,</li>
<li>Transportation,</li>
<li>Education, and</li>
<li>Health care, whose distribution across populations effectively determines length and quality of life".</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>These include access to care and resources such as:</p>
<ol>
<li>Food,</li>
<li>Insurance coverage,</li>
<li>Income,</li>
<li>Housing, and</li>
<li>Transportation.</li>
</ol>
<p>Social determinants of health influence health-promoting behaviours, and health equity among the population is not possible without equitable distribution of social determinants among groups.</p>
<p>"The degree to which social conditions affect health is illustrated by the association between education and mortality rates".</p>
<p>Based on the data collected, the social conditions such as education, income, and race were very much dependent on one another, but these social conditions also apply independent health influences.</p>
<p>Marmot and Bell found that in wealthy countries, income and mortality are correlated as a marker of relative position within society, and this relative position is related to social conditions that are important for health including:</p>
<ol>
<li>Good early childhood development,</li>
<li>Access to good quality education,</li>
<li>Rewarding work with some degree of autonomy,</li>
<li>Decent housing, and</li>
<li>A clean and safe living environment.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="concept-and-historical-evolution-of-epidemiology">CONCEPT AND HISTORICAL EVOLUTION OF EPIDEMIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#concept-and-historical-evolution-of-epidemiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><strong>HISTORY OF EPIDEMIOLOGY</strong>: The Greek physician Hippocrates, known as the father of medicine, sought logic to sickness; he is the first person known to have examined the relationships between the occurrence of disease and environmental influences. He coined the terms <em>endemic</em> (for diseases usually found in some places but not in others) and <em>epidemic</em> (for diseases that are seen at some times but not others).</p>
<p>Although epidemiology as a discipline has blossomed since World War II, epidemiologic thinking has been traced from Hippocrates through John Graunt, William Farr, John Snow, and others.</p>
<p>In the mid- and late-1800s, epidemiological methods began to be applied in the investigation of disease occurrence. At that time, most investigators focused on acute infectious diseases. In the 1930s and 1940s, epidemiologists extended their methods to noninfectious diseases. The period since World War II has seen an explosion in the development of research methods and the</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>theoretical underpinnings of epidemiology. Epidemiology has been applied to the entire range of health-related outcomes, behaviors, and even knowledge and attitudes. The studies by Doll and Hill linking lung cancer to smoking and the study of cardiovascular disease among residents of Framingham, Massachusetts are two examples of how pioneering researchers have applied epidemiologic methods to chronic disease since World War II. During the 1960s and early 1970s health workers applied epidemiologic methods to eradicate naturally occurring smallpox worldwide. This was an achievement in applied epidemiology of unprecedented proportions.</p>
<p>In the 1980s, epidemiology was extended to the studies of injuries and violence. In the 1990s, the related fields of molecular and genetic epidemiology (expansion of epidemiology to look at specific pathways, molecules and genes that influence risk of developing disease) took root. Meanwhile, infectious diseases continued to challenge epidemiologists as new infectious agents emerged (Ebola virus, Human Immunodeficiency virus (HIV)/ Acquired Immunodeficiency Syndrome (AIDS)), were identified (Legionella, Severe Acute Respiratory Syndrome (SARS)), or changed (drug-resistant Mycobacterium tuberculosis, Avian influenza). Beginning in the 1990s and accelerating after the terrorist attacks of September 11, 2001, epidemiologists have had to consider not only natural transmission of infectious organisms but also deliberate spread through biologic warfare and bioterrorism.</p>
<p>Today, public health workers throughout the world accept and use epidemiology regularly to characterize the health of their communities and to solve day-to-day problems, large and small.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="uses-of-epidemiology">Uses of Epidemiology:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#uses-of-epidemiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Count health-related events</li>
<li>Describe the distribution of health-related events in the population</li>
<li>Describe clinical patterns</li>
<li>Identify risk factors for developing diseases</li>
<li>Identify causes or determinants of disease</li>
<li>Identify control and/or preventive measures</li>
<li>Establish priorities for allocating resources</li>
<li>Select interventions for prevention and control</li>
<li>Evaluate programs</li>
<li>Conduct research on:</li>
</ol>
<ul>
<li>risk factors and causes</li>
<li>drug trials / vaccine trialount health-related events</li>
<li>risk factors and causes</li>
<li>drug trials / vaccine trials</li>
<li>operational research</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="core-epidemiologic-functions">CORE EPIDEMIOLOGIC FUNCTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#core-epidemiologic-functions" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>In the mid-1980s, five major tasks of epidemiology in public health practice were identified:</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>i. Public health surveillance,
ii. Field investigation, analytic studies,
iii. Evaluation and linkages.</p>
<p>A sixth task, policy development, was recently added. These tasks are described below.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-public-health-surveillance">1. Public health surveillance<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-public-health-surveillance" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Public health surveillance is the ongoing:</p>
<p>i. Systematic collection,
ii. Analysis,
iii. Interpretation, and
iv. Dissemination of health data to help guide public health decision making and action. Surveillance is equivalent to monitoring the pulse of the community.</p>
<p>The purpose of public health surveillance, which is sometimes called “information for action,” is to portray the ongoing patterns of disease occurrence and disease potential so that:</p>
<p>i. Investigation,
ii. Control, and
iii. Prevention measures can be applied efficiently and effectively.</p>
<p>This is accomplished through the systematic collection and evaluation of morbidity and mortality reports and other relevant health information, and the dissemination of these data and their interpretation to those involved in disease control and public health decision making.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="surveillance-cycle">SURVEILLANCE CYCLE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#surveillance-cycle" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251226-4284e1b8.jpeg" alt="img-3.jpeg"></p>
<p>Morbidity and mortality reports are common sources of surveillance data for local and state health departments. These reports generally are submitted by:</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>i. Health-care providers,
ii. Infection control practitioners, or
iii. Laboratories that are required to notify the health department of any patient with a reportable disease such as:
a) Pertussis,
b) Meningococcal meningitis, or
c) AIDS.</p>
<p>Other sources of health-related data that are used for surveillance include:
i. Reports from investigations of individual cases and disease clusters,
ii. Public health program data such as:
a) Immunization coverage in a community,
b) Disease registries and health surveys.</p>
<p>Most often, surveillance relies on simple systems to collect a limited amount of information about each case. Although not every case of disease is reported, health officials regularly review the case reports they do receive and look for patterns among them. These practices have proven invaluable in detecting problems, evaluating programs, and guiding public health action.</p>
<p>While public health surveillance traditionally has focused on communicable diseases, surveillance systems now exist that target:
i. Injuries,
ii. Chronic diseases,
iii. Genetic and birth defects,
iv. Occupational and
v. Potentially environmentally-related diseases, and
vi. Health behaviors.</p>
<p>Since September 11, 2001, a variety of systems that rely on electronic reporting have been developed, including those that report daily emergency department visits, sales of over-the-counter medicines, and worker absenteeism. Because epidemiologists are likely to be called upon to design and use these and other new surveillance systems, an epidemiologist's core competencies must include design of data collection instruments, data management, descriptive methods and graphing, interpretation of data, and scientific writing and presentation.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-field-investigation">2. Field investigation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-field-investigation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>As noted above, surveillance provides information for action. One of the first actions that results from a surveillance case report or report of a cluster is investigation by the public health department. The investigation may be as limited as a phone call to the health-care provider to confirm or clarify the circumstances of the reported case, or it may involve a field investigation</p>
<p>Prepared by O.E. Akoth
This document is available on
5
studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>requiring the coordinated efforts of dozens of people to characterize the extent of an epidemic and to identify its cause.</p>
<p>The objectives of such investigations also vary. Investigations often lead to the identification of additional unreported or unrecognized ill persons who might otherwise continue to spread infection to others. For example, one of the hallmarks of investigations of persons with sexually transmitted disease is the identification of sexual partners or contacts of patients. When interviewed, many of these contacts are found to be infected without knowing it, and are given treatment they did not realize they needed. Identification and treatment of these contacts prevents further spread.</p>
<p>For some diseases, investigations may identify a source or vehicle of infection that can be controlled or eliminated. For example, the investigation of a case of <em>Escherichia coli</em> O157:H7 infection usually focuses on trying to identify the vehicle, often ground beef but sometimes something more unusual such as fruit juice. By identifying the vehicle, investigators may be able to determine how many other persons might have already been exposed and how many continue to be at risk. When a commercial product turns out to be the culprit, public announcements and recalling the product may prevent many additional cases.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="symbol-of-eis">Symbol of EIS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#symbol-of-eis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251226-f9e45516.jpeg" alt="img-4.jpeg"></p>
<p>Occasionally, the objective of an investigation may simply be to learn more about:</p>
<p>i. The natural history,
ii. clinical spectrum,
iii. descriptive epidemiology, and
iv. risk factors of the disease before determining what disease intervention methods might be appropriate.</p>
<p>Early investigations of the epidemic of SARS in 2003 were needed to establish a case definition based on the clinical presentation, and to characterize the populations at risk by:</p>
<p>i. Time,
ii. Place, and
iii. Person.</p>
<p>As more was learned about the epidemiology of the disease and communicability of the virus, appropriate recommendations regarding isolation and quarantine were issued.</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Field investigations of the type described above are sometimes referred to as “shoe leather epidemiology,” conjuring up images of dedicated, if haggard, epidemiologists beating the pavement in search of additional cases and clues regarding source and mode of transmission. This approach is commemorated in the symbol of the Epidemic Intelligence Service (EIS), CDC's training program for disease detectives — a shoe with a hole in the sole.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-analytic-studies">3. Analytic studies<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-analytic-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Surveillance and field investigations are usually sufficient to identify:</p>
<p>i. Causes,
ii. Modes of transmission, and
iii. Appropriate control and prevention measures.</p>
<p>But sometimes analytic studies employing more rigorous methods are needed. Often the methods are used in combination — with surveillance and field investigations providing clues or hypotheses about causes and modes of transmission, and analytic studies evaluating the credibility of those hypotheses.</p>
<p>Clusters or outbreaks of disease frequently are investigated initially with descriptive epidemiology. The descriptive approach involves the study of disease incidence and distribution by:</p>
<p>i. Time,
ii. Place, and
iii. Person.</p>
<p>It includes the calculation of rates and identification of parts of the population at higher risk than others. Occasionally, when the association between exposure and disease is quite strong, the investigation may stop when descriptive epidemiology is complete and control measures may be implemented immediately. More frequently, descriptive studies, like case investigations, generate hypotheses that can be tested with analytic studies. While some field investigations are conducted in response to acute health problems such as outbreaks, many others are planned studies.</p>
<p>The hallmark of an analytic epidemiologic study is the use of a valid comparison group. Epidemiologists must be skilled in all aspects of such studies, including:</p>
<ol>
<li>design,</li>
<li>conduct,</li>
<li>analysis,</li>
<li>interpretation, and</li>
<li>Communication of findings.</li>
</ol>
<p>a. Design includes:</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>i. Determining the appropriate research strategy and study design,
ii. Writing justifications and protocols,
iii. Calculating sample sizes,
iv. Deciding on criteria for subject selection (e.g., developing case definitions),
v. Choosing an appropriate comparison group, and
vi. Designing questionnaires.</p>
<p>b. Conduct involves:
i. Securing appropriate clearances and approvals,
ii. Adhering to appropriate ethical principles,
iii. Abstracting records,
iv. Tracking down and interviewing subjects,
v. Collecting and handling specimens, and
vi. Managing the data.</p>
<p>c. Analysis begins with describing the characteristics of the subjects. It progresses to:
i. Calculation of rates,
ii. Creation of comparative tables (e.g., two-by-two tables), and
iii. computation of measures of association (e.g., risk ratios or odds ratios), tests of significance (e.g., chi-square test),
iv. Confidence intervals and the like.</p>
<p>Many epidemiologic studies require more advanced analytic techniques such as:
i. Stratified analysis,
ii. Regression, and
iii. Modeling.</p>
<p>d. Finally, interpretation involves:
i. Putting the study findings into perspective,
ii. Identifying the key take-home messages, and
iii. Making sound recommendations.</p>
<p>Doing so requires that the epidemiologist be knowledgeable about the subject matter and the strengths and weaknesses of the study.</p>
<ol start="4">
<li>Evaluation: Epidemiologists, who are accustomed to using systematic and quantitative approaches, have come to play an important role in evaluation of public health services and other activities. Evaluation is the process of determining, as systematically and objectively as possible:</li>
</ol>
<p>c) The relevance,</p>
<p>Prepared by O.E. Akoth
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>d) Effectiveness,
e) Efficiency, and
f) Impact of activities with respect to established goals.</p>
<ol start="5">
<li>
<p>Effectiveness refers to the ability of a program to produce the intended or expected results in the field; effectiveness differs from efficacy, which is the ability to produce results under ideal conditions.</p>
</li>
<li>
<p>Efficiency refers to the ability of the program to produce the intended results with a minimum expenditure of time and resources.</p>
</li>
</ol>
<p>The evaluation itself may focus on:</p>
<p>i. Plans (formative evaluation),
ii. Operations (process evaluation),
iii. Impact (summative evaluation), or
iv. Outcomes — or any combination of these.</p>
<p>Evaluation of an immunization program, for example, might assess the efficiency of the operations, the proportion of the target population immunized, and the apparent impact of the program on the incidence of vaccine-preventable diseases. Similarly, evaluation of a surveillance system might address operations and attributes of the system, its ability to detect cases or outbreaks, and its usefulness.</p>
<ol start="7">
<li>Linkages: Epidemiologists working in public health settings rarely act in isolation. In fact, field epidemiology is often said to be a "team sport." During an investigation an epidemiologist usually participates as either a member or the leader of a multidisciplinary team. Other team members may be:</li>
</ol>
<p>i. Laboratorians,
ii. Sanitarians,
iii. Infection control personnel,
iv. Nurses or other
v. Clinical staff, and, increasingly,
vi. Computer information specialists.</p>
<p>Many outbreaks cross geographical and jurisdictional lines, so co-investigators may be from local, state, or federal levels of government, academic institutions, clinical facilities, or the private sector. To promote current and future collaboration, the epidemiologists need to maintain relationships with staff of other agencies and institutions. Mechanisms for sustaining such linkages include official memoranda of understanding, sharing of</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>published or on-line information for public health audiences and outside partners, and informal networking that takes place at professional meetings.</p>
<ol start="8">
<li><strong>Policy development</strong>: The definition of epidemiology ends with the following phrase: “...and the application of this study to the control of health problems.” While some academically minded epidemiologists have stated that epidemiologists should stick to research and not get involved in policy developments or even make recommendations. Public health epidemiologists do not have this luxury. Indeed epidemiologist who understand a problem and the population in which it occurs are often in a uniquely qualified position to recommend appropriate interventions. As a result, epidemiologists working in public health regularly provide input, testimony and recommendations regarding disease control strategies, reportable disease regulations, and health - care policy.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="epidemiological-approaches">Epidemiological Approaches<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#epidemiological-approaches" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>As with all scientific endeavors, the practice of epidemiology relies on a systematic approach.</p>
<p>In very simple terms Epidemiologist:</p>
<ol>
<li>
<p><strong>Counts</strong>:
i. cases or
ii. health events, and
iii. describes them in terms of:
a) time,
b) place, and
c) person;</p>
</li>
<li>
<p><strong>Divides</strong> the number of cases by appropriate denominator to calculate rates; and</p>
</li>
<li>
<p><strong>Compares</strong> these rates over time or for different groups of people.</p>
</li>
</ol>
<p>Before counting cases, however, the epidemiologist must decide what a case is.</p>
<p>This is done by developing a case definition.</p>
<p>Then, using this case definition, the epidemiologist finds and collects information about the case-patients.</p>
<p>The epidemiologist then performs descriptive epidemiology by characterizing the cases collectively according to:</p>
<ol>
<li>Time,</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="2">
<li>Place, and</li>
<li>Person.</li>
</ol>
<p>To calculate the disease rate, the epidemiologist divides the number of cases by the size of the population.</p>
<p>Finally, to determine whether this rate is greater than what one would normally expect, and if so identify factors contributing to this increase, the epidemiologist compares the rate from this population to the rate in an appropriate comparison group, using analytic epidemiology techniques.</p>
<p>Before counting cases, the epidemiologist must decide what to count, that is, what to call a case.</p>
<p>For that, the epidemiologist uses a case definition.</p>
<p>A case definition is a set standard criterion for classifying whether a person has a particular:</p>
<ol>
<li>Disease,</li>
<li>Syndrome, or</li>
<li>Other health condition.</li>
</ol>
<p>Populations are used for Epidemiological studies, but more specific characteristics and outcomes at the individual level.</p>
<p>The following approaches may also be used:</p>
<ol>
<li>Routinely available data e.g. hospital out-patient, birth and deaths, registration of persons data e.t.c.</li>
<li>Disease surveillance: close observation of circumstances that are likely to cause disease.</li>
<li>Health systems research or approach [approach to health delivery] which includes:</li>
</ol>
<p>i. Equitable access to health service
ii. The quality and responsiveness of health services,
iii. The efficiency and effectiveness of interventions,
iv. A combination of the three elements above together determine the out-come of service delivery.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>51</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="4">
<li>
<p>Community studies [community diagnosis].</p>
</li>
<li>
<p>KAPB [knowledge, attitude, practice and belief] surveys.</p>
</li>
<li>
<p>Qualitative Epidemiology, involving distinctions based on qualities or relating to or involving comparison based on qualities.</p>
</li>
<li>
<p>Epidemiological studies like:
i. Case control studies: used to study associations between environmental or genetic factors suspected from ecologic associations.
ii. Cohort [group] studies: used for the study of a more intensive resource study.
iii. Meta-analysis: used to analyze data accumulated from several separate studies.
iv. Human experimentation: used to test effects on a controlled population.</p>
</li>
</ol>
<p>Epidemiological approaches can be broadly classified as follows:</p>
<ol>
<li>A diagnostic phase, in which the presence of the disease is confirmed.</li>
<li>A descriptive phase, which describes the population at risk and the distribution of disease, both in time and space, within these populations. This may then allow a series of hypotheses to be formed about the likely determinants of the disease and the effects of these on the frequency with which the disease occurs in populations at risk.</li>
</ol>
<p>This phase captures disease distribution and frequency.</p>
<p>It includes questions like:
a) What is the problem?
b) What is the frequency?
c) Who is involved?</p>
<p>Prepared by O.E. Akoth
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>d) Where does it occur?
e) When does it occur?</p>
<p>Answers to the above questions provide clues to the factors which determine the occurrence of diseases/health problems.</p>
<ol start="3">
<li>
<p>An investigating phase, which normally involves the implementation of a series of field studies designed to test these hypotheses.</p>
</li>
<li>
<p>An Experimental phase, in which experiments are performed under controlled conditions to test these hypotheses in more detail, should the results of phase three prove promising. This phase is normally applied in clinical and community trials to answer questions about the effectiveness of new methods for controlling diseases or for improving underlying conditions.</p>
</li>
<li>
<p>Analytical phase, in which the results produced by the above investigations are analyzed. This is often combined with attempts to model epidemiology of the disease using information generated. Such a process often enables the epidemiologist to determine whether any vital bits of information about the disease process are missing. It attempts to analyze causes or determinants of diseases by testing hypothesis to answer questions such as:</p>
</li>
</ol>
<p>a) How is the disease caused and
b) Why is it continuing?</p>
<ol start="6">
<li>An intervention phase: aim at seeing the effects of active intervention which results in either the exposure or the prevention of exposure of a group of people to some determinant or risk factor.</li>
</ol>
<p>In this approach, appropriate methods of control of the disease are examined either under experimental conditions or in the field to answer questions about the effectiveness of new methods for controlling diseases or for improving underlying conditions. Interventions in the disease process are affected by manipulating existing determinants or introducing new ones.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>53</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="7">
<li>
<p>A decision-making phase, in which knowledge of the epidemiology of the disease is used to explore the various options available for its control. This often involves the modeling of the effects that these different options are likely to have on the incidence of the disease. These models can be combined with other models that examine the costs of the various control measures and compare them with the benefits, in terms of increased productivity, that these measures are likely to produce. The optimum control strategy can then be selected as a result of the expected decrease in disease incidence in the populations at risk.</p>
</li>
<li>
<p>A monitoring phase, which takes place during the implementation of the control measures are to ensure that these measures are being properly applied, are having desired effect on reducing disease incidence, and that developments that are likely to jeopardize the success of the control program are quickly detected.</p>
</li>
<li>
<p>Evaluative phase: in this phase, attempts are made to measure the effectiveness of different health services.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="descriptive-epidemiology">DESCRIPTIVE EPIDEMIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#descriptive-epidemiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Descriptive epidemiology seeks to summarize conditions based on:</p>
<ol>
<li>person,</li>
<li>place, and</li>
<li>Time by analyzing disease (or other outcomes of exposure) patterns.</li>
</ol>
<p>Through data collection, this field seeks to understand a population’s health status, make hypotheses about the causes of diseases, and inform program planning and evaluation. In other words, descriptive epidemiology describes the distribution of disease (recall that epidemiology is the study of the distribution and determinants of disease in populations). This is done through describing a condition by various characteristics of person (race, age, or sex, for example), place (geographic location), and time (a specific year or a span of time).</p>
<p>In order to make inferences about causes or determinants of health conditions—the second part of the definition of epidemiology—one must conduct studies to study the relationship between exposures (risk or protective factors) and outcomes.</p>
<p>There are two major types of studies:</p>
<ol>
<li>Experimental studies and</li>
<li>Observational studies.</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>In public health and epidemiology, most studies are observational in nature. Although an outcome may be a disease, we will primarily refer to outcomes as any result of interest that may be linked to a specific exposure (which may be a risk factor, protective factor, or intervention).</p>
<p><strong>Study Designs:</strong> There are two main types of study designs:</p>
<p>i. Descriptive studies [designed to collect facts].
ii. Analytical studies [designed to test hypothesis and examine cause-effect-relationship.</p>
<p><strong>Descriptive Study Design:</strong> This study is limited to description of occurrence of disease in a population and is often the first step in epidemiological investigation.</p>
<p>Descriptive studies make no attempt to analyze the link between exposures and effect. They are designed to describe certain characteristics of a problem or variables as WHO, WHERE, and WHEN [person, place and time] by collecting information on specific diseases in specified population groups.</p>
<p><strong>Who - in terms of:</strong></p>
<ol>
<li>Sex,</li>
<li>Age,</li>
<li>Occupation,</li>
<li>Income,</li>
<li>Culture,</li>
<li>Religion, and</li>
<li>Nutritional status.</li>
</ol>
<p><strong>Where</strong> – the place where people live or work may determine which disease and/or the health problems they suffer from.</p>
<p><strong>When</strong> – it is important to know when the health problem is severe or the incidence of new cases.</p>
<p><strong>Descriptive studies may be:</strong></p>
<ol>
<li><strong>Cross-sectional study</strong>, which investigates individual at single point in time thus giving estimates of point prevalence.</li>
<li><strong>Longitudinal study</strong>, which measures individuals over a period of time, thus giving estimates of incidences. Longitudinal studies may either be:</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>55</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>i. Prospective [looking forward], measuring individuals as they become ill or recover, or
ii. Retrospective [looking back], studying events of illness that occurred in the study population in the past.</p>
<p>The information which is obtained may enable us to develop hypothesis about the pattern of disease.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="analytical-epidemiology">ANALYTICAL EPIDEMIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#analytical-epidemiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Analytical Epidemiology is a study designed to:</p>
<ol>
<li>Investigate hypothesized causal relationships.</li>
<li>Tries to determine why disease is occurring.</li>
<li>Tests hypotheses.</li>
</ol>
<p>Analytical Study Design - This attempts to analyze causes or determinants of disease by testing hypotheses [A proposal intended to explain certain facts or observations] to answer such questions as how is disease caused, its significance, and important causative or predisposing factors so as to take appropriate action for solution.</p>
<p>Analytical study design also tests hypotheses about the influence which determines that one person is affected by disease and another one is not.</p>
<p>Analytical studies are designed to explain the distribution of diseases in specified population groups by testing hypotheses.</p>
<p>These hypotheses may be arrived at from a:</p>
<ol>
<li>Descriptive study,</li>
<li>Clinical observation or from</li>
<li>An examination of existing records.</li>
</ol>
<p>Analytical studies attempt to show whether particular events e.g. consumption of certain foods or states such as malnutrition or living in overcrowded conditions acts as "causes "whose "effects" is the resulting disease.</p>
<p>Analytical studies are therefore based on the comparison of two or more groups of individuals. Three kinds of comparisons can be made and there are correspondingly three types of analytical studies namely:</p>
<ol>
<li>Cross-sectional study,</li>
<li>Retrospective study,</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="3">
<li>Cohort [A group of people having approximately the same age] or prospective study.</li>
</ol>
<p>The effects of the intervention on the study group are determined by comparing this group with a similar group of controls who did not receive the intervention. The evaluation of a disease control program is a type of intervention study.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="natural-history-of-disease">NATURAL HISTORY OF DISEASE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#natural-history-of-disease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The natural history of disease is the course a disease takes in individual people from its pathological onset ("inception") until its eventual resolution through complete recovery or death. The inception of a disease is not a firmly defined concept. The natural history of a disease is sometimes said to start at the moment of exposure to causal agents. Knowledge of the natural history of disease ranks alongside causal understanding in importance for disease prevention and control. Natural history of disease is one of the major elements of descriptive epidemiology.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chain-of-infection">CHAIN OF INFECTION,<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chain-of-infection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><img src="assets/images/image-20251226-eca8bad0.jpeg" alt="img-5.jpeg"></p>
<p>For an infection to develop, each link of the chain must be connected. Breaking any link of the chain can stop the transmission of infection.</p>
<p>INFECTIOUS DISEASE: Any microorganism that can cause a disease such as a bacterium, virus, parasite, or fungus.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>57</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Reasons that the organism will cause an infection are virulence (ability to multiply and grow), invasiveness (ability to enter tissue), and pathogenicity (ability to cause disease).</p>
<p><strong>RESERVOIR</strong>: The place where the microorganism resides, thrives, and reproduces, i.e., food, water, toilet seat, elevator buttons, human feces, respiratory secretions.</p>
<p><strong>PORTAL OF EXIT</strong>: The place where the organism leaves the reservoir, such as the respiratory tract (nose, mouth), intestinal tract (rectum), urinary tract, orblood and other body fluids.</p>
<p><strong>MODE OF TRANSMISSION</strong>: The means by which an organism transfers from one carrier to another by either direct transmission (direct contact between infectious host and susceptible host) or indirect transmission (which involves an intermediate carrier like an environmental surface or piece of medical equipment).</p>
<p><strong>PORTAL OF ENTRY</strong>: The opening where an infectious disease enters the host’s body such as mucus membranes, open wounds, or tubes inserted in body cavities like urinary catheters or feeding tubes.</p>
<p><strong>SUSCEPTIBLE HOST</strong>: The person who is at risk for developing an infection from the disease. Several factors make a person more susceptible to disease including age (young people and elderly people generally are more at risk), underlying chronic diseases such as diabetes or asthma, conditions that weaken the immune system like HIV, certain types of medications, invasive devices like feeding tubes, and malnutrition. For an infection to develop, each link of the chain must be connected. Breaking any link of the chain can stop the transmission of infection!</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="epidemic-disease-occurrence">EPIDEMIC DISEASE OCCURRENCE.<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#epidemic-disease-occurrence" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>An epidemic is the rapid spread of infectious disease to a large number of people in a given population within a short period of time, usually two weeks or less.</p>
<p>Epidemics of infectious disease are generally caused by several factors including:</p>
<ol>
<li>A change in the ecology of the host population (e.g. increased stress or increase in the density of a vector species),</li>
<li>A genetic change in the pathogen reservoir or the introduction of an emerging pathogen to a host population (by movement of pathogen or host).</li>
</ol>
<p>Generally, an epidemic occurs when host immunity to either an established pathogen or newly emerging novel pathogen is suddenly reduced below that found in the endemic equilibrium and the transmission threshold is exceeded.</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>An epidemic may be restricted to one location; however, if it spreads to other countries or continents and affects a substantial number of people, it may be termed a pandemic.</p>
<p><strong>Causes:</strong> There are several changes that may occur in an infectious agent that may trigger an epidemic. These include:</p>
<ol>
<li>Increased virulence</li>
<li>Introduction into a novel setting</li>
<li>Changes in host susceptibility to the infectious agent</li>
</ol>
<p>The conditions which govern the outbreak of epidemics include infected food supplies such as contaminated drinking water and the migration of populations of certain animals, such as rats or mosquitoes, which can act as disease vectors. Certain epidemics occur at certain seasons: for example, whooping-cough occurs in spring, whereas measles produces two epidemics, one in winter and one in March. Influenza, the common cold, and other infections of the upper respiratory tract, such as sore throat, occur predominantly in the winter.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-out-breaks">TYPES OF OUT BREAKS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-out-breaks" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p><strong>Common source outbreak:</strong> In a common source outbreak, the affected individuals had an exposure to a common agent. If the exposure is singular and all of the affected individuals develop the disease over a single exposure and incubation course, it can be termed a point source outbreak. If the exposure was continuous or variable, it can be termed a continuous outbreak or intermittent outbreak, respectively.</p>
</li>
<li>
<p><strong>Propagated outbreak:</strong> In a propagated outbreak, the disease spreads from person-to-person. Affected individuals may become independent reservoirs leading to further exposures.</p>
</li>
</ol>
<p>Many epidemics will have characteristics of both common source and propagated outbreaks. For example, secondary person-to-person spread may occur after a common source exposure or environmental vectors may spread a zoonotic diseases agent.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="transmission">Transmission:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#transmission" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Airborne transmission: Airborne transmission is the spread of infection by droplet nuclei or dust in the air. Without the intervention of winds or drafts the distance over which airborne infection takes place is short, say 10 to 20 feet.</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>59</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="2">
<li>
<p>Arthropod transmission: Arthropod transmission takes place by an insect, either mechanically through a contaminated proboscis or feet, or biologically when there is growth or replication of an organism in the arthropod.</p>
</li>
<li>
<p>Biological transmission: Involving a biological process, e.g. passing a stage of development of the infecting agent in an intermediate host. Opposite to mechanical transmission.</p>
</li>
<li>
<p>Colostral transmission: A form of vertical transmission via successive generations.</p>
</li>
<li>
<p>Contact transmission: The disease agent is transferred directly by biting, sucking, chewing or indirectly by inhalation of droplets, drinking of contaminated water, traveling in contaminated vehicles.</p>
</li>
<li>
<p>Cyclopropagative transmission: The agent undergoes both development and multiplication in the transmitting vehicle.</p>
</li>
<li>
<p>Developmental transmission: The agent undergoes some development in the transmission vehicle.</p>
</li>
<li>
<p>Fecal-oral transmission: The infectious agent is shed by the infected host in feces and acquired by the susceptible host through ingestion of contaminated material.</p>
</li>
<li>
<p>Horizontal transmission: Lateral spread to others in the same group and at the same time; spread to contemporaries.</p>
</li>
<li>
<p>Mechanical transmission: The transmitter is not infected in that tissues are not invaded and the agent does not multiply.</p>
</li>
<li>
<p>Preparative transmission: The agent multiplies in the transmission vehicle.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="12">
<li>Vertical transmission: From one generation to the next, perhaps transovarially or by intrauterine infection of the fetus. Some retroviruses are transmitted in the germ line, i.e. their genetic material is integrated into the DNA of either the ovum or sperm.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="disease-prevention">DISEASE PREVENTION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disease-prevention" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Preventive healthcare (alternately preventive medicine or prophylaxis) consists of measures taken for disease prevention, as opposed to disease treatment.</p>
<p>Just as health encompasses a variety of physical and mental states, so do disease and disability, which are affected by:</p>
<ol>
<li>Environmental factors,</li>
<li>Genetic predisposition, disease agents, and</li>
<li>Lifestyle choices.</li>
</ol>
<p>Health, disease, and disability are dynamic processes which begin before individuals realize they are affected. Disease prevention relies on anticipatory actions that can be categorized as:</p>
<ol>
<li>Primary,</li>
<li>Secondary, and</li>
<li>Tertiary prevention.</li>
</ol>
<p>Each year, millions of people die preventable deaths.</p>
<p>Preventive healthcare is especially important given the worldwide rise in prevalence of chronic diseases and deaths from these diseases.</p>
<p>There are many methods for prevention of disease.</p>
<p>Some common disease screenings include checking for:</p>
<ol>
<li>hypertension (high blood pressure),</li>
<li>hyperglycemia (high blood sugar, a risk factor for diabetes mellitus),</li>
<li>hypercholesterolemia (high blood cholesterol),</li>
<li>screening for colon cancer,</li>
<li>depression,</li>
<li>HIV and</li>
<li>other common types of sexually transmitted disease such as:
i. Chlamydia,
ii. syphilis, and
iii. gonorrhea,
iv. mammography (to screen for breast cancer),</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>61</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>v. colorectal cancer screening,
vi. a pap test (to check for cervical cancer), and
vii. Screening for osteoporosis.</p>
<p>Genetic testing can also be performed to screen for mutations that cause genetic disorders or predisposition to certain diseases such as breast or ovarian cancer.</p>
<p>However, these measures are not affordable for every individual and the cost effectiveness of preventive healthcare is still a topic of debate.</p>
<p><strong>Levels of Disease prevention:</strong> Preventive healthcare strategies are typically described as taking place at the:</p>
<ol>
<li>Primary,</li>
<li>Secondary, and</li>
</ol>
<p>These levels might be better described as:</p>
<ol>
<li>"Prevention,</li>
<li>Treatment, and</li>
<li>Rehabilitation though the terms:</li>
</ol>
<p>i. Primary,
ii. Secondary, and
iii. Tertiary prevention are still commonly in use today.</p>
<p>Prepared by O.E. Akoth
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<table><thead><tr><th>Level</th><th>Definition</th></tr></thead><tbody><tr><td>Primary prevention</td><td>Methods to avoid occurrence of disease either through eliminating disease agents or increasing resistance to disease.</td></tr><tr><td>Examples include immunization against disease, maintaining a healthy diet and exercise regimen, and avoiding smoking.</td><td></td></tr><tr><td>Secondary prevention</td><td>Methods to detect and address an existing disease prior to the appearance of symptoms. Examples include treatment of hypertension (a risk factor for many cardiovascular diseases), cancer screenings.</td></tr><tr><td>Tertiary prevention</td><td>Methods to reduce negative impact of symptomatic disease, such as disability or death, through rehabilitation and treatment.</td></tr><tr><td>Examples include surgical procedures that halt the spread or progression of disease.</td><td></td></tr></tbody></table>
<p>Primary prevention: Primary prevention consists of "health promotion" and "specific protection.</p>
<p>Health promotion activities are non-clinical life choices, for example, eating nutritious meals and exercising daily, that both prevents disease and creates a sense of overall well-being.</p>
<p>Preventing disease and creating overall well-being, prolongs our life expectancy.</p>
<p>Health-promotional activities do not target a specific disease or condition but rather promote health and well-being on a very general level.</p>
<p>On the other hand, specific protection targets a type or group of diseases and complements the goals of health promotion.</p>
<p>In the case of a sexually transmitted disease such as syphilis health promotion activities would include avoiding microorganisms by maintaining personal hygiene, routine check-up appointments with the doctor, general sex education, etc. whereas specific protective measures would be using prophylactics (such as condoms) during sex and avoiding sexual promiscuity.</p>
<p>Food is very much the most basic tool in preventive health care.</p>
<p>Secondary prevention: Secondary prevention deals with latent diseases and attempts to prevent an asymptomatic disease from progressing to symptomatic disease.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>63</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Certain diseases can be classified as primary or secondary.</p>
<p>This depends on definitions of what constitutes a disease, though, in general, primary prevention addresses the root cause of a disease or injury whereas secondary prevention aims to detect and treat a disease early on.</p>
<p>Secondary prevention consists of "early diagnosis and prompt treatment" to contain the disease and prevent its spread to other individuals, and "disability limitation" to prevent potential future complications and disabilities from the disease.</p>
<p>Disability limitation for syphilitic patients includes continued check-ups on the:</p>
<ol>
<li>Heart,</li>
<li>Cerebrospinal fluid, and</li>
<li>Central nervous system of patients to curb any damaging effects such as blindness or paralysis.</li>
</ol>
<p><strong>Tertiary prevention</strong>: Finally, tertiary prevention attempts to reduce the damage caused by symptomatic disease by focusing on:</p>
<ol>
<li>Mental, physical, and</li>
<li>Social rehabilitation.</li>
</ol>
<p>Unlike secondary prevention, which aims to prevent disability, the objective of tertiary prevention is to maximize the remaining capabilities and functions of an already disabled patient. Goals of tertiary prevention include:</p>
<ol>
<li>Preventing pain and</li>
<li>Damage,</li>
<li>Halting progression and</li>
<li>Complications from disease, and</li>
<li>Restoring the health and functions of the individuals affected by disease.</li>
</ol>
<p>The three levels of prevention each have corresponding health programs:</p>
<p>As for the primary level of intervention, Primary preventive measures would include:</p>
<ol>
<li>Educating,</li>
<li>Counseling,</li>
<li>Lifestyle modifications,</li>
<li>Health education programs for communities,</li>
<li>Wellness and fitness programs,</li>
<li>Mandatory immunization for children,</li>
<li>Environmental sanitation activities,</li>
<li>The adoption other specific health practices and other programs geared towards the safety and wellness of the community.</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Primordial Prevention: Primordial prevention is defined as prevention of risk factors themselves, beginning with change in social and environmental conditions in which these factors are observed to develop, and continuing for high risk children, adolescents and young adults.</p>
<p>Disease Prevention Strategy: The strategy provides evidence-based recommendations that are fundamental to improving the nation's health through the active engagement of all sectors of society to help achieve four broad strategic directions:</p>
<ol>
<li>
<p>Building Healthy and Safe Community Environments: Prevention of disease starts in our communities and at home; not just in the doctor's office. For example, businesses and employers can adopt practices to encourage their workforce to increase physical activity and reduce pollution (e.g., workplace flexibility, rideshare and vanpool programs, park-and-ride incentives, travel demand management initiatives, and telecommuting options).</p>
</li>
<li>
<p>Expanding Quality Preventive Services in Both Clinical and Community Settings: When people receive preventive care, such as immunizations and cancer screenings, they have better health and lower health care costs. For example, expanding the linkages between clinical and community prevention efforts, such as diabetes prevention programs that support preventive efforts among underserved groups and can improve access to preventive services.</p>
</li>
<li>
<p>Empowering People to Make Healthy Choices: Policies and programs can make healthy options the easy and affordable choice, and when people have access to actionable and easy-to-understand information and resources, they are empowered to make healthier choices. For example, health care professionals can use multiple communication tools (e.g., mobile phone applications, personal health records, and credible health websites) and culturally competent methods to support more traditional written and oral communication.</p>
</li>
<li>
<p>Eliminating Health Disparities: By eliminating disparities in achieving and maintaining health, we can help improve quality of life for all Americans. For example, health care providers can train and hire more qualified staff from underrepresented racial and ethnic minority groups and people with disabilities.</p>
</li>
</ol>
<p>To help achieve these goals, the Strategy identifies evidence-based recommendations that are most likely to reduce the burden of leading causes of preventable death and major illness.</p>
<p>The Strategy's seven priority areas are:</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>65</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>Tobacco free living</li>
<li>Preventing drug abuse and excessive alcohol use</li>
<li>Healthy eating</li>
<li>Active living</li>
<li>Injury and violence-free living</li>
<li>Reproductive and sexual health</li>
<li>Mental and emotional wellbeing</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="measures-of-epidemiology">MEASURES OF EPIDEMIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#measures-of-epidemiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>There are two measures used in Epidemiology namely:</p>
<ol>
<li>Prevalence rate.</li>
<li>Incidence rate.</li>
</ol>
<p>i. Incidence: counts new cases of the disease (or outcome)
ii. Prevalence: counts new and existing cases of the disease (or outcome)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="incidence-new-cases">INCIDENCE (NEW CASES)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#incidence-new-cases" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Incidence quantifies development of disease. Incidence can be estimated using data from a disease registry data or a cohort trial. There is an implicit assumption of a period of time, such as new cases within a month (or a year).</p>
<p>A summary incidence rate can estimate risk (e.g., probability of disease in an individual) if risk is constant across the summarized groups.</p>
<p>As defined, incidence is a count of new cases. However it is often expressed as a proportion of those at risk. The denominator includes all persons at-risk for the disease or condition, i.e. disease-free or condition-free individuals in the population at the start of the time period. Persons in the denominator, those at-risk, should be able to appear in the numerator. Obviously, the denominator would not include persons who already have the disease or condition. Incidence can also be expressed in terms of person-time at risk.</p>
<p>Rates are usually expressed per 100, 1,000, or 100,000 persons. In a strict application, "rate" should only be used when the denominator is an estimate of the total person-time at risk. (You will find the term "rate" used inconsistently in epidemiologic reports. It is better to seek the source of the numbers than to rely on the nomenclature [A system of words used to name things in a particular discipline].)</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="two-common-measures-of-incidence">Two Common Measures of Incidence<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#two-common-measures-of-incidence" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The cumulative incidence rate (also known as incidence rate, especially for public health surveillance) consists of the number of persons who newly experience the disease or studied outcome during a specified period of time divided by the (average) total population at risk. This calculation assumes all persons in denominator contribute an equal amount of time to the measure. It is usually presented with an upper and lower bound.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="incidence-rates">Incidence Rates<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#incidence-rates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Incidence is the relative frequency of occurrence of something.</p>
<p>Incidence rates are the measure of the risk of developing some new condition within a specified time. Although sometimes loosely expressed as the number of new cases during sometime period, it is better expressed as a proportion or rate with a denominator.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="incidence">Incidence<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#incidence" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>proportion is the number of new cases within a specified period divided by the size of the population initially at risk. For example, if a population initially contains 1000 non diseased persons and 28 diseased or cases over two years of observation, the incidence proportion is 28 cases per 1,000 persons i.e. 28%</p>
<p>Incidence rates are designed to provide measures of rate at which people without a disease, illness, and injury develop the conditions during a specified period of time eg a number of new cases in a population over a period of time stated as the number of case which came into existence within a certain period of time per specified unit of population.</p>
<p>In actual application of incidence rates, it is challenging as times of onset of disease may be unclear. In such cases,</p>
<ol>
<li>Time of diagnosis</li>
<li>Date of reporting</li>
<li>Time of appearance of symptoms</li>
<li>Visit to hospital</li>
<li>Appearance at the emergency room or</li>
<li>At other times element of factor that identify the beginning of an outbreak may be used.</li>
</ol>
<p>Incidence is not the onset of an outbreak, but the frequency of new cases or events in the time period and in a specific population.</p>
<p>A calculation of incidence rate involves:</p>
<p>a) The number of cases.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>67</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>b) Total population.
c) Period of time.</p>
<p>Incidence rate:
= Number of new cases of a disease occurring in the population during a specified Period of time x 1000</p>
<p>Number of persons exposed to risk of developing the disease during that period of time
Or</p>
<p>Incidence rate:
= Number of a disease or new cases over a period of time x 1,000</p>
<p>Population at risk of developing the disease.</p>
<p>For example, if there were 100 cases of TB in the catchment area of 20,000 [total population] in 12 month [period of time].</p>
<p>Calculate the incidence.</p>
<p>Incidence = New cases x 1,000</p>
<p>Total population
= 100 x 1,000
20,000</p>
<p>Incidence therefore = 5 cases per 1,000 population per year.</p>
<p>This means that in 12 months period you can expect to see 5 cases of TB for every 1,000 in your catchment area.</p>
<p>Incident rates may be used to measure short time acute communicable diseases such as cholera or measles or may be used to measure chronic or long time conditions such as cancer or diabetes mellitus.</p>
<p>Prepared by O.E. Akoth
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Incidence Rates Denominator/Numerator issues: The denominator as used in the incidence rates should accurately set forth the number at risk or under study in the group or population.</p>
<p>N/B as the time passes, the number of persons at risk in the population changes. Some people are exposed to the risk at the end of the period while other people are removed from risk shortly after the defined period starts.</p>
<p>To accommodate the transient population problem, the epidemiologist picks the population number/cases at midpoint in the time period to represent the average population at risk.</p>
<p>Since incidence rate is used to study the new cases of a disease, only those individuals at risk of developing the disease i.e. population at risk should be individuals in the denominator. The denominator should include:</p>
<ol>
<li>Individuals with the disease.</li>
<li>Those who have already had the disease [if they no longer susceptible].</li>
<li>Those not susceptible due to immunization.</li>
</ol>
<p>Numerator in Incidence: The numerator in incidence provides specific information about the occurrences of a disease. If the number of cases or persons can vary, the numerator should clearly reflect the differences. The numerator is the number of new cases or incidences starting within time period.</p>
<p>There are two approaches of incidence rates that are used:</p>
<ol>
<li>Cumulative incidence rate: This is the number of person's at risk and is used as denominator. In case of this nature, cumulative incidence rates useful longitudinal studies due time and secular variations. The cumulative incidence is used to study a group of persons followed over a period of time.</li>
<li>Incidence density or Force morbidity: This is the number of cases of disease which occur per unit of a population and at a point in unit time. It is used to predict the risk that a well person has of getting ill over a certain period of time. The population and time element are used in the denominator; whereas the numerator includes new cases of disease or disorder.</li>
</ol>
<p>Force morbidity is also referred to as incidence density.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>69</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Note: the prevalence rate equals the incidence rate multiplied by the average duration of the disease.</p>
<p>For example, if the average duration of a disease is three years and its incidence rate is 10 per 1000; the prevalence rate would be 30 per 1000.</p>
<p>The duration of disease is usually measured from the time of diagnosis to death.</p>
<p>In summary, the incidence rate is an accurate estimate of the risk probability of getting a disease within a certain time period and the denominator is only “at risk” population.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="principles-of-incidence-rate">Principles of Incidence Rate:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#principles-of-incidence-rate" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>An incidence rate can be used to estimate the probability of or risk of developing a disease during a specific period.</li>
<li>As the incidence rate goes up, the risk possibility or the probability of getting the disease goes up.</li>
<li>Time- if the incidence rate is consistently higher during a specified time of the year, such as rainy season, the risk of developing diseases goes up at that time eg cholera or malaria are highest during rainy seasons.</li>
<li>Place- if the incidence rates are consistently higher, among people, who live in a certain place, the risk goes up for developing disease if one lives within the area.</li>
<li>Person- if incidence rates are consistently higher among individuals with specific life style factor the risk goes up among that group eg lung cancer increases among cigarette smokers.</li>
<li>Higher incidence implies many new cases, thus risk increases.</li>
<li>When incidence of disease is known to be high, the existence of or potential for an epidemic becomes known and predictable.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="reflections">Reflections:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#reflections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It is important to note that incidence is a bit like a motion picture of the development of a disease in a population. It provides a picture of the measure of the movement of disease through a population, the rate at which people without disease develop the disease during a specific period of time.</p>
<p>i. Incidence is a fundamental tool for studying the etiologic factors of both acute and chronic illness.</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>ii. Incidence rates are important because they provide a direct measure of the rate at which individuals in a given population become ill and thus provide basis for statements about probability or risk of illness.</p>
<p>Prevalence varies in direct relation to both duration and incidence.</p>
<p>Successful intervention and treatment will prolong life and will have an effect on reducing prevalence. The decrease in incidence and shortening of the duration of a disease decreases the prevalence</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="prevalence-new-and-old-cases">PREVALENCE (NEW AND OLD CASES)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#prevalence-new-and-old-cases" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Since prevalence counts both new and existing cases, the duration of the disease affects the prevalence. Diseases with a long duration will be more prevalent than those with shorter duration. Chronic, non-fatal conditions are more prevalent than conditions with high mortality. The prevalence of disease is directly related to the duration of the disease:</p>
<p>Prevalence = Incidence × Average Duration</p>
<p>Prevalence is not an apt descriptor of an acute condition.</p>
<p>Similar to incidence, persons included in the denominator must have the potential for being in the numerator, i.e. at-risk for the disease or condition. Prevalence is often expressed after multiplication by 100 (%), 1000 or 100,000.</p>
<p>The term rate may be inappropriately applied to prevalence. Prevalence is a proportion, usually reflecting the proportion with a disease at a particular time. (Point prevalence)</p>
<p>The prevalence pool is the subset of the population with the condition of interest. The prevalence pool is not generally useful for hypothesis-driven epidemiologic research because these are not new cases, but can be useful in tracking the natural history of the disease, evaluating effects of treatments or disease burden.</p>
<p>For most etiologic research, incidence is the more appropriate measure. Studying the incidence of a rare condition however, poses a challenge. Given a small number of new cases, it can be preferable to estimate prevalence instead of incidence in these situations. For example, birth defect rates, reported as the numbers of cases/live births is a prevalent measure. Similarly, an autopsy rate is a prevalent measure.</p>
<p>Two common measures are point prevalence and period prevalence. The difference is whether the estimate is made over a period of time or at one specific time as illustrated below:</p>
<p>Point prevalence: prevalence of condition of interest at a specific time.</p>
<p>Number of existing cases on a specific date/ Number in the defined population on this date</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>0</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Point prevalence ranges from 0 to 100. (%)</p>
<p>Point prevalence can be estimated from a cross-sectional survey or disease registry data by calculating the percentage with a particular disease or condition on a particular date. E.g. what percentage had a particular type of flu on 1/17/2009?</p>
<p><strong>Period prevalence</strong>: prevalence of outcome of interest during a specified period of time. Less frequently used.</p>
<p>Number of cases that occurred in a specified period of time/ Number in the defined population during this period</p>
<p>Period prevalence generally ranges from 0 to 100%. (Theoretically, period prevalence can exceed 100% if you allow individuals who had the disease more than once to be counted for each case of the disease within the reporting period.)</p>
<p>E.g. what percentage of the population had an episode of flu between October and May in the most recent flu season?</p>
<p><strong>Prevalence Rate</strong>: In Epidemiology, the prevalence of a disease in a statistical population is defined as the total cases of the disease in the population at any given time or the total number of cases in the population divided by the number of individuals in the population. It is used as an estimate of how a common condition is within a population over a certain period of time. It is also defined as a measure of morbidity which is the number of cases of a disease, infected persons, or condition present at a particular time in relation to the size of the population from which it is drawn. For example, the number of cases of Measles with in a population as of 1st July. It helps physicians or other health professionals understand the probability of certain diagnoses and are routinely used by Epidemiologists, health care providers, government agencies and insurers.</p>
<p>Prevalence rate is controlled by two elements:</p>
<p>i. The number of individuals who have been diseased in the past.
ii. The length of/ or duration of the illness.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="factors-which-affect-prevalence-in-a-population">Factors which affect Prevalence in a Population<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#factors-which-affect-prevalence-in-a-population" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Prevalence rates are increased by:</p>
<p>i. Immigration of ill cases [in coming].
ii. Emigration of healthy persons [out going].</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>iii. Immigration of susceptible cases or those with the potential of becoming cases.
iv. Prolongation of life of cases in throat cure [increased duration of disease-chronicity]
v. Increased occurrences of new cases [increase in incidence]</p>
<p>Prevalence rates are increased by:
i. Immigration of healthy persons.
ii. Emigration of all cases.
iii. Improved cure rate of cases.
iv. Increased death rates from the diseases.
v. Decreased occurrences of diseases [incidence].
vi. Shorter duration of illnesses [acuteness]
vii. Death.</p>
<p>As new diseases develop in a population [as new cases rise] incidence goes up. As incidence goes up prevalence goes up.</p>
<p>The duration of disease affects prevalence: When disease has a long duration, prevalence remains higher and longer.</p>
<p>Intervention and treatment have effects on prevalence: as treatment reduces case, the duration of diseases and number of cases goes down – prevalence reduces.</p>
<ul>
<li>Immigration prevents new cases and reduces prevalence.</li>
<li>Prolongation of life of cases can increase duration and can add to the prevalence of chronic diseases.</li>
</ul>
<p>Prolongation of non-diseased and healthy population can reduce prevalence of acute diseases and and as healthy people increased, life expectancy increases.</p>
<p>Mathematically, prevalence rate [1] = <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mtext>Number&nbsp;of&nbsp;existing&nbsp;cases&nbsp;of&nbsp;a&nbsp;disease&nbsp;at&nbsp;a&nbsp;point&nbsp;in&nbsp;time</mtext><mtext>x&nbsp;1000</mtext></mfrac></mrow><annotation encoding="application/x-tex">\frac{\text{Number of existing cases of a disease at a point in time}}{\text{x 1000}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.2772em; vertical-align: -0.345em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.9322em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">x&nbsp;1000</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Number&nbsp;of&nbsp;existing&nbsp;cases&nbsp;of&nbsp;a&nbsp;disease&nbsp;at&nbsp;a&nbsp;point&nbsp;in&nbsp;time</span></span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.345em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span>.</p>
<p>Total population</p>
<p>Prepared by O.E. Akoth
This document is available on
5 studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Prevalence [2] = <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mrow><mtext>Total&nbsp;number&nbsp;of&nbsp;cases&nbsp;of&nbsp;disease&nbsp;at&nbsp;a&nbsp;given&nbsp;time</mtext><mo>×</mo><mn>1000</mn></mrow><mtext>Total&nbsp;number&nbsp;of&nbsp;population&nbsp;at&nbsp;risk&nbsp;at&nbsp;a&nbsp;given&nbsp;time</mtext></mfrac></mrow><annotation encoding="application/x-tex">\frac{\text{Total number of cases of disease at a given time} \times 1000}{\text{Total number of population at risk at a given time}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.4133em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.9322em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Total&nbsp;number&nbsp;of&nbsp;population&nbsp;at&nbsp;risk&nbsp;at&nbsp;a&nbsp;given&nbsp;time</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Total&nbsp;number&nbsp;of&nbsp;cases&nbsp;of&nbsp;disease&nbsp;at&nbsp;a&nbsp;given&nbsp;time</span></span><span class="mbin mtight">×</span><span class="mord mtight">1000</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></p>
<p>To calculate the prevalence of a disease the following is involved:</p>
<p>a) Total cases.
b) Total population.
c) Specific point in time. i.e.</p>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mrow><mtext>Total&nbsp;cases</mtext><mo>×</mo><mn>1000</mn></mrow><mtext>Total&nbsp;population</mtext></mfrac></mrow><annotation encoding="application/x-tex">\frac{\text{Total cases} \times 1000}{\text{Total population}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.3612em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8801em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Total&nbsp;population</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.394em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Total&nbsp;cases</span></span><span class="mbin mtight">×</span><span class="mord mtight">1000</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></p>
<p>If the TB register on June <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>30</mn><mtext>th</mtext></msup></mrow><annotation encoding="application/x-tex">30^{\text{th}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8491em;"></span><span class="mord">3</span><span class="mord"><span class="mord">0</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8491em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">th</span></span></span></span></span></span></span></span></span></span></span></span></span></span> [specific point in time] shows 200 cases [total cases] and the population of the catchment area is 20,000 [total population] the prevalence of TB therefore equals,</p>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mrow><mn>200</mn><mo>×</mo><mn>1</mn><mo separator="true">,</mo><mn>000</mn></mrow><mtext>Total&nbsp;population</mtext></mfrac></mrow><annotation encoding="application/x-tex">\frac{200 \times 1,000}{\text{Total population}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.3783em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8972em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Total&nbsp;population</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">200</span><span class="mbin mtight">×</span><span class="mord mtight">1</span><span class="mpunct mtight">,</span><span class="mord mtight">000</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span> on June <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>30</mn><mtext>th</mtext></msup></mrow><annotation encoding="application/x-tex">30^{\text{th}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8491em;"></span><span class="mord">3</span><span class="mord"><span class="mord">0</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8491em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">th</span></span></span></span></span></span></span></span></span></span></span></span></span></span></p>
<p>20,000</p>
<p>=10 cases per 1,000.</p>
<p>There are four types of prevalence rates that are used by investigators:</p>
<ol>
<li><strong>Point Prevalence</strong>: This refers to the number of cases that occur during specified period of time, for example a year or the number of cases of individuals with a disease, condition, or illness at a single specific point in time divided by the number of existing cases at a point in time.</li>
</ol>
<p>Point prevalence therefore = <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mrow><mtext>Number&nbsp;of&nbsp;existing&nbsp;cases&nbsp;of&nbsp;the&nbsp;disease&nbsp;at&nbsp;a&nbsp;point&nbsp;in&nbsp;time</mtext><mo>×</mo><mn>1</mn><mo separator="true">,</mo><mn>000</mn></mrow><mtext>Total&nbsp;study&nbsp;population</mtext></mfrac></mrow><annotation encoding="application/x-tex">\frac{\text{Number of existing cases of the disease at a point in time} \times 1,000}{\text{Total study population}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.4133em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.9322em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Total&nbsp;study&nbsp;population</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Number&nbsp;of&nbsp;existing&nbsp;cases&nbsp;of&nbsp;the&nbsp;disease&nbsp;at&nbsp;a&nbsp;point&nbsp;in&nbsp;time</span></span><span class="mbin mtight">×</span><span class="mord mtight">1</span><span class="mpunct mtight">,</span><span class="mord mtight">000</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></p>
<p>Point prevalence measures the presence of a disease or a condition on a single short time point, theoretically stopping the clock for a minute, hour or day counting the existing cases of the disease.</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>The numerator includes all persons having the disease at a given moment irrespective of the length of time which has elapsed from the beginning of the illness to the time when prevalence is measured.</p>
<p>The denominator is the total population [affected and unaffected] within which the disease is present.</p>
<p>In contrast, incidence +rates measures events, while point prevalence rates measure what prevails or exists.</p>
<ol start="2">
<li>Period Prevalence: This is a measure that expresses the total number of cases of a disease known to have existed at some time during a specified period. It is the sum of point prevalence [the number of cases existing at the beginning of the period] and incidence [the number of case coming into existence during the period]i.e. period prevalence starts at the point in time and stops at a point in time.</li>
</ol>
<p>Period prevalence therefore= <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mrow><mtext>Number&nbsp;of&nbsp;existing&nbsp;cases&nbsp;of&nbsp;the&nbsp;disease&nbsp;within&nbsp;a&nbsp;period&nbsp;of&nbsp;time</mtext><mo>×</mo><mn>1</mn><mo separator="true">,</mo><mn>000</mn></mrow><mtext>Average&nbsp;study&nbsp;population</mtext></mfrac></mrow><annotation encoding="application/x-tex">\frac{\text{Number of existing cases of the disease within a period of time} \times 1,000}{\text{Average study population}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.4133em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.9322em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Average&nbsp;study&nbsp;population</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Number&nbsp;of&nbsp;existing&nbsp;cases&nbsp;of&nbsp;the&nbsp;disease&nbsp;within&nbsp;a&nbsp;period&nbsp;of&nbsp;time</span></span><span class="mbin mtight">×</span><span class="mord mtight">1</span><span class="mpunct mtight">,</span><span class="mord mtight">000</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="reflection-of-period-prevalence">Reflection of Period Prevalence:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#reflection-of-period-prevalence" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>i. All persons with disease that has been carried over from the previous time period or become ill at the end of the time period are included.
ii. New cases [incidence] occurring within the time period are included.
iii. Recurrences during a succeeding time period [usually one year] are included.</p>
<ol start="3">
<li>
<p>Life Time Prevalence: This refers to the total number of individuals that have had a condition, problem, or disease throughout their life, or at least major part of it. Life prevalence is considered as a form of period prevalence.</p>
</li>
<li>
<p>Annual Prevalence: The total number of people with a condition, problem, disease at any given time throughout the year. Cases of disease that started before the date of prevalence count but extended into study period are included in the annual prevalence rates. Those cases that started prior to the end of the study period and extended</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>throughout the year and/or had not yet recovered before the study period ended are counted.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="uses-of-prevalence-and-incidence-rates">Uses of Prevalence and Incidence Rates:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#uses-of-prevalence-and-incidence-rates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Planning health services - public health services, medical services community health services.</li>
<li>Projecting medical care and need for hospital beds.</li>
<li>Research-epidemiological studies.</li>
<li>Predicting future.</li>
<li>Describing events of illness as they are.</li>
<li>Making comparisons.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="methods-used-in-epidemiology">METHODS USED IN EPIDEMIOLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#methods-used-in-epidemiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These include:</p>
<p>i. Collection of health related data,
ii. As a diagnostic tool for numerator data,
iii. For estimating the population at risk for the denominator data,</p>
<p>For recording data,</p>
<p>iv. For tabulation and analysis of data to introduce the essential information.
v. Use of information for decision making and evaluation.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="unit-3">UNIT 3<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#unit-3" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="the-primary-applications-of-epidemiology-in-public-health">The Primary Applications of Epidemiology in Public Health<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-primary-applications-of-epidemiology-in-public-health" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>To set policy and plan programs, public health officials must assess the health of the population they serve and must determine whether health services are available, accessible, effective and efficient. Epidemiology provides data for directing public health action. The information is used when planning how to control and prevent disease in the community. Through public health surveillance, a health systematically collects, analyzes, interprets and disseminates health data on an ongoing basis. By knowing the ongoing pattern of disease occurrence and disease potential, a</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>health agency can effectively and efficiently investigate, prevent and control disease in the community.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="purposes-of-communicable-disease-investigation-and-general-principles-of-preventing-transmission">Purposes of Communicable Disease Investigation and General Principles of Preventing Transmission<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#purposes-of-communicable-disease-investigation-and-general-principles-of-preventing-transmission" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><strong>Introduction:</strong> These guidelines have been written to assist public health staff engaged in investigating communicable diseases. Their intent is to provide basic, practical, up-to-date and easy-to-understand information which has been coalesced and interpreted from a variety of sources. These guidelines have been written as carefully as possible to balance the amount of work necessary to follow up a reported case against the probability of controlling spread of the disease.</p>
<p>Only certain diseases are included in these guidelines. This is based upon their frequency and complexity. For further information about these and other diseases, consult Control of Communicable Diseases in Man.</p>
<p>Remember, <strong>these are only guidelines</strong>. All situations differ and best judgment should prevail. Some situations require a more stringent approach. Some require a less stringent approach.</p>
<p><strong>Purposes of Communicable Disease Investigation:</strong> Nothing is less self-fulfilling than going through the motions of a task without understanding its purpose. When investigating a report of communicable disease, always keeps in mind the purposes are to:</p>
<ol>
<li><strong>Prevent Transmission from Cases to Contacts:</strong> A full discussion of this topic begins below.</li>
<li><strong>Identify the Source of the Disease:</strong> The source may be in the environment, a food, or another person. Its identification can lead to control.</li>
<li><strong>Identify Other Cases:</strong> Each reported case should be regarded as a sentinel health event. Efforts to identify other cases which are not diagnosed and/or reported may uncover outbreaks and common sources. It is important to question the reported case about others who have been exposed or who have similar symptoms.</li>
<li><strong>Conduct Surveillance:</strong> Information collected when investigating a reported disease can be examined on a state or regional basis to identify outbreaks or trends and to formulate</li>
</ol>
<p>77</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>policy. This information is collected on standardized forms and often is sent to the Centers for Disease Control and Prevention for surveillance on a national basis.</p>
<ol start="5">
<li>Ensure that the Patient has Adequate Medical Supervision: Our responsibilities include making sure the patient is well cared for and understands the consequences of his illness. Where medical care is inadequate, appropriate referrals should be made.</li>
</ol>
<p>General Principles of Preventing Transmission: This section describes how cases and contacts can be managed to prevent transmission.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="case-management">Case Management:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#case-management" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Verify the Diagnosis: It is very important to promptly establish or verify the etiologic agent responsible for the disease. For many diseases reported by physicians or others, there are often little or no laboratory data initially available to verify the diagnosis. Since control efforts depend on the exact diagnosis, it is important to: (a) determine if this information exists; (b) arrange for laboratory tests if the information does not otherwise exist; or (c) make the best guess about diagnosis if it cannot be obtained.</p>
</li>
<li>
<p>Determine if the Case is Infectious or Possibly Infectious: If the case is still infectious, you must identify available measures for preventing transmission. There are two ways to assess the case's infectivity:</p>
</li>
</ol>
<p>i. Estimation--uses the date of onset of illness, dates of known treatment, and known periods of infectiousness for an illness. For example, hepatitis A is no longer infectious after 1 week of the onset of symptoms. Strep throat is no longer infectious after 24 hours of treatment.</p>
<p>ii. Verification--requires laboratory testing of specimens for the case (for example, a stool specimen for a food handler with salmonellosis). Which method you use depends upon the disease (the period of communicability for some diseases is precise; for others it is not precise), the quality of information about the case (e.g., is date of onset known?), and the need to know definitely whether the case is infectious.</p>
<p>In practice, because of delays in diagnosis and reporting, many cases will have passed the infectious stage by the time they are reported. In this instance, the opportunity to prevent transmission is lost, but preventive efforts can be directed to the case's contacts, and other purposes of case investigation can be fulfilled. You may need to contact the physician to fill in information about the case,</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>determine results of laboratory tests, or arrange for tests. Also ask about similar cases for which a report may be pending.</p>
<ol start="3">
<li>
<p>Minimize the Duration of the Case's Infectivity: Drugs (antimicrobials) are the most important means to shorten the duration of infectivity for many diseases. Usually, decisions about drug treatment will be made by the time you investigate. However, sometimes it may be necessary to work with the patient and physician to ensure the patient is appropriately treated.</p>
</li>
<li>
<p>Put into Effect Practices for Preventing Transmission: These practices depend upon the disease and other circumstances. If the disease warrants, the case may have to employ these practices while ill and for a period after recovery during which (s)he is still infectious:</p>
</li>
</ol>
<p>i. Disinfect and dispose of contaminated material (e.g., blood, saliva, feces, urine, eating utensils, bedding, clothes, toys, etc.)</p>
<p>ii. Disinfect the case, clothing, bedding, etc. (e.g., lice)</p>
<p>iii. Encourage behavioral practices of the case (e.g., hand washing, covering the nose and mouth when coughing/sneezing, and protecting lesions from contact with another person. Also, there may be a need for changes if individual are a food handler.)</p>
<p>iv. Isolate the case — the duration and degree depends upon the illness</p>
<p>Contact Management:</p>
<ol>
<li>Determine the risk of infection to contacts: What is the frequency, duration and dosage of the exposure? Often, these characteristics can only be described vaguely. It is usually reasonable to assume persons living in the same household had opportunity for exposure. Is the contact susceptible? Has the person been vaccinated, or previously infected? Is there evidence of a compromised immune system (surgery, steroids, etc.)? Does the disease result in immunity or are people generally susceptible?</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="2">
<li>
<p>Determine if the contact is ill or infected: Look for clinical signs or symptoms. It is important to know if the contact is in the early stages of an illness or asymptomatic infected, you must rely on the laboratory. If you determine that a contact is ill or infected, manage him/her as a case.</p>
</li>
<li>
<p>Prevent illness in susceptible: It may be useful for you to think of contacts in two ways: Those who have been exposed, and those who might yet be exposed, either to the original source or to a contact who subsequently acquires an infection.</p>
</li>
</ol>
<p>The choice of the preventive measure depends upon the disease. Rapid identification of susceptible is important. Remember, vaccines usually require a time period greater than one incubation period to develop antibody. Therefore, they rarely prevent illness in the first generation of contacts. They can, however prevent illness in later generations. Immune globulins must be given within a few days of contact to prevent or modify an infection, but they provide only short-term protection. Antimicrobials are particularly important for contacts exposed to strep, tuberculosis and meningitis.</p>
<p>Limit the activities of exposed persons — sometimes it may be prudent to recommend cessation of contact between the contact and the source. Another example is quarantining exposed persons to protect others not yet exposed.</p>
<p>Conduct personal surveillance of the exposed person — it may be important to call an exposed person by the end of the maximum incubation period to see if (s) he is ill (e.g., for hepatitis A), or simply ask the contact to call you if (s) he develops symptoms. The intensity of the surveillance depends upon the importance attached to preventing transmission from that person.</p>
<p>General Guidelines for Outbreak Investigations: The first action of a health agency when it receives a report of a case or a cluster of cases of a disease is to investigate. The investigation may be anything from a limited phone call to confirm reported information, or it may be as extensive as a field investigation coordinating the efforts of many people to determine the extent and cause of a large outbreak.</p>
<p>Outbreaks may be detected when routine, timely analysis of surveillance data reveals an increase in reported cases or an unusual clustering of cases. The weekly tabulation of disease reports by county surveillance officers are useful ways to monitor trends, evaluate geographical distribution throughout the county and identify possible clusters.</p>
<p>Why do we Investigate Outbreaks? The health agency has a responsibility to institute control and prevention measures. Outbreak investigations may be considered as opportunities to study disease events and are training exercises for those conducting the investigation. If cases are continuing to occur, the goal may be to prevent additional cases. If an outbreak appears to be almost over, the goal may be to prevent outbreaks in the future. The objective here would be to identify factors which contributed to the outbreak to implement measures that would prevent serious outbreaks in the future. Other concerns like public relations, political concerns and legal obligations may also need to be considered.</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Steps in the Investigation:</p>
<ol>
<li>
<p>Prepare for field work - talk to others with experience, review the literature.</p>
</li>
<li>
<p>Establish the existence of an outbreak - An outbreak or epidemic is the occurrence of more cases of disease than expected in a given area or among a specific group of people over a particular period of time. A cluster is an aggregation of cases in a given area over a particular period without regard to whether the number of cases is more than expected. Defining an epidemic requires that one determine what the expected number of cases would be usually from existing surveillance data. Some reasons for a "false" epidemic may be reports of sporadic cases of unrelated cases of the same disease, reports of similar cases but unrelated diseases, or changes in surveillance or reporting procedures.</p>
</li>
<li>
<p>Verify the diagnosis - Collect clinical information, contact the diagnosing physician, and confirm results of laboratory tests done.</p>
</li>
<li>
<p>Define and identify cases - Establish a case definition for the disease using a standard set of criteria for deciding whether an individual should be classified as having the health condition of interest.</p>
</li>
<li>
<p>Perform descriptive epidemiology - Collect information to characterize an outbreak by time, place and person. Remember the what, who, when and where of descriptive epidemiology.</p>
</li>
<li>
<p>Develop hypotheses - After collecting some of the initial information characterizing the outbreak, one should be able to formulate a hypothesis that addresses the source of the agent, the mode (and vehicle or vector) of transmission, and the exposures that caused the disease.</p>
</li>
<li>
<p>Evaluate hypotheses - Compare your hypothesis with the established facts. Is it plausible and consistent? If not, the hypothesis should be revised.</p>
</li>
</ol>
<p>81</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="8">
<li>
<p>As necessary, reconsider/refine hypotheses and execute additional studies.</p>
</li>
<li>
<p>Implement control and prevention measures - This is the primary goal of most outbreak investigations. Although mentioned far down on the list, prevention and control measures should be implemented as soon as possible in an outbreak setting. This may be accomplished by destroying contaminated foods, removing an infected food handler from the job, or immunizing and providing prophylaxis to a population at risk.</p>
</li>
<li>
<p>Communicate findings - An oral briefing or a written report are always useful to summarize an investigation. Formally presenting recommendations provides a blueprint for action and may serve in the health agency as a reference if the health agency encounters a similar situation in the future.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="data-collection-guidelines">Data Collection Guidelines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#data-collection-guidelines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol start="2">
<li>
<p>Line listings. Traditionally we collect data on a standard case report form or questionnaire. A separate sheet of information from each person interviewed often makes synthesizing the data difficult. To create a line listing, critical items are selected from the data collection form and are organized so that data from multiple cases can be entered in columns on a single sheet to summarize the data. In a line listing, each column represents an important variable, such as name or identification number, age, sex, case classification, etc., while each row represents a different case.</p>
</li>
<li>
<p>The epidemic curve. The "epi" curve serves as a map of an epidemic. It provides a simple visual display of the outbreak's magnitude and time trend. Although simple it provides a great deal of information about an epidemic. You will usually be able to tell where you are in the time course of an epidemic, and what the future course might be. If you have identified the disease and know its usual incubation period, you usually can deduce a probable time period of exposure and can develop a questionnaire focusing on that time period. Finally, you may be able to draw inferences about the epidemic pattern — whether it is common source or propagated, or both. Drawing an epidemic curve, plotting time on the x axis and the number of cases on the y axis, will provide additional clues in furthering the investigation. Mapping of individual cases should be done by their date of onset. Changing the unit of time on the x axis may be necessary to best "see" the outbreak. This will depend on the incubation period of the disease you are dealing with.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="application-of-epidemiological-concepts-on-health-services">Application of Epidemiological Concepts on Health Services:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#application-of-epidemiological-concepts-on-health-services" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>It is used in the investigation of diseases [communicable and non-communicable], problems, situations and events that have affected or are affecting or will be affecting health of the organism in our environment.</p>
</li>
<li>
<p>It is a basic tool for looking for signs and symptoms in a community health.</p>
</li>
<li>
<p>It can be used in the elucidation [An act of explaining that serves to clear up and cast light on or an interpretation that removes obstacles to understanding] of causal mechanisms, the explanation of local health characteristics of disease occurrence and administrative guidance in the provision of health services.</p>
</li>
<li>
<p>It can be used in preventive interventions.</p>
</li>
<li>
<p>It can be used to determine fertility in a population.</p>
</li>
<li>
<p>It can be used to determine the number of accidents and their causal mechanisms.</p>
</li>
<li>
<p>It can be used to study the health history of a population.</p>
</li>
<li>
<p>It can be used to diagnose the health of a community and measures of ill health [A state in which you are unable to function normally and without pain] in terms of incidence, prevalence, and mortality from a defined disease.</p>
</li>
<li>
<p>It can be used to study the working and utilization of health services.</p>
</li>
<li>
<p>It can be used to estimate the group experience; what are the individual’s risk on the average of disease incidence and defects.</p>
</li>
<li>
<p>It can be used to complete a clinical picture of chronic disease and describe its natural history [The scientific study of plants or animals (more observational than experimental) usually published in popular magazines rather than in academic journals].</p>
</li>
<li>
<p>It can be used to identify syndromes [A pattern of symptoms indicative of some disease] by describing the distribution, association and disassociation of phenomena [Any state or process known through the senses rather than by intuition or reasoning or a remarkable development] on the population.</p>
</li>
<li>
<p>It can be used to search for cases of health and disease by study the incidence in different groups to estimate the relative importance of different causes in multiple etiologies [The philosophical study of causation].</p>
</li>
<li>
<p>It can be used as strategy [An elaborate and systematic plan of action] for studying man and his total environment.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>83</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="15">
<li>It can be used to develop knowledge about both the earliest and beginnings of dysfunction and the characteristics of individuals within the groups that predispose them to futuristic problems.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="uses-of-epidemiologic-studies">Uses of Epidemiologic studies:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#uses-of-epidemiologic-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These are periodic or continuing assessment of the health status of the community.</p>
<p>i. Periodic or continuing evaluation of the effectiveness of health services.
ii. Surveillance of specific diseases.
iii. Investigation and containment of disease out-breaks.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="uses-of-epidemiologic-health-surveys">Uses of Epidemiologic Health Surveys:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#uses-of-epidemiologic-health-surveys" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>i. To measure the total amount of illness in the population.
ii. To measure the amount of illness caused by a specific disease.
iii. To study the nutritional status of the population.
iv. To examine the utilization of existing health care facilities and demand for new ones.
v. To measure the distribution in the population of a particular characteristic e.g. sources of water.
vi. To examine the role and relationship of one or more factors in etiology of disease.</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p><img src="assets/images/image-20251226-2f2e5beb.jpeg" alt="img-6.jpeg"></p>
<p>Simplified causal web linking exposures and outcomes for a discussion of the issues involved in quantification of risks within this framework.</p>
<p>Random: Lacking any definite plan or order or purpose; governed by or depending on chance</p>
<p>Random Sample: a sample in which every element in the population has an equal chance of being selected</p>
<p>Sampling Methods: These are:</p>
<ol>
<li>Random sampling: The selection of a random sample; each element of the population has an equal chance of been selected</li>
<li>Random sampling method: A sample may be defined as random if every individual in the population being sampled has an equal likelihood of being included in the sample. Random selection is the basis of all good sampling techniques. Selection of a sample entails identification of all the individuals from whom the selection will be made. Then make a list of the study population from whom to select the sample. You may also assign a number to each individual and then select certain numbers by reference to random sample. The starting point for selection should be randomly chosen.</li>
<li>Systematic Sampling: Here every nth is selected from the list or from some other ordering. A systematic sample can be drawn from patients ordered according to the time of their attendance, admission or discharge from a hospital. This enables a sample to be drawn without initial listing of all people among whom the selection will</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>85</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>be made. This method has major advantage over a simple random sample. The starting point for selection should be randomly chosen.</p>
<ol start="4">
<li>
<p>Multi-stage sampling method: In a survey covering a large area such as a district, province or country, an initial sample may be taken from units of population such as village or schools. The villages or schools are listed and a random sample of the required number is selected. Then a list of the individuals within the chosen villages is made and a sample taken from them. This is a two - stage sampling that is used for such surveys as B.C.G. scar and tuberculin test surveys. This procedure of subdividing population into two smaller units may be extended to two or more stages as required. Listing is restricted to the smaller units from whom the final selection is made. In this case, a village or a school is a cluster sample as the individuals selected are clustered in the same village/school. The method may cause error if the variable attribute or disease is itself clustered in the population e.g. Onchocerciasis clustering in the village near the streams where simulium flies breed.</p>
</li>
<li>
<p>Stratified Sampling/ proportional sampling/ representative sampling: The population is divided into subpopulations (strata) and random samples are taken of each stratum. If a disease is unevenly distributed within a population in respect to sex, age, etc a stratified sample is used.</p>
</li>
<li>
<p>Choice of Sampling Method: The choice of a particular sampling method is largely determined by practical consideration. In field work it is almost impossible to select a sample that is fully random. To check a bias that is always in every sample, the investigator must have some basic knowledge of the study population. For example, prevalence of trachoma cannot be determined solely by examining a sample of people attending health center.</p>
</li>
</ol>
<p>Control Groups: These are groups of subjects in analytical epidemiological surveys whereby the study group with a disease is compared with those without the disease or condition.</p>
<p>Examples:</p>
<p>i. In case-control study of the association between a causation and disease.</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>ii. In representative survey, the incidence of the disease among persons exposed to the causative factor can be compared with those persons not exposed.</p>
<p>iii. The ideal control group is one which is exactly the same as the study group in all respects except for the characteristics which are to be studied. Controls can be selected from the general population or patients with one or more other diseases.</p>
<p><strong>Attack Rate</strong>: Attack rates are cumulative incidence rates and are used in epidemics. These rates refer to the number of persons ill from a specific disease in a limited time period in a specific group i.e. they are computed based on limited time exposure and risk and the limited group of people at risk.</p>
<p>Sometimes the term infection rate shows the incidence of all persons with signs and symptoms of disease and also includes the unapparent cases of infections.</p>
<p>Attack rates are commonly used in food poisoning situations or chemical exposure in a group of workers.</p>
<p>In cases of food poisoning, food sanitation preparation measures vary and likely food borne illness due to bacteria occur among those who might have eaten a particular food. In carrying out an investigation of an out-break of this nature, one need to look at:</p>
<ol>
<li>Various food sources.</li>
<li>Who prepared what food?</li>
<li>Cases of ill people verses well people.</li>
<li>Who eats what when and how much?</li>
</ol>
<p>From the results of the investigation, attack rates are calculated.</p>
<p>The epidemiological concept here is to determine whether there is an association between the risk of exposure [eating the food], at specific event and the specific illness.</p>
<p>Attack rate therefore is number of persons developing the disease within the range of the incubation period within a total population exposed to the risk factor.</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mtext>Attack&nbsp;rate</mtext><mo>=</mo><mfrac><mrow><mtext>Number&nbsp;of&nbsp;cases&nbsp;in&nbsp;the&nbsp;exposed&nbsp;population</mtext><mo>×</mo><mn>100</mn></mrow><mtext>Total&nbsp;population&nbsp;exposed</mtext></mfrac></mrow><annotation encoding="application/x-tex">\text{Attack rate} = \frac{\text{Number of cases in the exposed population} \times 100}{\text{Total population exposed}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord text"><span class="mord">Attack&nbsp;rate</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 2.2519em; vertical-align: -0.8804em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.3714em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord text"><span class="mord">Total&nbsp;population&nbsp;exposed</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord text"><span class="mord">Number&nbsp;of&nbsp;cases&nbsp;in&nbsp;the&nbsp;exposed&nbsp;population</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mord">100</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.8804em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></div>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mtext>Crude&nbsp;attack&nbsp;rate</mtext><mo>=</mo><mfrac><mrow><mtext>Number&nbsp;of&nbsp;people&nbsp;[Cases]&nbsp;ill&nbsp;with&nbsp;disease</mtext><mo>×</mo><mn>1</mn><mo separator="true">,</mo><mn>000</mn></mrow><mrow></mrow></mfrac></mrow><annotation encoding="application/x-tex">\text{Crude attack rate} = \frac{\text{Number of people [Cases] ill with disease} \times 1,000}{}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord text"><span class="mord">Crude&nbsp;attack&nbsp;rate</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 2.113em; vertical-align: -0.686em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.427em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord text"><span class="mord">Number&nbsp;of&nbsp;people&nbsp;[Cases]&nbsp;ill&nbsp;with&nbsp;disease</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mord">1</span><span class="mpunct">,</span><span class="mspace" style="margin-right: 0.1667em;"></span><span class="mord">000</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.686em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></div>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>87</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Number of people attending the event [exposed]</p>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mtext>General&nbsp;attack&nbsp;rate</mtext><mo>=</mo><mfrac><mrow><mtext>Number&nbsp;of&nbsp;people&nbsp;ill&nbsp;[cases]&nbsp;within&nbsp;the&nbsp;time&nbsp;period</mtext><mo>×</mo><mn>1</mn><mo separator="true">,</mo><mn>000</mn></mrow><mtext>Number&nbsp;of&nbsp;people&nbsp;at&nbsp;risk&nbsp;within&nbsp;the&nbsp;time&nbsp;period</mtext></mfrac></mrow><annotation encoding="application/x-tex">\text{General attack rate} = \frac{\text{Number of people ill [cases] within the time period} \times 1,000}{\text{Number of people at risk within the time period}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord text"><span class="mord">General&nbsp;attack&nbsp;rate</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1.4911em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.01em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Number&nbsp;of&nbsp;people&nbsp;at&nbsp;risk&nbsp;within&nbsp;the&nbsp;time&nbsp;period</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.485em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Number&nbsp;of&nbsp;people&nbsp;ill&nbsp;[cases]&nbsp;within&nbsp;the&nbsp;time&nbsp;period</span></span><span class="mbin mtight">×</span><span class="mord mtight">1</span><span class="mpunct mtight">,</span><span class="mord mtight">000</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></p>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mtext>Food&nbsp;specific&nbsp;attack&nbsp;rate</mtext><mo>=</mo><mfrac><mrow><mtext>Number&nbsp;of&nbsp;people&nbsp;who&nbsp;ate&nbsp;a&nbsp;specific&nbsp;food&nbsp;and&nbsp;became&nbsp;ill</mtext><mo>×</mo><mn>1</mn><mo separator="true">,</mo><mn>000</mn></mrow><mtext>Total&nbsp;number&nbsp;of&nbsp;people&nbsp;who&nbsp;ate&nbsp;the&nbsp;food</mtext></mfrac></mrow><annotation encoding="application/x-tex">\text{Food specific attack rate} = \frac{\text{Number of people who ate a specific food and became ill} \times 1,000}{\text{Total number of people who ate the food}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mord text"><span class="mord">Food&nbsp;specific&nbsp;attack&nbsp;rate</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1.4133em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.9322em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Total&nbsp;number&nbsp;of&nbsp;people&nbsp;who&nbsp;ate&nbsp;the&nbsp;food</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Number&nbsp;of&nbsp;people&nbsp;who&nbsp;ate&nbsp;a&nbsp;specific&nbsp;food&nbsp;and&nbsp;became&nbsp;ill</span></span><span class="mbin mtight">×</span><span class="mord mtight">1</span><span class="mpunct mtight">,</span><span class="mord mtight">000</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></p>
<p>Attack rates are determine from the broad perspective [crude attack rate] downward to narrow focus [attack rate], and then finally a very specific assessment is conducted [food – specific attack rate]</p>
<p><strong>Primary and Secondary Attack:</strong> This refers to number of persons who had contact or exposure to the primary infectious person or the primary source of infection within the incubation period of the pathogen.</p>
<p>The assessment uses the total number of exposed cases of exposed cases i.e. the number of infected persons per number susceptible exposed persons multiplied by 1,000.</p>
<p><strong>Note:</strong> the denominator excludes individuals who have previously had the disease and are now immune of susceptibility exposed persons multiplied by 1,000.</p>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mtext>Secondary&nbsp;attack&nbsp;rate</mtext><mo>=</mo><mfrac><mrow><mtext>Number&nbsp;of&nbsp;exposed&nbsp;persons&nbsp;developing&nbsp;the&nbsp;disease&nbsp;within&nbsp;incubation&nbsp;period</mtext><mo>×</mo><mn>1</mn><mo separator="true">,</mo><mn>000</mn></mrow><mtext>Total&nbsp;number&nbsp;of&nbsp;persons&nbsp;exposed&nbsp;to&nbsp;the&nbsp;primary&nbsp;case</mtext></mfrac></mrow><annotation encoding="application/x-tex">\text{Secondary attack rate} = \frac{\text{Number of exposed persons developing the disease within incubation period} \times 1,000}{\text{Total number of persons exposed to the primary case}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mord text"><span class="mord">Secondary&nbsp;attack&nbsp;rate</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1.4133em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.9322em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Total&nbsp;number&nbsp;of&nbsp;persons&nbsp;exposed&nbsp;to&nbsp;the&nbsp;primary&nbsp;case</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.4461em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Number&nbsp;of&nbsp;exposed&nbsp;persons&nbsp;developing&nbsp;the&nbsp;disease&nbsp;within&nbsp;incubation&nbsp;period</span></span><span class="mbin mtight">×</span><span class="mord mtight">1</span><span class="mpunct mtight">,</span><span class="mord mtight">000</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></p>
<p><strong>Case Fatality:</strong> A number of people will die from those with the disease over a period of time.</p>
<p><strong>Mortality:</strong> This measure tells what proportion of the entire population die yearly from the disease.</p>
<p><strong>Significance:</strong> measures the spread of infection within a family or household following exposure to the first or primary case in the family.</p>
<p>The numerator is the number of cases and the denominator consists of all persons who are exposed to the risk.</p>
<p><span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mtext>Significance</mtext><mo>=</mo><mfrac><mtext>Number&nbsp;of&nbsp;cases</mtext><mtext>All&nbsp;persons&nbsp;who&nbsp;are&nbsp;exposed&nbsp;to&nbsp;the&nbsp;risk&nbsp;factor</mtext></mfrac></mrow><annotation encoding="application/x-tex">\text{Significance} = \frac{\text{Number of cases}}{\text{All persons who are exposed to the risk factor}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mord text"><span class="mord">Significance</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1.3612em; vertical-align: -0.4811em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8801em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">All&nbsp;persons&nbsp;who&nbsp;are&nbsp;exposed&nbsp;to&nbsp;the&nbsp;risk&nbsp;factor</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.394em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Number&nbsp;of&nbsp;cases</span></span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.4811em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Assessment of Accuracy of Validity: Two indices are used to evaluate the accuracy of a test – those of the sensitivity and specificity. These indices are usually determined by administering the test to one group of persons who have the disease and to another group who do not and then comparing the results.</p>
<p>Those testing positive have the disease and are called “true positive”, those testing positive and do not have the disease are called “false positive”.</p>
<p>Those testing negative and have the disease are called “false negative”, and those testing negative and do not have the disease are called “true negatives”.</p>
<p>Sensitivity: is defined as the percent of those who have the disease and are so indicated by the test.</p>
<p>Specificity: is defined as the percent of those who do not have the disease and are indicated by the test.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-epidemiological-studies">Types of Epidemiological Studies<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-epidemiological-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Case series: Case-series may refer to the qualitative study of the experience of a single patient, or small group of patients with a similar diagnosis, or to a statistical technique comparing periods during which patients are exposed to some factor with the potential to produce illness with periods when they are unexposed.</li>
</ol>
<p>Using the data from the series, analytic studies could be done to investigate possible causal factors. These can include case control studies or prospective studies. A case control study would involve matching comparable controls without the disease to the cases in the series. A prospective study would involve following the case series over time to evaluate the disease's natural history.</p>
<ol start="2">
<li>Case control studies: Case control studies select subjects based on their disease status. A group of individuals that are disease positive (the "case" group) is compared with a group of disease negative individuals (the "control" group). The control group should ideally come from the same population that gave rise to the cases. The case control study looks back through time at potential exposures that both groups (cases and controls) may have encountered. A <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>2</mn><mo>×</mo><mn>2</mn></mrow><annotation encoding="application/x-tex">2 \times 2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7278em; vertical-align: -0.0833em;"></span><span class="mord">2</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">2</span></span></span></span></span> table is constructed; displaying exposed cases (A), exposed controls (B), unexposed cases (C) and unexposed controls (D). The statistic generated to measure association is the odds ratio (OR), which is the ratio of the odds of exposure in the cases (A/C) to the odds of exposure in the controls (B/D), i.e. <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mrow><mi mathvariant="normal">O</mi><mi mathvariant="normal">R</mi></mrow><mo>=</mo><mo stretchy="false">(</mo><mrow><mi mathvariant="normal">A</mi><mi mathvariant="normal">D</mi></mrow><mi mathvariant="normal">/</mi><mrow><mi mathvariant="normal">B</mi><mi mathvariant="normal">C</mi></mrow><mo stretchy="false">)</mo></mrow><annotation encoding="application/x-tex">\mathrm{OR} = (\mathrm{AD} / \mathrm{BC})</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6833em;"></span><span class="mord"><span class="mord mathrm">OR</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mopen">(</span><span class="mord"><span class="mord mathrm">AD</span></span><span class="mord">/</span><span class="mord"><span class="mord mathrm">BC</span></span><span class="mclose">)</span></span></span></span></span>.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="case-controls">Case Controls<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#case-controls" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>89</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<table><thead><tr><th>Exposed</th><th>A</th><th>B</th></tr></thead><tbody><tr><td>Unexposed</td><td>C</td><td>D</td></tr></tbody></table>
<p>If the OR is clearly greater than 1, then the conclusion is "those with the disease are more likely to have been exposed," whereas if it is close to 1 then the exposure and disease are not likely associated. If the OR is far less than one, then this suggests that the exposure is a protective factor in the causation of the disease. Case control studies are usually faster and more cost effective than cohort studies, but are sensitive to bias (such as recall bias and selection bias). The main challenge is to identify the appropriate control group; the distribution of exposure among the control group should be representative of the distribution in the population that gave rise to the cases. This can be achieved by drawing a random sample from the original population at risk. This has as a consequence that the control group can contain people with the disease under study when the disease has a high attack rate in a population.</p>
<p>A major drawback for case control studies is that, in order to be considered to be statistically significant, the minimum number of cases required at the 95% confidence interval is related to the odds ratio by the equation:</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mtext>total&nbsp;cases</mtext><mo>=</mo><mo stretchy="false">(</mo><mi>a</mi><mo>+</mo><mi>c</mi><mo stretchy="false">)</mo><mo>=</mo></mrow><annotation encoding="application/x-tex">\text{total cases} = (a + c) =</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord text"><span class="mord">total&nbsp;cases</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mopen">(</span><span class="mord mathnormal">a</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord mathnormal">c</span><span class="mclose">)</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span></span></span></span></span></div>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mo stretchy="false">(</mo><mn>1.96</mn><msup><mo stretchy="false">)</mo><mo>∧</mo></msup><mn>2</mn><mo>×</mo><mo stretchy="false">(</mo><mn>1</mn><mo>+</mo><mi>N</mi><mo stretchy="false">)</mo><mo>×</mo><mo stretchy="false">(</mo><mn>1</mn><mo>÷</mo><mi>ln</mi><mo>⁡</mo><mo stretchy="false">(</mo><mtext>OR</mtext><mo stretchy="false">)</mo><msup><mo stretchy="false">)</mo><mo>∧</mo></msup><mn>2</mn><mo>×</mo><mo stretchy="false">(</mo><mo stretchy="false">(</mo><mtext>OR</mtext><mo>+</mo><mn>2</mn><msqrt><mrow><mtext>OR</mtext><mo>+</mo><mn>1</mn></mrow></msqrt><mo stretchy="false">)</mo><mo>÷</mo><msqrt><mtext>OR</mtext></msqrt><mo stretchy="false">)</mo><mo>≈</mo><mn>15.5</mn><mo>×</mo><mo stretchy="false">(</mo><mn>1</mn><mo>+</mo><mi>N</mi><mo stretchy="false">)</mo><mo>×</mo><mo stretchy="false">(</mo><mn>1</mn><mo>÷</mo><mi>ln</mi><mo>⁡</mo><mo stretchy="false">(</mo><mtext>OR</mtext><mo stretchy="false">)</mo><msup><mo stretchy="false">)</mo><mo>∧</mo></msup><mn>2</mn></mrow><annotation encoding="application/x-tex">(1.96)^\wedge 2 \times (1 + N) \times (1 \div \ln(\text{OR}))^\wedge 2 \times ((\text{OR} + 2 \sqrt{\text{OR} + 1}) \div \sqrt{\text{OR}}) \approx 15.5 \times (1 + N) \times (1 \div \ln(\text{OR}))^\wedge 2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.0519em; vertical-align: -0.25em;"></span><span class="mopen">(</span><span class="mord">1.96</span><span class="mclose"><span class="mclose">)</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8019em;"><span style="top: -3.113em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">∧</span></span></span></span></span></span></span></span><span class="mord">2</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mopen">(</span><span class="mord">1</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord mathnormal" style="margin-right: 0.10903em;">N</span><span class="mclose">)</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mopen">(</span><span class="mord">1</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">÷</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1.0519em; vertical-align: -0.25em;"></span><span class="mop">ln</span><span class="mopen">(</span><span class="mord text"><span class="mord">OR</span></span><span class="mclose">)</span><span class="mclose"><span class="mclose">)</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8019em;"><span style="top: -3.113em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">∧</span></span></span></span></span></span></span></span><span class="mord">2</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mopen">((</span><span class="mord text"><span class="mord">OR</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1.1839em; vertical-align: -0.25em;"></span><span class="mord">2</span><span class="mord sqrt"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.9339em;"><span class="svg-align" style="top: -3em;"><span class="pstrut" style="height: 3em;"></span><span class="mord" style="padding-left: 0.833em;"><span class="mord text"><span class="mord">OR</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mord">1</span></span></span><span style="top: -2.8939em;"><span class="pstrut" style="height: 3em;"></span><span class="hide-tail" style="min-width: 0.853em; height: 1.08em;"><svg xmlns="http://www.w3.org/2000/svg" width="400em" height="1.08em" viewBox="0 0 400000 1080" preserveAspectRatio="xMinYMin slice"><path d="M95,702
c-2.7,0,-7.17,-2.7,-13.5,-8c-5.8,-5.3,-9.5,-10,-9.5,-14
c0,-2,0.3,-3.3,1,-4c1.3,-2.7,23.83,-20.7,67.5,-54
c44.2,-33.3,65.8,-50.3,66.5,-51c1.3,-1.3,3,-2,5,-2c4.7,0,8.7,3.3,12,10
s173,378,173,378c0.7,0,35.3,-71,104,-213c68.7,-142,137.5,-285,206.5,-429
c69,-144,104.5,-217.7,106.5,-221
l0 -0
c5.3,-9.3,12,-14,20,-14
H400000v40H845.2724
s-225.272,467,-225.272,467s-235,486,-235,486c-2.7,4.7,-9,7,-19,7
c-6,0,-10,-1,-12,-3s-194,-422,-194,-422s-65,47,-65,47z
M834 80h400000v40h-400000z"></path></svg></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.1061em;"><span></span></span></span></span></span><span class="mclose">)</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">÷</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1.2255em; vertical-align: -0.25em;"></span><span class="mord sqrt"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.9755em;"><span class="svg-align" style="top: -3em;"><span class="pstrut" style="height: 3em;"></span><span class="mord" style="padding-left: 0.833em;"><span class="mord text"><span class="mord">OR</span></span></span></span><span style="top: -2.9355em;"><span class="pstrut" style="height: 3em;"></span><span class="hide-tail" style="min-width: 0.853em; height: 1.08em;"><svg xmlns="http://www.w3.org/2000/svg" width="400em" height="1.08em" viewBox="0 0 400000 1080" preserveAspectRatio="xMinYMin slice"><path d="M95,702
c-2.7,0,-7.17,-2.7,-13.5,-8c-5.8,-5.3,-9.5,-10,-9.5,-14
c0,-2,0.3,-3.3,1,-4c1.3,-2.7,23.83,-20.7,67.5,-54
c44.2,-33.3,65.8,-50.3,66.5,-51c1.3,-1.3,3,-2,5,-2c4.7,0,8.7,3.3,12,10
s173,378,173,378c0.7,0,35.3,-71,104,-213c68.7,-142,137.5,-285,206.5,-429
c69,-144,104.5,-217.7,106.5,-221
l0 -0
c5.3,-9.3,12,-14,20,-14
H400000v40H845.2724
s-225.272,467,-225.272,467s-235,486,-235,486c-2.7,4.7,-9,7,-19,7
c-6,0,-10,-1,-12,-3s-194,-422,-194,-422s-65,47,-65,47z
M834 80h400000v40h-400000z"></path></svg></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.0645em;"><span></span></span></span></span></span><span class="mclose">)</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">≈</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.7278em; vertical-align: -0.0833em;"></span><span class="mord">15.5</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mopen">(</span><span class="mord">1</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord mathnormal" style="margin-right: 0.10903em;">N</span><span class="mclose">)</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mopen">(</span><span class="mord">1</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">÷</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1.0519em; vertical-align: -0.25em;"></span><span class="mop">ln</span><span class="mopen">(</span><span class="mord text"><span class="mord">OR</span></span><span class="mclose">)</span><span class="mclose"><span class="mclose">)</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8019em;"><span style="top: -3.113em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mbin mtight">∧</span></span></span></span></span></span></span></span><span class="mord">2</span></span></span></span></span></div>
<p>Where N = the ratio of cases to controls. As the odds ratio approached 1, approaches 0; rendering case control studies all but useless for low odds ratios. For instance, for an odds ratio of 1.5 and cases = controls, the table shown above would look like this:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="case-control">Case Control<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#case-control" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>Exposed</th><th>103</th><th>85</th></tr></thead><tbody><tr><td>Unexposed</td><td>84</td><td>103</td></tr></tbody></table>
<p>For an odds ratio of 1.1:</p>
<table><thead><tr><th>Exposed</th><th>1732</th><th>1652</th></tr></thead><tbody><tr><td>Unexposed</td><td>1652</td><td>1732</td></tr></tbody></table>
<p><strong>Cohort studies</strong>: Cohort studies select subjects based on their exposure status. The study subjects should be at risk of the outcome under investigation at the beginning of the cohort study; this usually means that they should be disease free when the cohort study starts. The cohort is followed through time to assess their later outcome status. An example of a cohort study would</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>be the investigation of a cohort of smokers and non-smokers over time to estimate the incidence of lung cancer. The same <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>2</mn><mo>×</mo><mn>2</mn></mrow><annotation encoding="application/x-tex">2 \times 2</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7278em; vertical-align: -0.0833em;"></span><span class="mord">2</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">2</span></span></span></span></span> table is constructed as with the case control study. However, the point estimate generated is the relative risk (RR), which is the probability of disease for a person in the exposed group, <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>P</mi><mi mathvariant="normal">e</mi></msub><mo>=</mo><mi>A</mi><mi mathvariant="normal">/</mi><mo stretchy="false">(</mo><mi>A</mi><mo>+</mo><mi>B</mi><mo stretchy="false">)</mo></mrow><annotation encoding="application/x-tex">P_{\mathrm{e}} = A / (A + B)</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathnormal" style="margin-right: 0.13889em;">P</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.1514em;"><span style="top: -2.55em; margin-left: -0.1389em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">e</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord mathnormal">A</span><span class="mord">/</span><span class="mopen">(</span><span class="mord mathnormal">A</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord mathnormal" style="margin-right: 0.05017em;">B</span><span class="mclose">)</span></span></span></span></span> over the probability of disease for a person in the unexposed group, <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msub><mi>P</mi><mi mathvariant="normal">u</mi></msub><mo>=</mo><mi>C</mi><mi mathvariant="normal">/</mi><mo stretchy="false">(</mo><mi>C</mi><mo>+</mo><mi>D</mi><mo stretchy="false">)</mo></mrow><annotation encoding="application/x-tex">P_{\mathrm{u}} = C / (C + D)</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8333em; vertical-align: -0.15em;"></span><span class="mord"><span class="mord mathnormal" style="margin-right: 0.13889em;">P</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.1514em;"><span style="top: -2.55em; margin-left: -0.1389em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">u</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord mathnormal" style="margin-right: 0.07153em;">C</span><span class="mord">/</span><span class="mopen">(</span><span class="mord mathnormal" style="margin-right: 0.07153em;">C</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord mathnormal" style="margin-right: 0.02778em;">D</span><span class="mclose">)</span></span></span></span></span>, i.e. <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>R</mi><mi>R</mi><mo>=</mo><msub><mi>P</mi><mi mathvariant="normal">e</mi></msub><mi mathvariant="normal">/</mi><msub><mi>P</mi><mi mathvariant="normal">u</mi></msub></mrow><annotation encoding="application/x-tex">RR = P_{\mathrm{e}} / P_{\mathrm{u}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6833em;"></span><span class="mord mathnormal" style="margin-right: 0.00773em;">RR</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord"><span class="mord mathnormal" style="margin-right: 0.13889em;">P</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.1514em;"><span style="top: -2.55em; margin-left: -0.1389em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">e</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mord">/</span><span class="mord"><span class="mord mathnormal" style="margin-right: 0.13889em;">P</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.1514em;"><span style="top: -2.55em; margin-left: -0.1389em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathrm mtight">u</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span>.</p>
<table><thead><tr><th></th><th>Case</th><th>Non-Case</th><th>Total</th></tr></thead><tbody><tr><td>Exposed</td><td>A</td><td>B</td><td>A+B</td></tr><tr><td>Unexposed</td><td>C</td><td>D</td><td>C+D</td></tr></tbody></table>
<p>As with the OR, a RR greater than 1 shows association, where the conclusion can be read "those with the exposure were more likely to develop disease."</p>
<p>Prospective studies have many benefits over case control studies. The RR is a more powerful effect measure than the OR, as the OR is just an estimation of the RR, since true incidence cannot be calculated in a case control study where subjects are selected based on disease status. Temporality can be established in a prospective study, and confounders are more easily controlled for. However, they are more costly, and there is a greater chance of losing subjects to follow-up based on the long time period over which the cohort is followed.</p>
<p>Cohort studies also are limited by the same equation for number of cases as for cohort studies, but, if the base incidence rate in the study population is very low, the number of cases required is reduced by <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mn>1</mn><mn>2</mn></mfrac></mrow><annotation encoding="application/x-tex">\frac{1}{2}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.1901em; vertical-align: -0.345em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8451em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">2</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.394em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">1</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.345em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="validity">Validity<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#validity" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><strong>Precision and bias:</strong> Different fields in epidemiology have different levels of validity. One way to assess the validity of findings is the ratio of false-positives (claimed effects that are not correct) to false-negatives (studies which fail to support a true effect). To take the field of genetic epidemiology, candidate-gene studies produced over 100 false-positive findings for each false-negative. By contrast genome-wide association appears close to the reverse, with only one false positive for every 100 or more false-negatives. This ratio has improved over time in genetic epidemiology as the field has adopted stringent criteria. By contrast other epidemiological fields have not required such rigorous reporting and are much less reliable as a result.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="random-error">Random error<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#random-error" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Random error is the result of fluctuations around a true value because of sampling variability. Random error is just that: random. It can occur during data collection, coding, transfer, or analysis. Examples of random error include: poorly worded questions, a misunderstanding in</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>91</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>interpreting an individual answer from a particular respondent, or a typographical error during coding. Random error affects measurement in a transient, inconsistent manner and it is impossible to correct for random error.</p>
<p>There is random error in all sampling procedures. This is called sampling error.</p>
<p>Precision in epidemiological variables is a measure of random error. Precision is also inversely related to random error, so that to reduce random error is to increase precision. Confidence intervals are computed to demonstrate the precision of relative risk estimates. The narrower the confidence interval, the more precise the relative risk estimate.</p>
<p>There are two basic ways to reduce random error in an epidemiological study. The first is to increase the sample size of the study. In other words, add more subjects to your study. The second is to reduce the variability in measurement in the study. This might be accomplished by using a more precise measuring device or by increasing the number of measurements.</p>
<p>Note, that if sample size or number of measurements is increased, or a more precise measuring tool is purchased, the costs of the study are usually increased. There is usually an uneasy balance between the need for adequate precision and the practical issue of study cost.</p>
<p><strong>Systematic error:</strong> A systematic error or bias occurs when there is a difference between the true value (in the population) and the observed value (in the study) from any cause other than sampling variability. An example of systematic error is if, unknown to you, the pulse oximeter you are using is set incorrectly and adds two points to the true value each time a measurement is taken. The measuring device could be precise but not accurate. Because the error happens in every instance, it is systematic. Conclusions you draw based on that data will still be incorrect. But the error can be reproduced in the future (e.g., by using the same mis-set instrument).</p>
<p>A mistake in coding that affects all responses for that particular question is another example of a systematic error.</p>
<p>The validity of a study is dependent on the degree of systematic error. Validity is usually separated into two components:</p>
<ol>
<li>
<p><strong>Internal validity</strong> is dependent on the amount of error in measurements, including exposure, disease, and the associations between these variables. Good internal validity implies a lack of error in measurement and suggests that inferences may be drawn at least as they pertain to the subjects under study.</p>
</li>
<li>
<p><strong>External validity</strong> pertains to the process of generalizing the findings of the study to the population from which the sample was drawn (or even beyond that population to a more universal statement). This requires an understanding of which conditions are relevant (or irrelevant) to the generalization. Internal validity is clearly a prerequisite for external validity.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="types-of-bias">Types of bias:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-bias" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>
<p>Selection bias: Selection is one of three types of bias that can threaten the validity of a study.
Selection bias occurs when study subjects are selected or become part of the study as a result of a third, unmeasured variable which is associated with both the exposure and outcome of interest.</p>
</li>
<li>
<p>Information bias: Information bias is bias arising from systematic error in the assessment of a variable. An example of this is recall bias. A typical example is again provided by Sackett in his discussion of a study examining the effect of specific exposures on fetal health: "in questioning mothers whose recent pregnancies had ended in fetal death or malformation (cases) and a matched group of mothers whose pregnancies ended normally (controls) it was found that 28% of the former, but only 20% of the latter, reported exposure to drugs which could not be substantiated either in earlier prospective interviews or in other health records". In this example, recall bias probably occurred as a result of women who had had miscarriages having an apparent tendency to better recall and therefore report previous exposures.</p>
</li>
<li>
<p>Confounding: Confounding has traditionally been defined as bias arising from the co-occurrence or mixing of effects of extraneous factors, referred to as confounders, with the main effect(s) of interest. A more recent definition of confounding invokes the notion of counterfactual effects. According to this view, when one observes an outcome of interest, say Y=1 (as opposed to Y=0), in a given population A which is entirely exposed (i.e. exposure X = 1 for every unit of the population) the risk of this event will be R_A1. The counterfactual or unobserved risk R_A0 corresponds to the risk which would have been observed if these same individuals had been unexposed (i.e. X = 0 for every unit of the population). The true effect of exposure therefore is: R_A1 - R_A0 (if one is interested in risk differences) or R_A1/R_A0 (if one is interested in relative risk). Since the counterfactual risk R_A0 is unobservable we approximate it using a second population B and we actually measure the following relations: R_A1 - R_B0 or R_A1/R_B0. In this situation, confounding occurs when R_A0 ≠ R_B0. (NB: Example assumes binary outcome and exposure variables.)</p>
</li>
</ol>
<p>Some epidemiologists prefer to think of confounding separately from common categorizations of bias since, unlike selection and information bias, confounding stems from real causal effects</p>
<p>Broadly speaking there are two main types of epidemiological study:</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>Observational study.</li>
<li>Experimental study.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="observational-studies">Observational Studies:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#observational-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a. In an observational setting the epidemiologist is not able to control conditions.
b. Observational studies allow nature to take its own course.
c. Observational study involves the following approaches or studies:</p>
<p>i. Descriptive studies,
ii. Analytical studies,
iii. Ecological or correlation studies used in studying populations.
iv. Cross-sectional studies or prevalence studies used in individuals,
v. Case control or case-reference studies used in individuals,
vi. Cohort or follow-up studies used in studying individuals
vii. Evaluative studies used in studying the efficacy of health delivery services.
viii. Observational prospective studies,
ix. Observational retrospective studies,</p>
<ol>
<li>Descriptive Observational Studies: Descriptive observational studies are carried out to determine:</li>
</ol>
<p>a) The frequency of a disease,
b) The kind of people who suffer from it and
c) Where and when it occurs.</p>
<p>Information would be obtained about the patient's age, sex, where and when the patient developed the disease.</p>
<p>Since such information can only be obtained from hospital records, the patients are only characterized in terms of data in the case – notes. i.e.:</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>a) Age,
b) Sex,
c) marital status,
d) occupation, and
e) Place of residence and/work.
f) Geographical distribution of a disease and any variations in its occurrence at different time of the year can only be deduced from the addresses that patient recorded during admission.</p>
<p>More specific information can be obtained through interviews and examination of the patients.</p>
<p>Descriptive studies seek to characterize people who are affected by a disease and relate observation obtained from them to the general population.</p>
<p>Descriptive observational studies comprise:</p>
<ol>
<li>Observation made at one point in time [cross-sectional observational study] or</li>
<li>Longitudinal in which observations are repeated in the same community over a prolonged period of time.</li>
</ol>
<p>Descriptive observational studies are also indicated to understand:</p>
<p>a) The relationship between the environment and organism,
b) The disease agent and the vectors and
c) Geographical location of the vectors,
d) Age, and sex relationship and the frequency to the site.</p>
<p>In descriptive observational studies, it is usual to define study population and make observation on a sample taken from it. The study population in descriptive observational study is commonly defined by:</p>
<p>a) Geographical location,
b) Age,
c) Sex,
d) Occupation and</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>e) Ethnic groups.</p>
<ol start="2">
<li>Analytical Studies: These are carried to test the hypothesis about the influence which determines that one person is infected by a disease and other is not. They are designed to show whether particular events or states act as causes whose effects are the resulting disease i.e. the relationship between diet and pellagra.</li>
</ol>
<p>For example:</p>
<p>a) Comparing people with disorder and normal people show that the determinant occurs more frequently in some people with the disorder than those without it [among a group of people with pellagra, there will be a greater proportion of individuals eating maize diet than there will be among a comparable group not affected by the disease.</p>
<p>b) Comparing people exposed to the determinant and those not among the exposed show that a greater proportion of people develop the disease among the exposed group than among the non-exposed.</p>
<p>N/B: Population A=maize diet=more pellagra.</p>
<p>Population B=meat and vegetable=less pellagra.</p>
<p>In practice, practice analytical observational studies are not carried out on groups of patients who are atypical of all patients with the disorder unless there is a special indication to do this.</p>
<p>The most important characteristics of a study cohort are:</p>
<ol>
<li>
<p>It should include the individuals exposed to the determinant being investigated.</p>
</li>
<li>
<p>It should comprise a group of people who can be followed up for a period of time between exposure to the determinant and development of the disorder. If a reasonable proportion of persons in the cohort cannot be followed, the outcome will be biased because those untraced are likely to be different from the others making available proportion not to be representative of the initial cohort.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="3">
<li>
<p>Ecological [Correlational] Observational Studies: In these studies, the units of analysis are populations or groups of people rather than individuals e.g. sale of anti – asthma drugs and occurrence of high number of asthma deaths. Ecological studies usually rely on data collected for other purposes.</p>
</li>
<li>
<p>Cross-sectional [prevalence] Observational Studies: these are studies which compare the characteristics of a person with the disease [cases] with persons without disease [controls] to find out when the suspected determinant [a determining or causal element disease.ent or factor] occurs more frequently among persons with the disease. They attempt to examine and compare estimates of disease prevalence between various populations and subsets of populations at a particular point in time. They measure the prevalence of diseases and are often called prevalence studies. In cross-sectional studies, the measurements of exposure and effect are made at the same time. The key question to be asked is whether the exposure precedes or follows the effect. If the exposure data are known to represents exposure before any effect occurred, the date analysis can be approached in a similar way as in cohort studies. The format for conducting cross-sectional study is similar to that of conducting retrospective study. The difference is, while retrospective relies on past information to determine the cause of the disease, cross-sectional relies on instantaneous information to determine the cause of the disease. For example, in determining the relationship between cerebra-vascular disease [stroke] and the level of serum cholesterol, a group of cases and appropriate controls are selected and blood taken from them to determine their serum cholesterol levels. If the levels are significantly higher among the cases than controls, statistical association is said to exist between stroke and elevated serum cholesterol levels.</p>
</li>
</ol>
<p>NB: In cross-sectional approach, there is no way of determining whether the elevated serum cholesterol levels preceded stroke or followed.</p>
<p>Advantages of Cross-Sectional [prevalence] Observational Studies: These are:</p>
<p>i. It is relatively easy to conduct and economical.
ii. They are used for investigating exposure to fix characteristics of individuals such as ethnicity, socio-economical status and blood group.</p>
<ol start="5">
<li>Case - Control [reference] Observational Studies: These are used to study causes of diseases especially rare diseases:</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>a) They include people with a disease [or other outcome variable] of interest and a suitable control group [or comparison or reference group] of people unaffected by the disease or outcome variable.</p>
<p>b) The occurrence of the possible cause is compared with cases and control.</p>
<p>c) Case - control Observational studies are thus longitudinal. They have also been called retrospective studies since the investigator looks backwards from the disease to the possible cause.</p>
<p>d) Case - control Observational studies begin with the selection of cases which should represent all cases from a specified population.</p>
<p>e) Then the selection of controls so as to sample the exposure prevalence in the population that generated cases.</p>
<p>f) The controls should represent people who would have designated cases if they had developed the disease.</p>
<p>g) Case-control Observational studies use new [incident] cases.</p>
<p>h) In case-control Observational study design, the exposure status of cases is usually determined after the development of the disease [retrospective data] and usually by direct questioning of the affected persons or relative or friend.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="difference-between-case-control-and-cohort-studies">Difference between Case-Control and Cohort Studies<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#difference-between-case-control-and-cohort-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>To test the hypothesis that smoking is associated with lung cancer using a case-control study you would begin with a group of patients with lung cancer [cases] and a group of patients without lung cancer [controls]. You would then retrospectively determine the number of smokers in both cases and control groups.</p>
</li>
<li>
<p>To test your hypothesis that smoking is associated with a cohort of persons who are either smokers or non-smokers. You would then follow this cohort prospectively to determine how many smokers and non-smokers eventually develop cancer.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>99
Prepared by O.E. Akoth
This document is available on
s studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="advantages-of-case-control-retrospective-studies">Advantages of Case-Control [Retrospective] Studies:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#advantages-of-case-control-retrospective-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Study design guaranteed the number of persons with the disease because we begin the study by selecting a group of cases.</li>
<li>Study takes a short time compared with the cohorts which takes years.</li>
<li>Simple to carry out.</li>
<li>Relatively cheap.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="disadvantages-of-case-controls-studies-these-are">Disadvantages of Case-Controls Studies: These are:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disadvantages-of-case-controls-studies-these-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>It is difficult to select the proper controls.</li>
<li>Determining exposure will often rely on the memory of the persons in the study and may be biased by knowing whether the person is a case or control.</li>
<li>It is not easy to be certain that exposure to the determinant occurred before the disease manifested itself.</li>
<li>Persons die as a result of disease caused by the determinant may not be known to the study.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="design-of-case-control-study">DESIGN OF CASE-CONTROL STUDY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#design-of-case-control-study" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Time</p>
<table><thead><tr><th>Exposed</th><th>Direction of inquiry</th></tr></thead><tbody><tr><td>Not Exposed</td><td>Cases</td></tr><tr><td>Exposed</td><td>Controls</td></tr><tr><td>Not Exposed</td><td>Population</td></tr></tbody></table>
<p>Cohort Observational Studies: Compares over a period of time the characteristics of persons exposed to the determinant [controls] to find out whether a greater proportion of those exposed to the determinant develop the disease and those who are not exposed. These studies begin with the identification of a group of people who are exposed to the suspected determinant. It is defined as a group of people sharing a common experience. The study comprises observation of two groups of people, one exposed to a suspected determinant for a period of time and the other not.</p>
<p>The two types of studies give answers to two different questions:</p>
<p>Forceps delivery (a)</p>
<p>Case-control</p>
<p>Epilepsy</p>
<p>Normal delivery (c)</p>
<p>Forceps delivery (b)</p>
<p>Case-control</p>
<p>No epilepsy</p>
<p>Normal delivery (d)</p>
<p>Advantages of Cohort [Prospective] Studies: These are:</p>
<p>They provide direct estimate of the relative risk [the probability of the event occurring in the exposed group verses a non-exposed group or the risk of developing a disease relative to</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>exposure] of out-come associated with a particular exposure or factor compared with case-control studies in which only indirect estimate of relative risk- the odds ratio.</p>
<p>Relative risk [RR] = People [exposed]</p>
<p>People [non-exposed]</p>
<p>Example: probability of developing lung cancer among smokers was 20% and among non-smokers 1%.</p>
<p>This situation is expressed in the 2x2 table below.</p>
<table><thead><tr><th>Risk</th><th>Disease status</th><th></th></tr></thead><tbody><tr><td></td><td>Present</td><td>Absent</td></tr><tr><td>Smoker</td><td>a</td><td>b</td></tr><tr><td>Non-Smoker</td><td>c</td><td>d</td></tr></tbody></table>
<p>Where: a=20</p>
<p>b=80</p>
<p>c=1</p>
<p>d=99</p>
<table><thead><tr><th>Risk</th><th>Disease status</th><th></th></tr></thead><tbody><tr><td></td><td>Present</td><td>Absent</td></tr><tr><td>Smoker</td><td>20</td><td>80</td></tr><tr><td>Non-Smoker</td><td>1</td><td>99</td></tr></tbody></table>
<p>Relative risk associated with smoking would be:</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mrow><mi mathvariant="normal">R</mi><mi mathvariant="normal">R</mi></mrow><mo>=</mo><mfrac><mi mathvariant="normal">a</mi><mrow><mo stretchy="false">(</mo><mi mathvariant="normal">a</mi><mo>+</mo><mi mathvariant="normal">b</mi><mo stretchy="false">)</mo></mrow></mfrac><mo>=</mo><mfrac><mn>20</mn><mn>100</mn></mfrac></mrow><annotation encoding="application/x-tex">\mathrm{RR} = \frac{\mathrm{a}}{\mathrm{(a + b)}} = \frac{20}{100}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6833em;"></span><span class="mord"><span class="mord mathrm">RR</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 2.0436em; vertical-align: -0.936em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.1076em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord"><span class="mopen">(</span><span class="mord mathrm">a</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mord mathrm">b</span><span class="mclose">)</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord mathrm">a</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.936em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 2.0074em; vertical-align: -0.686em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.3214em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">100</span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">20</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.686em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span></div>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mrow><mi mathvariant="normal">c</mi><mi mathvariant="normal">/</mi><mo stretchy="false">(</mo><mi mathvariant="normal">c</mi><mo>+</mo><mi mathvariant="normal">d</mi><mo stretchy="false">)</mo></mrow><mo>=</mo><mn>1</mn><mi mathvariant="normal">/</mi><mn>100</mn></mrow><annotation encoding="application/x-tex">\mathrm{c / (c + d)} = 1 / 100</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord"><span class="mord mathrm">c/</span><span class="mopen">(</span><span class="mord mathrm">c</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mord mathrm">d</span><span class="mclose">)</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1/100</span></span></span></span></span></div>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mo>=</mo><mfrac><mn>20</mn><mn>20</mn></mfrac><mo>+</mo><mn>80</mn><mo>=</mo><mn>20</mn><mi mathvariant="normal">/</mi><mn>100</mn><mo>=</mo><mn>20</mn></mrow><annotation encoding="application/x-tex">= \frac{20}{20} + 80 = 20 / 100 = 20</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 2.0074em; vertical-align: -0.686em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.3214em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">20</span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord">20</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.686em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">80</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">20/100</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">20</span></span></span></span></span></div>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mn>1</mn><mi mathvariant="normal">/</mi><mo stretchy="false">(</mo><mn>1</mn><mo>+</mo><mn>99</mn><mo stretchy="false">)</mo><mo>=</mo><mn>1</mn><mi mathvariant="normal">/</mi><mn>100</mn></mrow><annotation encoding="application/x-tex">1 / (1 + 99) = 1 / 100</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1/</span><span class="mopen">(</span><span class="mord">1</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">99</span><span class="mclose">)</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord">1/100</span></span></span></span></span></div>
<p>Smokers would be 20 times as likely to develop lung cancer.</p>
<p>Another form of relative risk is the risk ratio because it is the risk in the exposed divided by the risk in the non-exposed.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="disadvantages-of-cohort-studies">Disadvantages of Cohort Studies<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disadvantages-of-cohort-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>If the disease in question is relatively rare, then this approach may require large populations and long time and thus would also be expensive.</li>
<li>Participation in the study may influence the relationship between the determinant and development of disease.</li>
<li>Problems may be created by people who drop out of the study.</li>
<li>We can be certain that the exposure or determinant was present before the disease outcome, and we can also note changes in exposure with time. More than one outcome can be studied, whereas in case-control studies, the groups are defined by a single disease out-break.</li>
</ol>
<p>Prospective Observational Studies, which look forward over a period of time and normally attempt to examine associations between determinants and the frequency of occurrence of a disease by comparing attack rates or incidences of diseases in groups of individuals in which the determinant is either present or absent, or its frequency of occurrence varies.</p>
<p>Prospective observational study involves:</p>
<ol>
<li>Selection of individuals based upon exposure to an agent or causal factor.</li>
<li>A sample of the population is selected and information obtained to determine which persons either has a particular characteristics such as certain living habit or physiological trait that is suspected of being investigated or have been exposed to a possible etiological agent.</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="3">
<li>
<p>The individuals are then followed up to a period of time to observe who develops and/or dies from that disease.</p>
</li>
<li>
<p>Incidences or death rates are then calculated and the rates are compared for those with the characteristics of interest and those without it. If the rates are different either relatively or absolute an association is referred or is said to be existing between the characteristic and the disease.</p>
</li>
</ol>
<p>The characteristics observed in the study group are:</p>
<ol>
<li>Age,</li>
<li>Sex,</li>
<li>color, and</li>
<li>Occupation.</li>
</ol>
<p>The above characteristics are in addition to the specific characteristics of interest in order to be able to account for an influence of factors that are known to be related to the disease.</p>
<p>Prospective observational study has been described by a variety of terms:</p>
<ol>
<li>Cohort,</li>
<li>Incidence,</li>
<li>Longitudinal,</li>
<li>Forward looking,</li>
<li>Follow-up,</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-prospective-observational-studies">Types of Prospective Observational Studies:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-prospective-observational-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>a. Concurrent [Occurring or operating at the same time] which involves:</p>
<p>i. The general population samples and
ii. Selection of the population.</p>
<p>b. Non-concurrent which involves:</p>
<p>i. Population censure taken in the past and</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>0</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>ii. Selecting groups of the population.</p>
<p>At times the investigator uses census results of the community which was conducted in the past.</p>
<p>Samples of the population covered by the census can be selected and be traced from the time of the census.</p>
<p>Non-concurrent prospective observational studies usually involves specially exposed groups or industrial populations because of unavailability of such past census information and unavailability of employment, medical or other types of records.</p>
<p>Non-concurrent prospective observational study of industrial exposure to a possible etiological agent of a disease can only be carried out by using the past company records of present employees which include information on the date of their employment, age at hiring and whether they are living or dead</p>
<p>A major source of carrying out a non-concurrent prospective observational study is maintenance of tracing up selected persons.</p>
<p>This is least troublesome in concurrent prospective observational study because at the very beginning of the study methods can be adopted for keeping contact with the population i.e.</p>
<p>i. Periodic home visit.
ii. Telephone calls.
iii. Mailed questionnaire.</p>
<p>These can be done on annual basis.</p>
<p>The names and addresses of several friends and relatives can be obtained at the beginning of the study so that they may be contacted if the person moves out of the area.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="diagrammatic-presentation-of-concurrent-and-non-concurrent-prospective-observational-studies">Diagrammatic Presentation of Concurrent and Non-Concurrent Prospective Observational Studies<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diagrammatic-presentation-of-concurrent-and-non-concurrent-prospective-observational-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>NON-CONCURRENT</th><th>CONCURRENT</th></tr></thead><tbody><tr><td>In 1980, select exposed and non-exposed groups.</td><td>In 1980, select exposed and non-exposed</td></tr><tr><td>Trace them for a number of years.</td><td>Groups and follow them for a number of years.</td></tr><tr><td>Trace the groups by various</td><td>Follow the groups by various means</td></tr><tr><td>means from 1950 to 1980</td><td>from 1980 to desired period.</td></tr><tr><td>1950</td><td>1980</td></tr></tbody></table>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Advantages of Prospective study: These are:</p>
<ol>
<li>They provide direct estimate of risk of developing diseases in individuals with specific characteristics relative to those without the characteristics.</li>
<li>If the criteria and procedure of the study are established in advance, they decrease the possibility of subjective bias in obtaining necessary information.</li>
<li>In prospective study, one starts with individuals who have the characteristics under study.</li>
<li>Depending on the disease, and characteristics under study one can obtain information on people whose status have changed with regard to the characteristics.</li>
<li>Information can be obtained on the relationship of the characteristics to the disease.</li>
</ol>
<p>Disadvantage of Prospective Observational Study: These are:</p>
<ol>
<li>The study is usually more difficult and expensive to execute requiring large study populations and long periods of observations for definite results.</li>
<li>In prospective study involving periodic examination of people, it is possible that participation in the study may influence the development of disease in individuals. For example, participants in a study of diet and heart disease may voluntary change their dietary habits simply because of their participation in the study.</li>
</ol>
<p>NB: Prospective study cannot be used in studying a rare disease.</p>
<p>Retrospective Observational Study [case history]: which look backward over a period of time and normally attempt to compare the frequency of occurrence of a determinant in groups of diseases and non-diseased individuals.</p>
<p>In retrospective study, comparison is made between groups of persons without the disease [control groups] and persons with disease [cases]. In the retrospective studies, the proportion of cases [those with necessary characteristics of interest or causal factor] is compared to the corresponding proportion of persons in the control group.</p>
<p>If higher frequency of individuals with characteristics of interest is found among the cases than controls then an association between cases and the characteristics can be inferred. For example, in a retrospective study one would see information on the level of serum cholesterol that was present before the onset of stroke. If statistical association is established a casual association can be inferred with greater confidence.</p>
<p>Disadvantage of Retrospective Studies: These are:</p>
<ol>
<li>In retrospective studies, the statement of relative risk is direct.</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>0</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="2">
<li>Estimating the developing of disease is not possible.</li>
<li>In retrospective studies, only one disease is selected for a study as opposed to prospective study where a whole spectrum of the exposed can be studied.</li>
<li>In retrospective study one has to depend on the individual’s memory for information on the occurrence of an event or on availability of records.</li>
<li>Even the best designed retrospective study is limited to individuals who have survived for a period of time after exposure to possible etiological agent or event.</li>
<li>During the period of the initial event and the occurrence of the disease at which time retrospective study is conducted some individuals in the groups will have died. If the characteristic or exposure under study is related to mortality, the deaths that occurred during the interval will not be presented in the groups selected for retrospective study. This may result into underestimating the degree of association between the characteristic under study and the disease which would not occur in prospective study.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="distinction-between-prospective-and-retrospective-studies">DISTINCTION BETWEEN PROSPECTIVE AND RETROSPECTIVE STUDIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#distinction-between-prospective-and-retrospective-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>PROSPECTIVE STUDY</th><th>RETROSPECTIVE STUDY</th></tr></thead><tbody><tr><td>Etiological characteristics or exposure [exposed or cases]</td><td>Diseased groups [cases]</td></tr><tr><td>Non-exposed or controls</td><td>Non-diseased groups [controls]</td></tr></tbody></table>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>EPIDEMIOLOGIC STUDY</p>
<p>CONTROL AD ASSIGNMENT</p>
<p>UN CONTROL AD ASSIGNMENT</p>
<p>NOT RANDOMIZED</p>
<p>EXPERIMENTAL STUDIES</p>
<p>OBSERVATIONAL STUDIES</p>
<p>NOT RANDOMIZED</p>
<p>RANDOMIZED ASSIGNMENT</p>
<p>SAMPLING WITH REGARD TO DISEASE OR EFFECT</p>
<p>SAMPLING UNITS IN REGARD TO EXPOSURE, CHARACTERISTICS OR CAUSE</p>
<p>COMMUNITY TRIALS</p>
<p>CLINICAL TRIALS</p>
<p>CROSS-SECTIONAL OR RETROSPECTIVE STUDY</p>
<p>PROSPECTIVE STUDY</p>
<p>HISTORY OF EXPOSURE OR CHARACTERISTIC [PRIOR TO TIME OF STUDY]</p>
<p>EXPOSURE OR CHARACTERISTIC AT TIME OF STUDY</p>
<p>RETROSPECTIVE STUDY</p>
<p>CROSS-SECTIONAL STUDY</p>
<p>Experimental Studies: Under experimental studies there are:</p>
<p>i. Randomized controlled trials [clinical trials] used in studying patients,
ii. Field trials used in studying healthy people,
iii. Community trials [community intervention or diagnosis] used in studying communities.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>The strength of the experimental study method lies in the investigator's direct control over the assignment of individuals in the study groups.</p>
<p>In observational studies by contrast, the investigator accepts the conditions as they are.</p>
<p>Broadly considered are two types of epidemiologic experiments:</p>
<ol>
<li>Clinical trials</li>
<li>Community trials or field experiments.</li>
</ol>
<p>Clinical Trials: In clinical trials, the efficacy of a preventive or therapeutic agent or procedure is tested in individual subjects. These are methods that are used to evaluate the efficacy of treatment of a disease. They are also used to evaluate a prophylactic agent such as vaccine or public health procedure such as screening methods. The clinical trial is an experiment in which individuals are randomly allocated to two groups known as experimental and control groups.</p>
<p>The experimental group is given the drug being tested and the control group is given the drug in use or a placebo [sugar pill or saline injection in absence of current drug].</p>
<p>Randomization: the major difference between a clinical trial and a prospective study is the randomization nature of clinical trial. The experiment and control groups must compare in all factors except in what is being studied – the drug. For example, if in randomized control trial a drug successfully lowers serum cholesterol levels and intern reduces the incidence of coronary heart disease, not only has the utility of the drug being demonstrated but also a strong link has been added to the chain of evidence showing a causal relationship between elevated serum cholesterol levels and heart disease.</p>
<p>Factors used to compare Experimental and Control Groups: These are:</p>
<ol>
<li>Age,</li>
<li>Sex,</li>
<li>Race.</li>
</ol>
<p>One cannot match individuals for factors whose influence are not known.</p>
<p>Those problems can be resolved by the random allocation of individuals to the experimental and control groups which ensure the comparability of these groups with respect to these factors – known and unknown, measurable and immeasurable except for the drug being studied.</p>
<p>In addition, randomization is the means by which the investigator avoids introducing conscious or sub-conscious bias into the process of allocating a degree of comparability to all other things being equal.</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="types-of-clinical-trials-these-are">Types of Clinical Trials: These are:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-clinical-trials-these-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Therapeutic trials: in these trials, therapeutic agent /procedure are given/used in an attempt to relieve symptoms and or improve survivorship of those with the disease. if in therapeutic trial, the therapeutic agent success successfully relieve the symptoms of disease or increases the survivorship of those with disease, then the agent may be used to treat the disease.</li>
<li>Intervention trials: in these trials the investigator intervenes before the disease develops in individuals with a characteristic that increases their risk of developing the disease. Intervention trials are used to reduce the risk factors by intervention.</li>
<li>Preventive [prophylactic] trials: in this trial all attempts are made to determine the efficacy of preventive agent/procedure.</li>
<li>Seization: Experiment: this experiment is used to evaluate the termination of living habits considered to be of etiological importance. To confirm the association between cigarette smoking and lung cancer, one would select a group of smokers and randomly allocate them to two groups. The first group continues with cigarette smoking and the second group stops/seizes smoking. If lung cancer mortality in the second group is lower than in the first group, causal implication is obvious.</li>
</ol>
<p>The testing of preventive agent can be illustrated by a vaccine or a given disease or some form of chemoprophylaxis such as Isoniazid for TB. If randomized clinical trial shows that the vaccine [chemo prophylactic agent] lowers the incident of disease, then that vaccine or agent may be used as a preventive measure against the disease.</p>
<p>TYPES AND EXAMPLES OF CLINICAL TRIALS</p>
<table><thead><tr><th>TYPE</th><th>EXAMPLES</th></tr></thead><tbody><tr><td>Therapeutic trials</td><td>○ Lesser treatment for diabetic retinopathy.</td></tr><tr><td>○ Simple mastectomy for breast cancer.</td><td></td></tr><tr><td>Intervention trials</td><td>○ Anti-hypertensive drugs which</td></tr></tbody></table>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>|   | reduces the risk of developing stroke.
○ Physical exercise for decreasing the risk of myocardial infarction.  |
| --- | --- |
|  Preventive trials | ○ BCG vaccination for TB.
○ Ionized drugs for preventing TB.  |</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="selection-of-study-groups">SELECTION OF STUDY GROUPS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#selection-of-study-groups" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>At the beginning of a clinical trial, a decision regarding the characteristics of a population [reference population] to be studied must be made e.g. age, sex, disease characteristics, etc making the population eligible for inclusion in the experiment.</p>
<p>In brief, the investigator selects a reference target population that may be composed of people suffering from a certain disease [a set of characteristics related to the disease / persons in a specific age group, geographical area or occupations that would suggest their inclusion in the study.</p>
<p>The type of reference population selected depends on the purpose of the study as well as the difficulties in reaching the individuals. Once a target population has been selected, the participants in the trial must be recruited. Several strategies are involved but can generally be classified into:</p>
<ol>
<li>Accrual [accumulative] strategy: where the subjects needed for trial are recruited during the course of the study.</li>
<li>Non-accrual strategy: where the subjects needed for trial are recruited before the study begins.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="historical-controls">HISTORICAL CONTROLS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#historical-controls" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Historical controls are selected from patients who have been treated in the past so that their outcome may be compared with that of patients using new method. The term is also used to decide a group of patients using drugs and compared to a much broader group prior to the experiment to the standard form of treatment. In this method there is no allocation of treatment and control groups. Such comparison is normally used if prior experience with a disease indicates that the standard method of treatment had resulted into very high case fatality rates such as 95%. This was the case with procaine penicillin. Before its introduction, the case fatality rate from some infections was 100% and this was sharply reduced when the infections were treated with procaine penicillin.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="problems-experienced-in-these-studies">Problems Experienced in These Studies:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#problems-experienced-in-these-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>Volunteers: in many studies only volunteers can be used. This limits the reference that can be derived from the results.</li>
<li>Refusal to continue [withdrawals]: in any follow-up study, there are those who at one point withdraw from the study.</li>
<li>Lost to follow-up: there are those who die during the study.</li>
</ol>
<p><img src="assets/images/image-20251226-ec7b261d.jpeg" alt="img-7.jpeg"></p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="ethical-consideration">ETHICAL CONSIDERATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ethical-consideration" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Clinical trials are similar to observation studies in many ways; however, because of random allocation of subjects of the experimental and control groups, certain ethical questions arise naturally. It is important therefore that before a trial can be carried out:</p>
<ol>
<li>The consent of the subjects must be obtained.</li>
<li>It is also important that the subject must be informed that they may be assigned to either the experimental or control groups.</li>
</ol>
<p><strong>Consent</strong>: Consent is the agreement of the volunteer to participate in the protocol. It involves more than a signature or agreement to sign a form obtained BEFORE any study specific procedures are done.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="informed-consent">Informed Consent:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#informed-consent" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>i. The volunteer is provided with all available information about the trial.
ii. The volunteer demonstrates understanding.
iii. The volunteer agrees to participate in the study.</p>
<p>If the subject, though provided with this information still decides to participate in the study then they are said to have given their “informed consent.” Such concerns should be obtained in accordance with the regulations of government agencies or of the institution where the trial is to be conducted. The following are the ethical consideration in clinical trial.</p>
<ol>
<li>Is the proposed treatment safe [unlikely to bring harm to] for the patient?</li>
<li>For the sake of controlled trials can the treatment ethically be withheld from any patient in doctor’s case?</li>
<li>Which patient may be brought into controlled trial and allocated randomly to any of the different treatments?</li>
<li>Is it ethical to use placebo [Anything of no direct medical benefit which nevertheless makes people feel better or benefit psychologically] or dummy treatment?</li>
<li>Is it proper for the trial to be in any way blind?</li>
</ol>
<p><strong>Consent Process</strong>: This is a series of steps over time:</p>
<ol>
<li>Provide information</li>
<li>Allow adequate time</li>
</ol>
<p>Prepared by O.E. Akoth
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="3">
<li>Assess comprehension</li>
<li>Address other influences of their decision</li>
<li>Obtain their decision or consent</li>
</ol>
<p><strong>Informed Consent Document:</strong> This document contains the following:</p>
<ol>
<li>Research</li>
<li>Purpose</li>
<li>Assignment</li>
<li>Trial procedures</li>
<li>Duration</li>
<li>Confidentiality</li>
<li>New findings</li>
<li>Contact information</li>
<li>Termination of participation</li>
<li>Risks</li>
<li>Benefits</li>
<li>Alternatives</li>
<li>Compensation</li>
<li>Experimental aspects</li>
<li>Anticipated expenses</li>
<li>Voluntary participation</li>
<li>Access to records</li>
<li>Number of volunteers.</li>
<li>Volunteer responsibilities.</li>
</ol>
<p>Prepared by O.E. Akoth
This document is available on
studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>114
Prepared by O.E. Akoth
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="general-plan-of-a-clinical-trial">GENERAL PLAN OF A CLINICAL TRIAL<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-plan-of-a-clinical-trial" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>The plan of a clinical trial is formerly stated in protocol [A procedure for how an activity should be performed] which contains the objectives and specific procedure to be used in the trial. It must be written before the trial starts and should contain such information as the methods of selecting the study groups and details for the performance of any laboratory tests. During the trial, if any question arises because of a given contingency, the protocol is referred to as the guide for what the investigator is to do.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="general-out-line-of-a-protocol-for-clinical-trial">GENERAL OUT-LINE OF A PROTOCOL FOR CLINICAL TRIAL<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#general-out-line-of-a-protocol-for-clinical-trial" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Rational background of the study.</li>
<li>Specific objectives of the study.</li>
<li>Concise [Expressing much in few words] statement of the study design [masking, randomization schemes, types and duration of treatment and number of patients].</li>
<li>Criterion [A basis for comparison; a reference point against which other things can be evaluated] for inclusion and exclusion of subjects.</li>
<li>Out-line of treatment procedures.</li>
<li>Definition of clinical, laboratory etc methods.</li>
<li>Methods of assuring the integrity [An undivided or unbroken completeness or totality with nothing wanting] of data.</li>
<li>Major and minor points [death, myocardial infarction]</li>
<li>Provision of observing and recording side effects.</li>
<li>Procedure of handling problems/cases.</li>
<li>Procedure of obtaining informed consent from the subjects.</li>
<li>Procedure of analyzing data.</li>
<li>Appendices.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="community-trials">COMMUNITY TRIALS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#community-trials" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>These are experiments/trials or field trials that involve communities as wholes, whether in animals or humans. They are used to determine the efficacy of a drug or a procedure.</p>
<p>In community trials, a group as a whole is collectively studied, while in a clinical trial, it is the individual within the group [the experimental or control group] that is studied.</p>
<p>Studies in which epidemics are experimentally produced in groups of animals are also called community trials.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="human-trial">HUMAN TRIAL<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#human-trial" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Human trials have been conducted when particular circumstances require that community as a whole serve as experimental unit with regard to testing specific etiological hypothesis or a preventive procedure. The very nature of such trials does not usually allow for the use of randomization. An example of this type of trial is the introduction of fluoride into community water supply in order to determine whether it would decrease frequency of dental carriers.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="unit-8">UNIT 8<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#unit-8" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="disease-surveilance">DISEASE SURVEILANCE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disease-surveilance" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><strong>Public health surveillance</strong>: Public health surveillance is the continuous, systematic collection, analysis and interpretation of health-related data needed for the planning, implementation, and evaluation of public health practice. Such surveillance can:</p>
<ol>
<li>Serve as an early warning system for impending public health emergencies;</li>
<li>Document the impact of an intervention, or track progress towards specified goals; and</li>
<li>Monitor and clarify the epidemiology of health problems, to allow priorities to be set and to inform public health policy and strategies.</li>
</ol>
<p>The concept of <strong>workplace health surveillance</strong> is new to occupational safety and health and is frequently confused with medical screening. Health screening refers to the early detection and treatment of diseases associated with particular occupations, while workplace health surveillance refers to the removal of the causative factors.</p>
<p>NIOSH defines occupational health surveillance as “the tracking of occupational injuries, illnesses, hazards, and exposures.” The Joint ILO/WHO Committee on Occupational Health at its 12th Session in 1995 defined an occupational health surveillance system as “a system which includes a functional capacity for data collection, analysis and dissemination linked to occupational health programmes”</p>
<p>Public health surveillance is the ongoing systematic collection, analysis, and interpretation of data, closely integrated with the timely dissemination of these data to those responsible for preventing and controlling disease and injury (Thacker and Berkelman 1988). Public health surveillance is a tool to estimate the health status and behavior of the populations served by</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>ministries of health, ministries of finance, and donors. Because surveillance can directly measure what is going on in the population, it is useful both for measuring the need for interventions and for directly measuring the effects of interventions. The purpose of surveillance is to empower decision makers to lead and manage more effectively by providing timely, useful evidence.</p>
<p>Increasingly, top managers in ministries of health and finance in developing countries and donor agencies are recognizing that data from effective surveillance systems are useful for targeting resources and evaluating programs. The HIV and severe acute respiratory syndrome (SARS) epidemics underscored the critical role of surveillance in protecting individual nations and the global community. For example, in 2005, China rapidly began to expand its surveillance and response capacity through its Field Epidemiology Training Program (FETP); Brazil and Argentina chose to use World Bank loans to develop surveillance capacity; and the U.S. Agency for International Development (USAID) redesigned its surveillance strategy to focus on the use of data to improve public health interventions (USAID 2005). Additionally, the guidelines for implementing the 2004 draft revised International Health Regulations require World Health Organization (WHO) member states to have key persons and core capacities in surveillance.</p>
<p>Just as decision makers require competent, motivated economists to provide quality technical analyses, they also need competent staff members to provide scientifically valid surveillance information and communicate the results as information for action. Competent epidemiologists and surveillance staff members are not a luxury in developing countries; they are a necessity for rational planning, implementation, and intervention.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="definitions-and-basic-concepts-of-terms-used-in-public-health-surveillance">Definitions and Basic Concepts of Terms Used in Public Health Surveillance<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#definitions-and-basic-concepts-of-terms-used-in-public-health-surveillance" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Indicator: a measurable factor that allows decision makers to estimate objectively the size of a health problem and monitor the processes, the products, or the effects of an intervention on the population (for example, the number of new cases of diarrhea, the proportion of children fully immunized in a district, or the percentage of high school students who report that they smoke at least one cigarette a day).</p>
</li>
<li>
<p>Active surveillance: a system employing staff members to regularly contact heath care providers or the population to seek information about health conditions. Active surveillance provides the most accurate and timely information, but it is also expensive.</p>
</li>
<li>
<p>Passive surveillance: a system by which a health jurisdiction receives reports submitted from hospitals, clinics, public health units, or other sources. Passive surveillance is a relatively inexpensive strategy to cover large areas, and it provides critical information for monitoring a community's health. However, because passive surveillance depends on people in different institutions to provide data, data quality and timeliness are difficult to control.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="4">
<li>
<p>Routine health information system: a passive system in which regular reports about diseases and programs are completed by public health staff members, hospitals, and clinics.</p>
</li>
<li>
<p>Health information and management system: a passive system by which routine reports about financial, logistic, and other processes involved in the administration of the public health and clinical systems can be used for surveillance.</p>
</li>
<li>
<p>Categorical surveillance: an active or passive system that focuses on one or more diseases or behaviors of interest to an intervention program. These systems are useful for program managers. However, they may be inefficient at the district or local level, at which staff may need to fill out multiple forms on the same patient (that is, the HIV program, the tuberculosis program, the sexually transmitted infections program, and the Routine Health Information System). At higher levels, allocating the few competent surveillance experts to one program may leave other programs under-served, and reconciling the results of different systems to establish the nation's official estimates may be difficult.</p>
</li>
<li>
<p>Integrated surveillance: a combination of active and passive systems using a single infrastructure that gathers information about multiple diseases or behaviors of interest to several intervention programs (for example, a health facility-based system may gather information on multiple infectious diseases and injuries). Managers of disease-specific programs may be evaluated on the results of the integrated system and should be stakeholders. Even when an integrated system is functioning well, program managers may continue to maintain categorical systems to collect additional disease-specific data and control the quality of the information on which they are evaluated. This practice may lead to duplication and inefficiency.</p>
</li>
<li>
<p>Syndromic surveillance: an active or passive system that uses case definitions that are based entirely on clinical features without any clinical or laboratory diagnosis (for example, collecting the number of cases of diarrhea rather than cases of cholera, or "rash illness" rather than measles). Because syndromic surveillance is inexpensive and is faster than systems that require laboratory confirmation, it is often the first kind of surveillance begun in a developing country. However, because of the lack of specificity (for example, a "rash illness" could be anything from the relatively minor rubella to devastating hemorrhagic fevers), reports require more investigation from higher levels. Also an increase in one disease causing a syndrome may mask an epidemic of another (for example, rotavirus diarrhea decreases at the same time cholera increases).</p>
</li>
<li>
<p>In the specialized area of surveillance for biologic terrorism, syndromic surveillance refers to active surveillance of syndromes that may be caused by potential agents used by</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>biologic terrorists and sometimes refers to alternative measures such as increases in the use of over-the-counter drugs or increases in calls to emergency departments.</p>
<ol start="10">
<li>Behavioral risk factor surveillance system (BRFSS): an active system of repeated surveys that measure behaviors that are known to cause disease or injury (for example, tobacco or alcohol use, unprotected sex, or lack of physical exercise). Because the aim of many intervention program strategies is to prevent disease by preventing unhealthy behavior, these surveys provide a direct measure of their effect in the population, often long before the anticipated health effects are expected. These surveys are useful for providing timely measures of program effectiveness for both communicable and non-communicable disease interventions.</li>
</ol>
<p>Objectives of Surveillance Systems: Public health surveillance provides the scientific and factual database essential to informed decision making and appropriate public health action. The key objective of surveillance is to provide information to guide interventions. The public health objectives and actions needed to make successful interventions determine the design and implementation of surveillance systems. For example, if the objective is to prevent the spread of epidemics of acute infectious diseases, such as SARS, managers need to intervene quickly to stop the spread of disease. Therefore, they need a surveillance system that provides rapid early warning information from clinics and laboratories. In contrast, chronic diseases and health-related behaviors change slowly. Managers typically monitor the effect of programs to change risky behaviors such as tobacco smoking or chronic diseases once a year or even less often. A surveillance system to measure the population effects of a tuberculosis control program might provide information only every one to five years—for example, through a series of demographic and health surveys. The principle is that different public health objectives and the actions required to reach them require different information systems. The type of action that can be taken, when or how often that action needs to be taken, what information is needed to take or monitor the action, and when or how frequently the information is needed should determine the type of surveillance or health information system.</p>
<p>Principles and Uses of Surveillance: Foege, Hogan, and Newton (1976) state that "the reason for collecting, analyzing, and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow." The fundamental principle of public health surveillance is that the surveillance should be designed and implemented to provide valid (true) information to decision makers in a timely manner at the lowest possible cost. Because managers are unlikely to need to make interventions to address small differences between areas, sacrificing precision makes sense to improve timeliness and save resources that can be used for public health interventions. The utility of surveillance data can be viewed as immediate, annual, and archival, on the basis of the public health actions that can be taken.</p>
<p>Establishing and Maintaining a Surveillance System: What is worth doing is worth doing right. Managers who decide to use public health surveillance as a management tool must recognize that they will need to commit political support and human and financial resources. As with every health system, competent, motivated health workers need to be found or trained and provided with career paths and supervision. After a manager decides to create a surveillance</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>system, there are six steps to establishing the system. Because the system must adapt constantly to changes in the population and the physical and social environment, these steps are linked continuously.</p>
<p><strong>Analysis and Dissemination of Surveillance Data</strong>: Surveillance information is analyzed by time, place, and person. Knowledgeable technical personnel should review data regularly to ensure their validity and to identify information of use to top managers. Simple tables and graphs are most useful for summarizing and presenting data. Timely dissemination of data to those who make policy and implement intervention programs is critical to the usefulness of surveillance data.</p>
<p>The rapidly evolving field of public health informatics, which deals with collection, classification, storage, retrieval, analysis, and presentation of large amounts of health data, offers the potential for truly integrated public health surveillance based on data standardization, a communications infrastructure, and policies on data access and sharing. Surveillance will benefit by incorporating a systematic approach to standards for data content. For example, the U.S. Centers for Disease Control and Prevention (CDC) has used standards-based systems to support automatic electronic reporting of diagnostic laboratory results of notifiable diseases, thereby both increasing the number of cases reported and receiving results more rapidly). Use of data standards facilitates comparability of surveillance information over time (for example, measurement of effect of program interventions), across different surveillance approaches (for example, facility-based reporting compared with sample surveys), and across countries and regions. To be credible, a standard should be developed through an open, participatory process, by an internationally recognized accredited standards-development organization that is also capable of long-term maintenance and evolution of the standard. Public health data needs extend into multiple areas beyond clinical medicine (for example, environmental toxins, unintentional injury, and food safety).</p>
<p><strong>Surveillance as a Component of National Public Health Systems</strong>: WHO and the World Bank cite public health surveillance as an essential function of a public health system. When linked to policy and program units, surveillance information improves the efficiency and effectiveness of health services by targeting interventions and documenting their effect on the population.</p>
<p>A critical challenge in the health sector in developing countries is to ensure quality and effectiveness of surveillance and public health response in an environment of decentralization. National-level program and surveillance system managers may lose control of the quality and timeliness of locally collected data. This situation can be avoided by training local decision makers in how to use information to meet their needs and negotiating with them over the core information collected by each district local unit. National-level managers or donors can also improve information quality by sponsoring national surveillance scientific and quality assurance networks, linking funding to provision of adequate data, and performing periodic surveys to confirm the results of local reporting. If the responsibility for implementing programs is devolved to local managers, then national-level managers need only a few summary indicators,</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>rather than the detailed information they may be used to. District or local managers tend to prefer integrated systems to minimize filling out redundant forms.</p>
<p>Donors need surveillance data to target and evaluate their investments. If they perceive weakness in the national system, they may create parallel nongovernmental surveillance systems to gather data directly to meet their needs. These systems invariably pay workers more than government jobs do, so the most competent people in the government system may leave to work for the parallel system. Although this system meets donors' short-term needs, it invariably weakens government systems. Parallel systems may weaken the very ministries that they are meant to help and may not be sustainable after external funding ends. Therefore, parallel systems are inherently inequitable and should be used only as a last resort.</p>
<p><strong>Surveillance as a Tool to Improve Public Health:</strong> Managers need focused, timely, scientifically sound information that provides evidence to make decisions on interventions for improving the health of the population in their jurisdiction. Simply collecting data and presenting them are not enough.</p>
<p><strong>Using Surveillance Information for Evidence-based Decisions:</strong> A major gap in promoting effective surveillance lies between the production of data and the ability to convert those data into usable information and then initiate the appropriate public health action. Surveillance and response can be described in terms of a data generation hemisphere and a data use hemisphere). The data generation hemisphere is the traditional view of surveillance, whereas the data use hemisphere is the public health response that begins with interpretation of the data from the surveillance system.</p>
<p><strong>Surveillance and Response Conceptual Framework:</strong> Substantial attention and the accompanying resources in surveillance have been devoted to the prompt and complete production of surveillance data. Although developing countries experience weaknesses in both hemispheres, more attention is needed to creating and strengthening the local capacity within developing countries to identify and manage effective responses to disease outbreaks and public health conditions of national and international concern. In some disease-specific programs, this capacity has to be imported through short-term expatriate assistance. Even when local capacity is developed, it is often specific to the disease program, making transfer of skills to other areas problematic. The failure to develop this indigenous capacity has limited the ability of developing countries to build national surveillance systems that respond to both international public health threats and local health concerns. This capability is essential to the sustained development of countries.</p>
<p><strong>Role of Field Epidemiologists in Providing Evidence:</strong> Developed countries have constructed their public health and disease control strategies by using the principles of field epidemiology. Developing countries need to build and sustain human capacity in field epidemiology. Strengthened field epidemiologic capacity can serve a country in the following specific areas:</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>Providing a response to acute problems</li>
<li>Providing the scientific basis for program and policy decisions</li>
<li>Implementing disease surveillance systems</li>
<li>Supporting national health planning</li>
<li>Making resource allocation decisions</li>
<li>Allocating the human capacity base for national health priorities.</li>
</ol>
<p>Specific competencies that should be developed include, but are not limited to, the ability to accomplish the following:</p>
<ol start="3">
<li>Design, implement, and evaluate surveillance for a health event</li>
<li>Identify and assess an actual public health problem</li>
<li>Design and conduct a scientific investigation</li>
<li>Analyze and interpret data from an investigation</li>
<li>Recommend logical and practical public health actions after the analysis and interpretation of data</li>
<li>Be proficient in all aspects of diseases of public health importance (for example, HIV and AIDS, sexually transmitted diseases, malaria, tuberculosis, and zoonoses).</li>
</ol>
<p>These competencies need to be tailored to the various levels of the health care system.</p>
<p><strong>Selected Surveillance Strategies:</strong> Surveillance systems need to be designed and implemented to meet top management's needs for focused, reliable, timely evidence gathered efficiently and presented effectively. Because these needs differ, depending on management's needs, a number of different strategies have been developed. Here are some of the most useful.</p>
<p><strong>Sentinel Surveillance:</strong> In a sentinel surveillance system, a prearranged sample of reporting sources agrees to report all cases of defined conditions, which might indicate trends in the entire target population. When properly implemented, these systems offer an effective method of using limited resources and enable prompt and flexible monitoring and investigation of suspected public health problems. Examples of sentinel surveillance are networks of private practitioners reporting cases of influenza or a laboratory-based sentinel system reporting cases of certain bacterial infections among children. Sentinel surveillance is excellent for detecting large public health problems, but it may be insensitive to rare events, such as the early emergence of a new disease, because these infections may emerge anywhere in the population.</p>
<p><strong>Periodic Population-based Surveys:</strong> Population-based surveys can be used for surveillance if they are repeated on a regular basis). Examples of population-based surveys in surveillance include the BRFSS in the United States, HIV-prevalence surveys, household surveys, and the demographic and health surveys that many developing countries conduct every five years. Population-based surveys require careful attention to the methodology, particularly the use of standard protocols, supervision of interviewers, comparable sampling strategy, and standard questionnaires. These surveys require a clear definition of the target population to which the</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>results can be generalized, and they need careful attention to the sample size, based on efficiency and the epidemiologic characteristics of the health condition under surveillance (for example, rare conditions require substantial samples). Supervising interviewers and maintaining high response rates are critical to avoid bias. Because the surveys are repetitive, population changes (caused, for example, by mortality or mobility) might bias results.</p>
<p><strong>Environmental Public Health Surveillance</strong>: Surveillance for environmental public health practice requires the collection, analysis, and dissemination of data on hazards, exposures, and health outcomes.</p>
<p><strong>The Process of Adverse Effects and the Corresponding Surveillance</strong>: Health outcomes of relevance include death, disease, injury, and disability. However, relating those outcomes to specific environmental hazards and exposures is critical to environmental public health surveillance. Hazards include toxic chemical agents, physical agents, biomechanical stressors, and biologic agents that are located in air, water, soil, food, and other environmental media. Exposure surveillance is the monitoring of members of the population for the presence of an environmental agent, its metabolites, or its clinically in apparent (for example, subclinical or preclinical) effects.</p>
<p>Four challenges complicate environmental public health surveillance. First, the ability to link specific environmental causes to adverse outcomes is limited by our poor understanding of disease processes, long lead times, inadequate measures of exposure, and multiple potential causes of disease. Second, data collected for other purposes rarely include sufficient information to meet a case definition for a condition caused by an environmental agent. Third, public alarm is often out of proportion to the hazard of concern, and sentiment will often influence public policy disproportionately to scientific information. Fourth, biologic markers will become increasingly critical elements of environmental exposure surveillance.</p>
<p>Obtaining data on exposure, which can include estimates derived from hazard data through sophisticated modeling or direct measurements of individual exposure obtained from use of personal monitors (for example, passive air samplers), is generally impractical in developing countries. Childhood blood lead levels are the only bio-monitoring data that are collected routinely in several countries, either in national surveys or from screening programs for children at high risk.</p>
<p>Health outcome surveillance as applied to environmental public health is similar to traditional surveillance efforts. In the United States, the focus is on surveillance for birth defects; developmental disabilities (for example, cerebral palsy, autism, and mental retardation); asthma and other chronic respiratory diseases (for example, bronchitis and emphysema); cancer; and neurological diseases (for example, Parkinson's disease, multiple sclerosis, and Alzheimer's disease). Other nations have different sets of priority conditions for surveillance. Disease registries, vital statistics data, annual health surveys, and administrative data systems (for example, hospital discharge data) are sources that have been used for monitoring health</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>conditions. The challenges mentioned previously have constrained our ability in all nations, regardless of level of development, to establish and maintain effective and comprehensive environmental public health surveillance systems. As we invest in understanding the enlarging threats in the global environment, we must overcome these challenges and establish improved surveillance systems. The health of the global community depends on this investment.</p>
<p><strong>Injury Surveillance</strong>: Injuries are a major public health problem and are among the 10 leading causes of death worldwide, killing an estimated 5 million persons each year and causing high rates of disability. People from all economic groups are at risk for injuries, but death rates caused by injury tend to be higher in developing countries. Injury surveillance includes monitoring the incidence, causes, and circumstances of fatal and nonfatal injuries. Injuries are classified by the intention of the act into two groups: unintentional injuries and violence-related injuries. WHO and the Pan American Health Organization have developed guidelines for establishing injury surveillance systems in developing countries.</p>
<p>If the range of fatal and nonfatal injuries, as well as the risk factors that can lead to injury, are to be fully captured, surveillance systems need to be established in multiple settings. Fatal injuries can be captured by using forensic or death certificate data. A far greater number of injuries are nonfatal and can be tracked through hospital- or primary care-based systems. Systematic information on nonfatal injuries, including prevalence, incidence, and related risk behaviors can also be obtained through ongoing population-based surveys.</p>
<p>Critical points should be addressed when planning an injury surveillance system in a developing country. First, data sources need to be clarified. In some developing countries, routine data on injuries are not always captured in health information systems. It is therefore necessary to consider other sources of data—for example, law enforcement agencies, coroners, or medical examiners. Next, the events and variables in an injury surveillance system should be defined according to the objectives of the system. Criteria such as the intentionality (violence-related injuries versus unintentional injuries); the outcome (fatal injuries versus nonfatal injuries); and the nature of violence-related injuries (physical, sexual, psychological, deprivation, or neglect) should be considered when establishing the system. Finally, case definitions and coding procedures should be defined before implementing the system</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="epidemiological-surveillance">EPIDEMIOLOGICAL SURVEILLANCE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#epidemiological-surveillance" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This is an ongoing or continuous systemic collection, analysis and interpretation of health data essential to the planning, implementation and evaluations of public health practice as well as the timely dissemination of these data to those who need to know.</p>
<p>Epidemiologic surveillance may be carried out to monitor changes in disease frequency and changes in prevalence of risk factors. Much information on morbidity and mortality of diseases come from programs of systemic disease surveillance.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Epidemiologic surveillance is most frequently conducted for infectious diseases but in recent years it has become increasingly important in monitoring changes in other types of conditions such as congenital malformation, cancer, asthma, and chemical poisoning, injuries and illnesses; after disasters hurricanes or earthquakes.</p>
<p>The aim of epidemiologic Surveillance:</p>
<ol>
<li>To estimate the epidemiological importance of disease in order to identify health needs and to rank priorities of health actions.</li>
<li>Measures the impacts of health actions.</li>
<li>Identify health problems that need immediate actions.</li>
<li>Select major fields of research.</li>
</ol>
<p>Epidemiologic Surveillance is also used to monitor:</p>
<ol>
<li>Completeness of vaccination and immunization coverage,</li>
<li>Population protection,</li>
<li>The prevalence of drug resistance,</li>
<li>Organisms such as drug resistant T.B. and Malaria.</li>
</ol>
<p>Surveillance is carried out by observing trends in:</p>
<ol>
<li>Time when the effect occurs</li>
<li>Place where the effect occurs and</li>
<li>Persons who is affected?</li>
</ol>
<p>Changes can be observed or anticipated then appropriate action including investigative or control measures taken.</p>
<p>Sources of surveillance data should relate directly to:</p>
<ol>
<li>Disease or</li>
<li>Factors influencing health.</li>
</ol>
<p>These sources include:</p>
<ol>
<li>Registration of births,</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="2">
<li>
<p>Morbidity and mortality rates reports based on:
i. Death certificates
ii. Hospital records
iii. General practice sentinels or
iv. Notification of diseases.</p>
</li>
<li>
<p>Laboratory diagnosis,</p>
</li>
<li>
<p>Out-breaks of epidemics,</p>
</li>
<li>
<p>Vaccine utilization – up-take and side effects,</p>
</li>
<li>
<p>Sickness absence reports or records,</p>
</li>
<li>
<p>Disease determinants such as biological changes in:
a. Agent,
b. Vectors,
c. Reservoirs.</p>
</li>
<li>
<p>Data concerning availability, use and untoward effect of vaccine and toxoids, immune globins, insecticides and other substances in control.</p>
</li>
<li>
<p>Information regarding immunity levels in segment populations.</p>
</li>
<li>
<p>Investigation of individual cases and epidemics,</p>
</li>
<li>
<p>Distribution of animal reservoir and vector,</p>
</li>
<li>
<p>Production, distribution and care of vaccines, sera and drugs,</p>
</li>
<li>
<p>Demographic data,</p>
</li>
<li>
<p>Environmental data.</p>
</li>
</ol>
<p><strong>Effective of surveillance</strong>: This depends on the:</p>
<ol>
<li>Data derived survey and programs,</li>
<li>Mechanism by which pertinent epidemiological data are brought together to be evaluated, correlated and interpreted by competent epidemiologists. Most programs, control and eradication use surveillance to:</li>
</ol>
<p>125
Prepared by O.E. Akoth</p>
<p>This document is available on
studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>a) Make initial assessment,
b) Evaluate the progress of the program.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="purpose-of-epidemiologic-surveillance">Purpose of Epidemiologic Surveillance:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#purpose-of-epidemiologic-surveillance" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Planning for public health programs,</li>
<li>Identification of disease occurrence changes,</li>
<li>Identification of risk factors associated with disease and suggests hypothesis.</li>
<li>To look at case-control study e.g. AIDS pandemic.</li>
<li>Monitor safety and effectiveness of preventive and control measures.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="components-of-epidemiologic-surveillance-these-are">Components of Epidemiologic Surveillance: These are:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#components-of-epidemiologic-surveillance-these-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Study population,</li>
<li>Target population,</li>
<li>Resources,</li>
<li>Planning.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="forms-of-epidemiologic-surveillance-these-are">Forms of Epidemiologic Surveillance These are:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#forms-of-epidemiologic-surveillance-these-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Individual case investigation [applicable in infections e.g. paralytic polio, Ebola, Yellow fever, Cancer e.t.c.]</li>
<li>Epidemic reporting,</li>
<li>Sentinel system [screening without informing the individuals being screened],</li>
<li>Health surveys [incidences and prevalence]</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="activities-involved-in-surveillance-these-are">Activities Involved in Surveillance: These are:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#activities-involved-in-surveillance-these-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Data collection,</li>
<li>Data analysis,</li>
<li>Data summary,</li>
<li>Data presentation,</li>
<li>Case identification,</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="6">
<li>Logistic management [helps in determining conducts of personnel]</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-epidemiologic-surveillance-data-these-are">Types of Epidemiologic Surveillance Data: These are:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-epidemiologic-surveillance-data-these-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Mortality data whose sources are:
a. Health institutions,
b. Formal and informal leaders.</p>
</li>
<li>
<p>Morbidity data generated by notification of diseases under Public Health cap. 242 LOK.</p>
</li>
<li>
<p>Laboratory data given out during epidemics and during analysis of an item.</p>
</li>
<li>
<p>Drug use data,</p>
</li>
<li>
<p>Performance survey data,</p>
</li>
<li>
<p>Demographic data,</p>
</li>
<li>
<p>Environmental data.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="uses-of-epidemiologic-surveillance-data-surveillance-data-are-basically-used-to-portray-the-natural-history-of-a-disease-they-are">Uses of Epidemiologic Surveillance Data: Surveillance data are basically used to portray the natural history of a disease. They are:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#uses-of-epidemiologic-surveillance-data-surveillance-data-are-basically-used-to-portray-the-natural-history-of-a-disease-they-are" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Trends,</p>
</li>
<li>
<p>Communicability,</p>
</li>
<li>
<p>Period of communicability,</p>
</li>
<li>
<p>It is used to test hypothesis e.g. utilization of health services,</p>
</li>
<li>
<p>It is used to monitor changes in infectious agents,</p>
</li>
<li>
<p>It is used to identify and evaluate control measures,</p>
</li>
<li>
<p>It is used to monitor isolation activities eg quarantine,</p>
</li>
<li>
<p>It is used to detect changes in health practices</p>
</li>
<li>
<p>It is used in planning.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="how-to-plan-epidemiologic-surveillance-data-collection">How to Plan Epidemiologic Surveillance Data Collection:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#how-to-plan-epidemiologic-surveillance-data-collection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Define roles,</p>
</li>
<li>
<p>Define resources,</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="3">
<li>Define management in-put.</li>
</ol>
<p><strong>Dissemination of Epidemiologic Surveillance Results:</strong> The main method is the media:-</p>
<ol>
<li>Electronic [internet, med-line, radio, TV etc],</li>
<li>Print.</li>
</ol>
<p>The information disseminated has acknowledgement of those who assisted.</p>
<p><strong>Criteria for Establishing an Epidemiologic Surveillance System:</strong></p>
<ol>
<li>The frequency and severity of the disease,</li>
<li>Case-fatality rate,</li>
<li>Segment of population:
a. Age differences,
b. Sex differences,
c. Occupation.</li>
<li>To introduce intervention,</li>
<li>Associate risk factors with prevention.</li>
</ol>
<p><strong>Factors to consider when establishing Epidemiologic Surveillance Systems:</strong></p>
<ol>
<li>Statement of objective</li>
<li>Definition of the problem within the community,</li>
<li>Identification of implementers of surveillance eg:
a. Health providers,
b. The community,
c. Health agencies.</li>
</ol>
<p>Epidemiologic Surveillance is divided into two types:</p>
<ol>
<li>Active Epidemiologic surveillance,</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="2">
<li>Passive Epidemiologic surveillance.</li>
</ol>
<p><strong>Passive Epidemiologic Surveillance</strong>: this involves collection of data on reportable diseases and examination of hospital records. Passive surveillance is relatively inexpensive and relatively easy to develop since the data collected concern morbidity and mortality within institution – health facility. The information collected helps in:</p>
<ol>
<li>Determining the trends and patterns of a disease,</li>
<li>Evaluating existing programs in disease control.</li>
</ol>
<p>In passive epidemiologic surveillance those expected to report new cases are often our burden by their primary responsibility of preventive health care and administering health services.</p>
<p><strong>Record Review</strong>: This is a form of passive epidemiologic surveillance which involves use of information obtained from routine record of activities.</p>
<p><strong>Active Epidemiologic Surveillance</strong>: This involves surveys. The surveys used in active surveillance are:</p>
<ol>
<li>Cross-sectional,</li>
<li>Longitudinal,</li>
<li>Sentinel centers.</li>
</ol>
<p>SURVEILLANCE</p>
<table><thead><tr><th>Active</th><th>Passive</th></tr></thead><tbody><tr><td>Routine</td><td>Records</td></tr><tr><td>Surveys</td><td>Epidemic</td></tr></tbody></table>
<p>investigation</p>
<p>129</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on
studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Cross-sectional Longitudinal Sentinel Center</p>
<p>In active epidemiologic surveillance, those involved are employed to carry out the responsibility and this makes it more accurate than passive surveillances.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="unit-9">UNIT 9<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#unit-9" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="out-break-or-epidemic-investigation">OUT-BREAK OR EPIDEMIC INVESTIGATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#out-break-or-epidemic-investigation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This is a form of active surveillance when there is an epidemic. This kind of surveillance or survey involves:</p>
<p>a. Interviews i.e.:</p>
<p>i. Questionnaire,
ii. Interview schedule.</p>
<p>b. Physical examination,
c. Specimen collection and examination,
d. Combination of all the above.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="system-of-carrying-out-disease-out-break-investigation">System of Carrying out Disease Out-Break Investigation:<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#system-of-carrying-out-disease-out-break-investigation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Confirm out-break [verification of diagnosis] by:</li>
</ol>
<p>i. Signs
ii. Symptoms,
iii. Laboratory,
iv. Records.</p>
<ol start="2">
<li>
<p>Identify the affected and their characteristics [A prominent attribute or aspect of something or a distinguishing quality].</p>
</li>
<li>
<p>Formulate hypothesis as to source of spread of epidemic based on what you are seeing,</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="4">
<li>Manage epidemic by:
i. Treating cases
ii. Preventing the spread of the epidemic using control measures'
iii. Writing report.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="case-investigation">CASE INVESTIGATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#case-investigation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Identify the information by:
a. Name and case number,
b. Age,
c. Sex'
d. Address of the family head and occupation,
e. Date of interview,
f. Name of interviewer.</p>
</li>
<li>
<p>Clinical information:
a. Signs,
b. Symptoms.</p>
</li>
<li>
<p>Past medical history:
a. Immunization status,
b. Any previous cases.</p>
</li>
<li>
<p>Laboratory information:
a. The agent isolated,
b. Body response to the agent.</p>
</li>
<li>
<p>Possible source of infection,</p>
</li>
<li>
<p>Contacts since infection.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="format-of-an-epidemiologic-investigation">FORMAT OF AN EPIDEMIOLOGIC INVESTIGATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#format-of-an-epidemiologic-investigation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>131</p>
<p>Prepared by O.E. Akoth
This document is available on
studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p><img src="assets/images/image-20251226-958115c2.jpeg" alt="img-8.jpeg">
START
Own observation
Suggestion from
Others
idear a problem
for investigation
Conduct search for
post studies records
of similar situations
post records
past studies
Journal articles
Unpublished data
Possibility of problem
No
Yes
End
State problem
Formulate hypothesis
Determine objectives
Determine methods
Study design
Sampling
Aspects
Measurements required
Instruments
Study aspects
Materials
Implement study
Collect data
Process data
administration
and Logistics
Observation
population
Study Materials
Transport
Schedule
manpower
Communication
shelter
Prepared by O.E. Akoth
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Finance</p>
<p>Analyze data</p>
<p>Present data</p>
<p>End</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="the-study-population">THE STUDY POPULATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#the-study-population" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>This is the population of individual units [whether they are persons, families, medical records, certificates, nursery schools etc] to be investigated.</p>
<p>Epidemiologically, a human population is a group of people including both sick and healthy about whose health statement is to be made or any group of people defined in a specific way. This is known as target population. A subset of this is the study population. Usually, the study population will be larger than the one the investigation requires and actual examination will be limited to a sample of this population.</p>
<p>All epidemiological findings must relate to the defined population. It relates the disease to the population in which it occurs in terms of location and restriction to a particular age-group, sex, or occupation.</p>
<p>For example, if the study is to determine the nutrition status of children in Kuria District, then the population must comprise children in Kuria District. One needs to be more specific in terms of age limits of the children and their migration status.</p>
<p>It is usually unnecessary and impractical to make observations on an entire population such as all children in Kuria district.</p>
<p>A properly selected sample of appropriate size which is usually referred to as a representative sample, will enable generalization to be made about the population.</p>
<p>For example, if a study is to</p>
<p>If it is human study population, then the following decisions are considered:</p>
<p>133</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>a) Description of the study population in terms of place, time, and any other relevant criteria [A basis for comparison; a reference point against which other things can be evaluated]</p>
<p>i. If the study comprises cases of disease, the procedures to be used for case identification should be tested</p>
<p>ii. If controls are to be chosen, their method of selection should be stated.</p>
<p>iii. Selecting the study population depends on objectives [The goal intended to be attained (and which is believed to be attainable)] of the study otherwise this is where there is likely to be variations which may not validate the subsequent generalization from the findings e.g.</p>
<ol>
<li>
<p>Volunteer populations: persons who volunteer to enter a study or submit to a procedure may be different in many respects from those who do not volunteer therefore the findings in a volunteer population do not necessarily apply to the population at large.</p>
</li>
<li>
<p>Persons diagnosed as having a disease: Such persons are not necessarily a representative of all those who have the disease for the following reasons:</p>
</li>
</ol>
<p>i. Differences between population groups in the availability and use of medical services and the,</p>
<p>ii. Establishment of diagnosis may be influenced by the diagnostic facilities available, the severity of symptoms, cases with wild or no symptoms may remain undiagnosed.</p>
<ol start="3">
<li>Hospitals or clinics: persons receiving medical care are obviously not representatives of general population or necessarily of all ill persons.</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="4">
<li>
<p>Population with good medical records: this is essential for studies like surveys of work of general practitioners whereby doctors are selected for comparison.</p>
</li>
<li>
<p>Persons living at home: a study population comprises persons living at home. This may exclude those who are in hospitals and other institutions.</p>
</li>
<li>
<p>Autopsy populations: persons submitted to autopsy [An examination and dissection or post-mortem of/on a dead body to determine cause of death or the changes produced by disease] e.g. those suspected or diagnosed as cancer cases.</p>
</li>
<li>
<p>Groups characterized by their behavior or occupation: These are:
i. Smokers
ii. Joggers
iii. Migrants
iv. Truck drivers</p>
</li>
<li>
<p>Population in which the same individuals appear more than once: if the same individuals appear more than once in a study population, the findings in these individuals may have an undue effect on the results. This may arise because a researcher may not obtain the required information due to over researching based on the past findings.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sampling">SAMPLING<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sampling" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Conditions for sampling are:
a. Sample must be well chosen so as to be representative of the parent population.
b. Sample must be sufficiently large so that if a number of representative samples are drawn from the same parent population and are investigated by chance there</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>will be difference between findings in each sample. This is a problem of sampling variations which is minimized by selecting a large sample.</p>
<p>c. There must be adequate coverage of the sample to minimize sample bias.</p>
<p>The most commonly used sampling technique is:</p>
<ol>
<li>
<p>Sample size: to generalize sample observation to the study population, one needs to work out an appropriate sample size. Although samples cannot be exactly representative of the study population, it should give a reasonable estimate of what happens in the study population. The larger the sample the more precise the sample estimate will become. This needs to be examined against the cost and the time that the sample will require.</p>
</li>
<li>
<p>Choice of sample size: A sample must be chosen in such a way that specified sampling error [qualitative data] or standard error [quantitative data] are taken into account while calculating the size that gives the degree of precision that is required. The dominant considerations in the choice of the sample size are practical ones such as the availability of resources, staff and time. In descriptive observational study this may be acceptable as long as accompanying errors may not reveal the effect of the measure thus not meriting any form firm conclusions. It should be noted that there are many other sources of errors such as:</p>
</li>
</ol>
<p>a) Mistakes in the measurements,</p>
<p>b) Laboratory techniques, and</p>
<p>Non-response of individuals selected for inclusion in the sample.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="screening">SCREENING<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#screening" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It is the presumptive identification of unrecognized disease or defect by application of tests, examination or procedures which can rapidly be applied.</p>
<p>It can be referred to as the search for unsuspected disease. Screening tests sort out apparently well persons who probably have the disease from those who probably do not.</p>
<p>A screen test is not diagnostic. Those with suspicious positive findings must be referred to their physicians for diagnosis and necessary treatment. Screening is initial examination only and positive respondents require diagnostic examination. The initiative for screening comes from the</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>investigator or a person or an agency providing care rather than from the patient with a complaint. Screening is usually concerned with chronic illness and aims at detecting diseases not under medical care.</p>
<p><strong>Types of Screening:</strong> There are different types of screening each with its own aim:</p>
<ol>
<li><strong>Mass screening:</strong> This is carried out when the tests are applied to a large unselected population.</li>
<li><strong>Multiple or Multiphasic screening:</strong> This type involves a variety of screening tests used at the same time.</li>
<li><strong>Prescriptive Screening:</strong> This type is used in early detection of presumptive healthy individuals of a specific disease that can controlled better if detect early in their natural history. For example, the use of mammography in breast cancer.</li>
</ol>
<p><strong>Characteristics of Screening Tests:</strong> These include:</p>
<ol>
<li>Accuracy – reliability,</li>
<li>Estimates of yields,</li>
<li>Precision,</li>
<li>Reproducibility, Repeatability</li>
<li>sensitivity,</li>
<li>Specificity and Measures of validity</li>
<li>Validity.</li>
</ol>
<p><strong>Validity:</strong> Validity has been defined as the ability a test has to distinguish a patient who have a disease and who doesn't.</p>
<p>Validity has two components:</p>
<ol>
<li>Sensitivity,</li>
<li>Specificity.</li>
</ol>
<p><strong>Sensitivity Test:</strong> It is defined as the ability of a test to identify correctly those who have the disease.</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>137</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Specificity Test: it is defined as the ability of a test to identify correctly those who do not have the disease.</p>
<p>Sensitivity therefore measures false negative rates, while specificity measures false positive rates.</p>
<p>A good screening test must therefore have high sensitivity in order not to miss the few cases of disease that are present, and a high specificity to reduce the number of people with false positive who require further tests.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="true-disease-classification-of-apparently-well-population">TRUE DISEASE CLASSIFICATION OF APPARENTLY WELL POPULATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#true-disease-classification-of-apparently-well-population" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>SCREENING RESULTS</th><th>SENSITIVITY DISEASE</th><th>SPECIFICITY DISEASE</th></tr></thead><tbody><tr><td>Positives</td><td>Positive Tests [True positives]</td><td>False positives [Those without disease - positive tests]</td></tr><tr><td>Negatives</td><td>False negatives [Those with disease - Negative results]</td><td>True negatives [Negative results]</td></tr><tr><td>Totals</td><td>Positive cases [Total known cases]</td><td>Total negatives.</td></tr></tbody></table>
<p>Sensitivity = T.P.</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mrow><mi mathvariant="normal">T</mi><mi mathvariant="normal">.</mi><mi mathvariant="normal">P</mi><mi mathvariant="normal">.</mi></mrow><mo>+</mo><mrow><mi mathvariant="normal">F</mi><mi mathvariant="normal">.</mi><mi mathvariant="normal">P</mi><mi mathvariant="normal">.</mi></mrow></mrow><annotation encoding="application/x-tex">\mathrm{T.P.} + \mathrm{F.P.}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7667em; vertical-align: -0.0833em;"></span><span class="mord"><span class="mord mathrm">T.P.</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6833em;"></span><span class="mord"><span class="mord mathrm">F.P.</span></span></span></span></span></span></div>
<p>Specificity = TN</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mrow><mi mathvariant="normal">T</mi><mi mathvariant="normal">N</mi></mrow><mo>+</mo><mrow><mi mathvariant="normal">F</mi><mi mathvariant="normal">P</mi></mrow></mrow><annotation encoding="application/x-tex">\mathrm{TN} + \mathrm{FP}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7667em; vertical-align: -0.0833em;"></span><span class="mord"><span class="mord mathrm">TN</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6833em;"></span><span class="mord"><span class="mord mathrm">FP</span></span></span></span></span></span></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="concept-of-sensitivity-and-specificity-of-screening-examination">CONCEPT OF SENSITIVITY AND SPECIFICITY OF SCREENING EXAMINATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#concept-of-sensitivity-and-specificity-of-screening-examination" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Example: Discuss a population of 1000 people out of whom 100 have a disease and 900 of them do not have. Curry out a test to identify the people with the disease.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="true-characteristics-in-of-the-population">TRUE CHARACTERISTICS IN OF THE POPULATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#true-characteristics-in-of-the-population" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>RESULTS OF SCREENING</th><th>DISEASED [POSITIVES]</th><th>NOT DISEASED [NEGATIVES]</th><th>TOTALS</th></tr></thead><tbody><tr><td>Positives</td><td>80</td><td>100</td><td>180</td></tr><tr><td>Negatives</td><td>20</td><td>800</td><td>820</td></tr><tr><td>Totals</td><td>100</td><td>900</td><td>1000</td></tr></tbody></table>
<p>Sensitivity = 80 × 100 = 80%</p>
<p>100</p>
<p>138</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Specificity = 800x100 = 89%</p>
<p>900</p>
<p>Acceptable Screening Test: The screening test must be acceptable to the population being tested. It therefore calls for awareness creation of what is to be done. It is also important and ethical that what is discovered must be adequately followed up because it is not good for the people concerned when a screening is undertaken and then the whole matter is dropped. The follow up program must be a prominent part of planning a screening survey.</p>
<p>Yield of a Screening Test: This is the measure of previously unrecognized disease. Other forms of yield are provided by patients with known disease who previously lapsed in treatment.</p>
<p>NB: sensitivity and specificity can also be used to evaluate screening test.</p>
<p>Benefits of Screening Test: These are:</p>
<ol>
<li>They improve prognosis,</li>
<li>They minimize resources.</li>
<li>They help in prevention of Public Health diseases.</li>
<li>They define carriers.</li>
<li>They help avoid radical treatment [very expensive]</li>
<li>They are tools for assurance for those who are disease positive especially those with unpreventable diseases.</li>
<li>They help in identification of the type of intervention programs.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="screening-programs">SCREENING PROGRAMS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#screening-programs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Mammography,</li>
<li>Breast cancer- self- examination,</li>
<li>Ante-natal-mothers screening program,</li>
<li>Pelvic assessment,</li>
<li>Height of ante-natal-mothers to determine pelvic size,</li>
<li>Pap smear for cancer of the cervix,</li>
<li>Head circumference of children for micro and hydrocephalus,</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="8">
<li>Screening of food-handlers for infectious diseases,</li>
<li>Mantoux test for TB,</li>
<li>X-ray for TB of the lungs.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="unit-10">UNIT 10<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#unit-10" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="concept-of-demography">CONCEPT OF DEMOGRAPHY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#concept-of-demography" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Demography can be defined as the scientific study of human populations.</p>
<p>There are two types of demography:</p>
<ol>
<li>Formal demography or demographic analysis and</li>
<li>Population studies.</li>
</ol>
<p><strong>Formal Demography</strong>: This is the scientific study of human populations with respect to their size, distribution, structure, and change.</p>
<p><strong>Size</strong>: refers to the number of persons in the population.</p>
<p><strong>Distribution</strong>: refers to the arrangement of the population in space at a given time – that is geographically or among various residential areas, or occupations.</p>
<p><strong>Structure</strong>: refers to the distribution of population according to sex and age groups.</p>
<p><strong>Change</strong>: refers to growth or decline in the total population or one of its structural units.</p>
<p><strong>Main Features of Formal Demography</strong>: These are:</p>
<ol>
<li>It is fundamentally descriptive or analytic rather than explanatory in nature.</li>
<li>It is concerned with demographic phenomena in isolation, not with their interaction with economic, social or other phenomena.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="common-rates-and-ratios">Common Rates and Ratios<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#common-rates-and-ratios" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>The crude birth rate, the annual number of live births per 1,000 people.</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="2">
<li>
<p>The general fertility rate, the annual number of live births per 1,000 women of childbearing age (often taken to be from 15 to 49 years old, but sometimes from 15 to 44).</p>
</li>
<li>
<p>Age-specific fertility rates, the annual number of live births per 1,000 women in particular age groups (usually age 15-19, 20-24 etc.)</p>
</li>
<li>
<p>The crude death rate, the annual number of deaths per 1,000 people.</p>
</li>
<li>
<p>The infant mortality rate, the annual number of deaths of children less than 1 year old per 1,000 live births.</p>
</li>
<li>
<p>The expectation of life (or life expectancy), the number of years which an individual at a given age could expect to live at present mortality levels.</p>
</li>
<li>
<p>The total fertility rate, the number of live births per woman completing her reproductive life, if her childbearing at each age reflected current age-specific fertility rates.</p>
</li>
<li>
<p>The replacement level fertility, the average number of children a woman must have in order to replace herself with a daughter in the next generation. For example the replacement level fertility in the US is 2.11. This means that 100 women will bear 211 children, 103 of which will be females. About 3% of the alive female infants are expected to decrease before they bear children, thus producing 100 women in the next generation.</p>
</li>
<li>
<p>The gross reproduction rate, the number of daughters who would be born to a woman completing her reproductive life at current age-specific fertility rates.</p>
</li>
<li>
<p>The net reproduction ratio is the expected number of daughters, per newborn prospective mother, who may or may not survive to and through the ages of childbearing.</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5 studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="11">
<li>
<p>A stable population, one that has had constant crude birth and death rates for such a long period of time that the percentage of people in every age class remains constant, or equivalently, the population pyramid has an unchanging structure.</p>
</li>
<li>
<p>A stationary population, one that is both stable and unchanging in size (the difference between crude birth rate and crude death rate is zero.</p>
</li>
</ol>
<p><strong>Basic equation:</strong> Suppose that a country (or other entity) contains <em>Population</em> persons at time <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>t</mi></mrow><annotation encoding="application/x-tex">t</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6151em;"></span><span class="mord mathnormal">t</span></span></span></span></span>. What is the size of the population at time <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>t</mi><mo>+</mo><mn>1</mn></mrow><annotation encoding="application/x-tex">t + 1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6984em; vertical-align: -0.0833em;"></span><span class="mord mathnormal">t</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">1</span></span></span></span></span>?</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mi>P</mi><mi>o</mi><mi>p</mi><mi>u</mi><mi>l</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><msub><mi>n</mi><mrow><mi>t</mi><mo>+</mo><mn>1</mn></mrow></msub><mo>=</mo><mi>P</mi><mi>o</mi><mi>p</mi><mi>u</mi><mi>l</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><msub><mi>n</mi><mi>t</mi></msub><mo>+</mo><mi>N</mi><mi>a</mi><mi>t</mi><mi>u</mi><mi>r</mi><mi>a</mi><mi>l</mi><mi>i</mi><mi>n</mi><mi>c</mi><mi>r</mi><mi>e</mi><mi>a</mi><mi>s</mi><msub><mi>e</mi><mi>t</mi></msub><mo>+</mo><mi>N</mi><mi>e</mi><mi>t</mi><mi>m</mi><mi>i</mi><mi>g</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><msub><mi>n</mi><mi>t</mi></msub></mrow><annotation encoding="application/x-tex">Population_{t+1} = Population_t + Naturalincrease_t + Netmigration_t</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.9028em; vertical-align: -0.2083em;"></span><span class="mord mathnormal" style="margin-right: 0.13889em;">P</span><span class="mord mathnormal">o</span><span class="mord mathnormal">p</span><span class="mord mathnormal">u</span><span class="mord mathnormal" style="margin-right: 0.01968em;">l</span><span class="mord mathnormal">a</span><span class="mord mathnormal">t</span><span class="mord mathnormal">i</span><span class="mord mathnormal">o</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.3011em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mathnormal mtight">t</span><span class="mbin mtight">+</span><span class="mord mtight">1</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.2083em;"><span></span></span></span></span></span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mord mathnormal" style="margin-right: 0.13889em;">P</span><span class="mord mathnormal">o</span><span class="mord mathnormal">p</span><span class="mord mathnormal">u</span><span class="mord mathnormal" style="margin-right: 0.01968em;">l</span><span class="mord mathnormal">a</span><span class="mord mathnormal">t</span><span class="mord mathnormal">i</span><span class="mord mathnormal">o</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.2806em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight">t</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.8444em; vertical-align: -0.15em;"></span><span class="mord mathnormal" style="margin-right: 0.10903em;">N</span><span class="mord mathnormal">a</span><span class="mord mathnormal">t</span><span class="mord mathnormal">u</span><span class="mord mathnormal" style="margin-right: 0.02778em;">r</span><span class="mord mathnormal">a</span><span class="mord mathnormal" style="margin-right: 0.01968em;">l</span><span class="mord mathnormal">in</span><span class="mord mathnormal">cre</span><span class="mord mathnormal">a</span><span class="mord mathnormal">s</span><span class="mord"><span class="mord mathnormal">e</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.2806em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight">t</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.8778em; vertical-align: -0.1944em;"></span><span class="mord mathnormal" style="margin-right: 0.10903em;">N</span><span class="mord mathnormal">e</span><span class="mord mathnormal">t</span><span class="mord mathnormal">mi</span><span class="mord mathnormal" style="margin-right: 0.03588em;">g</span><span class="mord mathnormal" style="margin-right: 0.02778em;">r</span><span class="mord mathnormal">a</span><span class="mord mathnormal">t</span><span class="mord mathnormal">i</span><span class="mord mathnormal">o</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.2806em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight">t</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span></div>
<p>Natural increase from time <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>t</mi></mrow><annotation encoding="application/x-tex">t</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6151em;"></span><span class="mord mathnormal">t</span></span></span></span></span> to <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>t</mi><mo>+</mo><mn>1</mn></mrow><annotation encoding="application/x-tex">t + 1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6984em; vertical-align: -0.0833em;"></span><span class="mord mathnormal">t</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">1</span></span></span></span></span>:</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mi>N</mi><mi>a</mi><mi>t</mi><mi>u</mi><mi>r</mi><mi>a</mi><mi>l</mi><mi>i</mi><mi>n</mi><mi>c</mi><mi>r</mi><mi>e</mi><mi>a</mi><mi>s</mi><msub><mi>e</mi><mi>t</mi></msub><mo>=</mo><mi>B</mi><mi>i</mi><mi>r</mi><mi>t</mi><mi>h</mi><msub><mi>s</mi><mi>t</mi></msub><mo>−</mo><mi>D</mi><mi>e</mi><mi>a</mi><mi>t</mi><mi>h</mi><msub><mi>s</mi><mi>t</mi></msub></mrow><annotation encoding="application/x-tex">Naturalincrease_t = Births_t - Deaths_t</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8444em; vertical-align: -0.15em;"></span><span class="mord mathnormal" style="margin-right: 0.10903em;">N</span><span class="mord mathnormal">a</span><span class="mord mathnormal">t</span><span class="mord mathnormal">u</span><span class="mord mathnormal" style="margin-right: 0.02778em;">r</span><span class="mord mathnormal">a</span><span class="mord mathnormal" style="margin-right: 0.01968em;">l</span><span class="mord mathnormal">in</span><span class="mord mathnormal">cre</span><span class="mord mathnormal">a</span><span class="mord mathnormal">s</span><span class="mord"><span class="mord mathnormal">e</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.2806em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight">t</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.8444em; vertical-align: -0.15em;"></span><span class="mord mathnormal" style="margin-right: 0.05017em;">B</span><span class="mord mathnormal">i</span><span class="mord mathnormal" style="margin-right: 0.02778em;">r</span><span class="mord mathnormal">t</span><span class="mord mathnormal">h</span><span class="mord"><span class="mord mathnormal">s</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.2806em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight">t</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">−</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.8444em; vertical-align: -0.15em;"></span><span class="mord mathnormal">De</span><span class="mord mathnormal">a</span><span class="mord mathnormal">t</span><span class="mord mathnormal">h</span><span class="mord"><span class="mord mathnormal">s</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.2806em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight">t</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span></div>
<p>Net migration from time <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>t</mi></mrow><annotation encoding="application/x-tex">t</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6151em;"></span><span class="mord mathnormal">t</span></span></span></span></span> to <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mi>t</mi><mo>+</mo><mn>1</mn></mrow><annotation encoding="application/x-tex">t + 1</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6984em; vertical-align: -0.0833em;"></span><span class="mord mathnormal">t</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">1</span></span></span></span></span>:</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mi>N</mi><mi>e</mi><mi>t</mi><mi>m</mi><mi>i</mi><mi>g</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><msub><mi>n</mi><mi>t</mi></msub><mo>=</mo><mi>I</mi><mi>m</mi><mi>m</mi><mi>i</mi><mi>g</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><msub><mi>n</mi><mi>t</mi></msub><mo>−</mo><mi>E</mi><mi>m</mi><mi>i</mi><mi>g</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><msub><mi>n</mi><mi>t</mi></msub></mrow><annotation encoding="application/x-tex">Netmigration_t = Immigration_t - Emigration_t</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8778em; vertical-align: -0.1944em;"></span><span class="mord mathnormal" style="margin-right: 0.10903em;">N</span><span class="mord mathnormal">e</span><span class="mord mathnormal">t</span><span class="mord mathnormal">mi</span><span class="mord mathnormal" style="margin-right: 0.03588em;">g</span><span class="mord mathnormal" style="margin-right: 0.02778em;">r</span><span class="mord mathnormal">a</span><span class="mord mathnormal">t</span><span class="mord mathnormal">i</span><span class="mord mathnormal">o</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.2806em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight">t</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.8778em; vertical-align: -0.1944em;"></span><span class="mord mathnormal" style="margin-right: 0.07847em;">I</span><span class="mord mathnormal">mmi</span><span class="mord mathnormal" style="margin-right: 0.03588em;">g</span><span class="mord mathnormal" style="margin-right: 0.02778em;">r</span><span class="mord mathnormal">a</span><span class="mord mathnormal">t</span><span class="mord mathnormal">i</span><span class="mord mathnormal">o</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.2806em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight">t</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">−</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.8778em; vertical-align: -0.1944em;"></span><span class="mord mathnormal" style="margin-right: 0.05764em;">E</span><span class="mord mathnormal">mi</span><span class="mord mathnormal" style="margin-right: 0.03588em;">g</span><span class="mord mathnormal" style="margin-right: 0.02778em;">r</span><span class="mord mathnormal">a</span><span class="mord mathnormal">t</span><span class="mord mathnormal">i</span><span class="mord mathnormal">o</span><span class="mord"><span class="mord mathnormal">n</span><span class="msupsub"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.2806em;"><span style="top: -2.55em; margin-left: 0em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mathnormal mtight">t</span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.15em;"><span></span></span></span></span></span></span></span></span></span></span></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="population-studies">POPULATION STUDIES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#population-studies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Demography is scientific study of human population</p>
<p>It focuses on 3 phenomena:</p>
<p>i. Changes in population size
ii. Composition of population
iii. Population distribution in space</p>
<p>Important ‘demographic processes’ include: fertility, mortality, marriage, education &amp; social mobility</p>
<p>In a broader sense, additional characteristics such as ethnicity (race, mother tongue), social characteristics (marital status, literacy, educational attainment, women’s status), and economic characteristics (employment status, occupation, income) also need to be considered when describing population characteristics:</p>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>Census</li>
<li>National Survey</li>
<li>Registration of vital events</li>
<li>Demographic Studies</li>
</ol>
<p>The wider scope of demography is concerned only with population variables but also with relationships between population changes and other variables e.g.</p>
<ol>
<li>Social,</li>
<li>Economic,</li>
<li>Political,</li>
<li>Biological,</li>
<li>Genetic,</li>
<li>Geographical,</li>
<li>Intelligence and</li>
<li>Health.</li>
</ol>
<p>Population studies extend to applications of its data findings in a number of fields including the study of problems associated with demographic processes. The field of demographic studies is as broad as the interest in determining the consequences of population trends.</p>
<p>In a broader sense, additional characteristics such as ethnicity (race, mother tongue), social characteristics (marital status, literacy, educational attainment, women's status), and economic characteristics (employment status, occupation, income) also need to be considered when describing population characteristics:</p>
<ol>
<li>Census</li>
<li>National Survey</li>
<li>Registration of vital events</li>
<li>Demographic Studies</li>
</ol>
<p>Population studies are concerned not only with population variables but also with relationships between population changes &amp; other variables – social, economic, political, biological, genetic, geographical, environmental, health &amp; the like</p>
<p>Definition of Key Words</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol>
<li>Size refers to the number of persons in the population</li>
<li>Distribution refers to the arrangement of the population in space at a given time</li>
<li>Structure is the distribution of population among its sex &amp; age groupings</li>
<li>Change is the growth or decline of the total population or one of its structural units. The components of change total population are births, deaths, &amp; migrations</li>
<li>Age-Sex Composition of a population refers to the proportion of males &amp; females in different age-groups. It has a direct bearing on social, economic, health needs of communities or countries. In an "old" population, for example, the society has to arrange for the care of the elderly, &amp; the country's health system must be organized accordingly. In a "young" population, on the other hand, the country has to provide more schools, immunizations, &amp; economic support for the young</li>
<li>Net-Migration refers to the total number of persons added or subtracted from a population as a result of the combined effect of immigration &amp; emigration</li>
<li>Urbanization refers to mass migration of rural population into urban centers resulting in increasing the urban population &amp; growth of cities</li>
<li>Population Growth Rate (%/ year) is the rate at which a given population is expected to increase in a given period of time.</li>
<li>Population Doubling Time refers to the time that would take for a population to double. Because the population increase is on the compound interest formula, a 1% per year increase would cause the population to double in about 70 years. If the population is increasing at 3% per year, than the doubling time will be 23.3 years</li>
<li>Population Pyramid is a pictorial presentation of the age-sex composition of a population</li>
<li>Replacement Level Fertility (or Zero population growth) is activated when a couple has two births during their reproductive life, just enough to replace themselves. At a community scale, the replacement level is considered when there are, on the average, 2.1 births per woman, to compensate for child deaths</li>
<li>Momentum of Population Growth is the characteristic of population growth when a sharp decline in births does not bring in an immediate reduction in natural increase</li>
</ol>
<p>There are four ways in which the number of people in an area can change during two time periods t0 &amp; t1</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mrow><mi mathvariant="normal">P</mi><mi mathvariant="normal">t</mi></mrow><mn>1</mn><mo>=</mo><mrow><mi mathvariant="normal">P</mi><mi mathvariant="normal">t</mi><mi mathvariant="normal">o</mi></mrow><mo>+</mo><mo stretchy="false">(</mo><mi mathvariant="normal">B</mi><mo>−</mo><mi mathvariant="normal">D</mi><mo stretchy="false">)</mo><mo>+</mo><mo stretchy="false">(</mo><mrow><mi mathvariant="normal">I</mi><mi mathvariant="normal">M</mi></mrow><mo>−</mo><mrow><mi mathvariant="normal">O</mi><mi mathvariant="normal">M</mi></mrow><mo stretchy="false">)</mo></mrow><annotation encoding="application/x-tex">\mathrm{Pt}1 = \mathrm{Pto} + (\mathrm{B} - \mathrm{D}) + (\mathrm{IM} - \mathrm{OM})</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6833em;"></span><span class="mord"><span class="mord mathrm">Pt</span></span><span class="mord">1</span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.7667em; vertical-align: -0.0833em;"></span><span class="mord"><span class="mord mathrm">Pto</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mopen">(</span><span class="mord mathrm">B</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">−</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord mathrm">D</span><span class="mclose">)</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mopen">(</span><span class="mord"><span class="mord mathrm">IM</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">−</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 1em; vertical-align: -0.25em;"></span><span class="mord"><span class="mord mathrm">OM</span></span><span class="mclose">)</span></span></span></span></span></div>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>B = number of live births to mothers in the area</p>
<p>D = number of residents died</p>
<p>IM = number of persons moving into the area fro permanent residence</p>
<p>OM = number of persons moving out of the area to live elsewhere</p>
<p>Thus the population of an area may change due to natural reasons (B – D) known as natural increase or due to migration (IM – OM) known as net-migration. Subsequently:</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mtext>Population&nbsp;Growth</mtext><mo>=</mo><mtext>Natural&nbsp;Increase</mtext><mo>+</mo><mtext>Net&nbsp;Migration</mtext></mrow><annotation encoding="application/x-tex">\text{Population Growth} = \text{Natural Increase} + \text{Net Migration}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mord text"><span class="mord">Population&nbsp;Growth</span></span><span class="mspace" style="margin-right: 0.2778em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.7778em; vertical-align: -0.0833em;"></span><span class="mord text"><span class="mord">Natural&nbsp;Increase</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.8778em; vertical-align: -0.1944em;"></span><span class="mord text"><span class="mord">Net&nbsp;Migration</span></span></span></span></span></span></div>
<p>While characteristic is an attribute of an individual (e.g. male, young, healthy, employed etc), composition is a property of a group of people. It describes how the total given population is constituted (e.g. 51% males, 20% below age 5, 85% healthy 7&amp; 30% employed etc).</p>
<p>Dependency Ratio is an index summarizing an age distribution. Strictly, this is the ratio of population who are economically not active to those who are economically active. However, due to the difficulties in defining economic activity in many countries, especially when international comparisons are made, a ratio of age group is used instead:</p>
<p>Population Composition</p>
<p>Dependency Ratio</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mo>=</mo><mtext>Children</mtext><mo>+</mo><mtext>Elderly</mtext><mo>×</mo><mn>100</mn></mrow><annotation encoding="application/x-tex">= \text{Children} + \text{Elderly} \times 100</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.3669em;"></span><span class="mrel">=</span><span class="mspace" style="margin-right: 0.2778em;"></span></span><span class="base"><span class="strut" style="height: 0.7778em; vertical-align: -0.0833em;"></span><span class="mord text"><span class="mord">Children</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.8889em; vertical-align: -0.1944em;"></span><span class="mord text"><span class="mord">Elderly</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">100</span></span></span></span></span></div>
<p>Working Age</p>
<div class="math math-display"><span class="katex-error" title="ParseError: KaTeX parse error: Expected 'EOF', got '&amp;' at position 35: …5} + 65 \text{ &amp;̲amp; above} \ti…" style="color: rgb(204, 0, 0);">= \text{Pop below 15} + 65 \text{ &amp;amp; above} \times 100</span></div>
<p>Pop 15 – 64 years</p>
<p>Dependency Ratio of Pakistan = 95.1</p>
<p>Dependency Ratio of UK = 66.5</p>
<p>&gt; Sex Ratio: The overall sex ratio is simply the ratio of males to females in the population &amp; is calculated by taking the number of males in a population &amp; dividing it by the number of females in the same population</p>
<p>Sex Ratio = <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mfrac><mtext>Number&nbsp;of&nbsp;Males</mtext><mtext>Number&nbsp;of&nbsp;Females</mtext></mfrac></mrow><annotation encoding="application/x-tex">\frac{\text{Number of Males}}{\text{Number of Females}}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 1.2251em; vertical-align: -0.345em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 0.8801em;"><span style="top: -2.655em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Number&nbsp;of&nbsp;Females</span></span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.394em;"><span class="pstrut" style="height: 3em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord text mtight"><span class="mord mtight">Number&nbsp;of&nbsp;Males</span></span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.345em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span></span></span></span></span> × 100</p>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>5</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>Demographic Cycle: World history suggests that every nation passes through a demographic cycle.</p>
<p>The stages are:</p>
<ol>
<li>High Stationary Stage: characterized by high birth rate and high death rate</li>
<li>Early Expanding: The death rate begins to decline while birth rate remains unchanged</li>
<li>Late Expanding: The death rate declined still further and birth rate tend to fall</li>
<li>Low Stationary Stage: Low birth and low death rates</li>
<li>Declining Stage: birth rate is lower than the death rate and population starts declining</li>
</ol>
<p>&gt; Old Balance: (High fertility &amp; High Mortality). A large supply of births was necessary to compensate for the large number of deaths. MMR &amp; IMR extremely high
&gt; New Balance: (Low fertility &amp; Low Mortality) Represents an improved condition of human efficiency &amp; health, with fewer deaths considerably less efforts required to bring a generation to maturity. Production of agricultural &amp; industrial commodities is greater &amp; life style is more comfortable
&gt; Imbalance: (High Fertility &amp; Low Mortality) In between old &amp; new balance is the period of rapid natural increase. This growth is helpful for under-populated nations. Too fast growth of population leading economic, social &amp; political chaos (being faced by numerous developing countries including Pakistan)</p>
<ol>
<li>World Population Trend/ Population Dynamics: The rampant population growth is viewed as the greatest obstacle to the economic &amp; social development of the majority of peoples in the underdeveloped world</li>
</ol>
<p>Approximately 95% of population growth is in developing countries</p>
<p>Currently, 1/3 of the world population is &lt; 15, &amp; will soon enter the reproductive bracket, giving more potential for population growth</p>
<p>The expected number of births per woman, at current fertility rate is:</p>
<table><thead><tr><th>Africa</th><th>6.1</th></tr></thead><tbody><tr><td>Asia</td><td>3.2</td></tr><tr><td>Latin America</td><td>3.4</td></tr><tr><td></td><td>146</td></tr></tbody></table>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>North America
2.0
Europe
1.6</p>
<p>Economic implications: Due to population explosion there are:</p>
<ol>
<li>Short term pressure affects during 2-3 decade</li>
<li>Long term over next century and beyond economic affects</li>
</ol>
<p>Demographic Implications: In population with low birth and death rate, 20-30% of population is under 15; 9-13% is 65 or more. The median age for this population is 32 and there is increased demand for senior citizen</p>
<p>Environmental / Ecological Implications</p>
<p>Due to population explosion there are</p>
<p>Short term pressure affects during 2-3 decade</p>
<p>Long term over next century and beyond economic affects</p>
<p>Social / Political Implications</p>
<p>In population with low birth and death rate, 20-30% of population is under 15; 9-13% is 65 or more. The median age for this population is 32 and there is increased demand for senior citizens</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="uses-of-demographic-information">USES OF DEMOGRAPHIC INFORMATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#uses-of-demographic-information" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Demographic information can be used in:</p>
<ol>
<li>Economic Planning: by providing basic data needed planning:</li>
</ol>
<p>a) Population size,
b) Growth rate,
c) Available labor force.</p>
<ol start="2">
<li>Policy making: the data on growth rate for example can be used by the government to encourage family planning.</li>
</ol>
<p>147
Prepared by O.E. Akoth</p>
<p>This document is available on
studocu
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="3">
<li>
<p>Administrative purposes: whether or not to sub-divide an administrative area mainly depends on the population to be served.</p>
</li>
<li>
<p>Political purposes: the number of constituencies in a given district depends on the population of the district.</p>
</li>
<li>
<p>Distribution of Social welfare: in institutions, facilities and services e.g. health, education, security, water supplies, transport, e.t.c. depend on the population of the area:</p>
</li>
</ol>
<p>i. The number of health institutions to be established in a given area depends on the population to be served.</p>
<p>ii. The number of primary schools to be established in an area depends on the population of the primary school going age.</p>
<p>iii. The capacity of water supply installation to supply an urban center depends on the population of the center’s catchment area besides other factors.</p>
<ol start="6">
<li>Health indicators: the health status of a community is easily portrayed by the various rates calculated in demography e.g.</li>
</ol>
<p>i. Mortality rates,</p>
<p>ii. Fertility rates,</p>
<p>iii. Morbidity rates,</p>
<p>iv. Birth rates and</p>
<p>v. Life expectancy.</p>
<ol start="7">
<li>
<p>Social Research: Any social research must make use of some demographic information.</p>
</li>
<li>
<p>Distribution of communal Burden: a country like Kenya which has relied on fund raising [Harambee] for development of most of the social infrastructures like schools and</p>
</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<p>health institutions has to allocate quotas to divisions, locations, sub-locations or villages primarily according to their populations.</p>
<ol start="9">
<li>Distribution of human resources: to determine human resources in terms of labor as a factor or economic production, its potential and actual exploitation [labor force, employed, underemployed and unemployed].</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="measurement-of-human-population">MEASUREMENT OF HUMAN POPULATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#measurement-of-human-population" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Health services apply demographic studies in several ways e.g.</p>
<p><strong>Fertility Measures</strong>: of a group of women reveals their performance in child bearing which in turn implies how their health may directly or indirectly be affected by the revealed fertility rate.</p>
<p><strong>Mortality Measure</strong>: of a population would reveal at what rate the people are dying. High mortality rate would indicate poor health which in turn would call for investigation to the causes in order to institute corrective measures.</p>
<p><strong>Average Life expectancy</strong>: of individual in a society indicates the general health status of the society.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="sources-of-demographic-data">SOURCES OF DEMOGRAPHIC DATA<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#sources-of-demographic-data" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The raw materials of informal demography are data collected in:</p>
<ol>
<li>Population census,</li>
<li>Demographic sample survey,</li>
<li>Registration of vital events e.g.
i. Births,
ii. Deaths,
iii. Migrations and
iv. Marriages.</li>
<li>Compulsory national social security scheme records,</li>
<li>Records of establishments,</li>
</ol>
<p>Prepared by O.E. Akoth</p>
<p>This document is available on</p>
<p>8</p>
<p>studocu</p>
<p>Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p>
<ol start="6">
<li>Statutory registration of persons,</li>
<li>Hospital records,</li>
<li>Various publications e.g. U.N. statistical year book.</li>
</ol>
<p>Prepared by O.E. Akoth
Downloaded by Patrick Ngobiro (<a href="mailto:pngobiro@gmail.com" target="_blank" rel="noopener noreferrer">pngobiro@gmail.com</a>)</p></div></div></div></div></div></div></div><div data-testid="stAppIframeResizerAnchor" data-iframe-height="true" class="st-emotion-cache-1dumvfu eht7o1d9"></div></section></div></div></div><div data-testid="portal" id="portal" class="st-emotion-cache-1q6lfs0 e19n7mk11"></div></div><div class=""></div></div>
  

</body></html>